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ABSTRACT 
ROLES OF PROTEIN FACTORS IN REGULATION OF IMPRINTED GENE 
EXPRESSION 
Shu Lin 
Marisa S. Bartolomei 
Genomic imprinting is an important epigenetic phenomenon in which only one 
parental allele is expressed. Allele-specific DNA methylation often exists in imprinted 
control regions (ICRs) and is required for properly imprinted expression. Imprinting 
control in mammals involves an insulator mechanism that requires CTCF or a long 
ncRNA silencing mechanism. In this dissertation, I studied functions of protein factors in 
genomic imprinting. First, methylated DNA binding proteins are involved in maintenance 
of DNA methylation at imprinted loci and required for selective silencing of one specific 
allele. We showed that MBD3 was localized to paternal H19 ICR. By RNA interference 
experiments in preimplantation embryos, we showed that MBD3 and its NuRD complex 
cofactor MTA2 were required for maintenance of the paternal methylation at the H19 
ICR, and for silencing of the paternal H19. MTA2 is also required for Peg3 allelic 
expression. These results demonstrate new roles of the NuRD complex in genomic 
imprinting. Moreover, I showed allele-specific associations of MBD1 and Kaiso with 
imprinted loci, implicating functional requirements of these proteins in imprinted 
regulation. Second, I demonstrated colocalization of CTCF and the cohesin complex at 
three imprinted loci. CTCF and cohesins preferentially bind to the unmethylated allele of 
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H19 ICR and Gtl2 DMR, and both alleles of KvDMR1 in mouse embryonic fibroblast 
cells (MEFs). To determine the functional importance of CTCF and cohesins, CTCF and 
cohesins were depleted in MEFs. Monoallelic expression of imprinted genes was 
maintained. However, mRNA levels for imprinted genes were typically increased; for 
H19 and Igf2 the increased expression was independent of the CTCF binding sites in the 
ICR. These experiments demonstrate an unappreciated role for CTCF and cohesins in the 
repression of imprinted genes in somatic cells. Finally, I have established F1 hybrid 
trophoblast stem (TS) cell lines that can be used as a model system to further study 
functions of protein factors in genomic imprinting and extraembryonic development. 
Overall, this dissertation has provided new and important insights into roles of protein 
factors in regulation of imprinted gene expression. 
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Chapter 1. Introduction 
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1.1.  Genomic Imprinting 
Genomic imprinting is an epigenetic phenomenon in which certain genes, termed 
imprinted genes, are expressed in a parent-of-origin dependent manner. In mammals and 
flowering plants, genomic imprinting occurs in embryonic tissues as well as 
embryo-nourishing tissues: the placenta and the endosperm, respectively [reviewed in 
(Ideraabdullah et al., 2008; Köhler and Weinhofer-Molisch, 2010)]. Loss of imprinting 
has been reported in a number of human diseases including cancers and genetic disorders 
[reviewed in (Butler, 2009; Lim and Maher, 2010)]. Imprinted gene expression requires 
establishment of imprinting marks in the germ line and the early embryo, and 
subsequently, maintenance of these marks during cell division in somatic tissues. In 
extraembryonic tissues, imprinting marks persist without reprogramming, because the 
placenta and the endosperm are terminally differentiated. Differential DNA methylation 
and posttranslational histone modifications are the best-established epigenetic marks that 
are critical for the allele-specific expression of imprinted genes (Ideraabdullah et al., 
2008; Köhler and Weinhofer-Molisch, 2010). In mammals, differential sex-dependent 
deposition of DNA methylation marks happens during gametogenesis at a group of 
cis-regulatory elements (germ-line differentially methylated regions/DMRs) that are 
required for proper imprinted expression. In contrast to mammals, plant imprinting marks 
are created by differential removal of DNA methylation at the end of female 
gametogenesis. 
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1.1.1. Genomic imprinting and evolution 
Genomic imprinting is a phenomenon that only exists, as far as we currently know, in 
mammals and flowering plants. Imprinted genes express one copy of the gene; therefore, 
any deleterious mutations on the active allele become dominant. Because such a process 
overcomes the advantages of diploidy, the question arises as to why genomic imprinting 
is evolutionary beneficial. Among the different theories that try to explain this paradox, 
the parental conflict theory and the defense theory have received the most serious 
consideration.  
1.1.1.1. The parental conflict theory 
Evidence for genomic imprinting in mouse came from studies demonstrating that 
both maternal and paternal genomes are essential for successful development of the 
conceptus and normal phenotype of the adult (McGrath and Solter, 1984; Surani et al., 
1984; Barton et al., 1984; Cattanach and Kirk, 1985). Embryos with two female or male 
pronuclei were generated using nuclear transplantation. In embryos with two female 
genetic complements, embryonic development was good but extraembryonic 
development was poor; in embryos with two male genetic complements, the reverse was 
true. A similar phenomenon was observed in flowering plants by interploidy crosses, in 
which an increased dosage of paternal chromosomes promotes endosperm 
(extraembryonic lineage) development, whereas an increased dosage of maternal 
chromosomes represses endosperm development (Birchler, 1993; Scott et al., 1998). 
Based on these observations, the parental conflict theory or the kinship theory was 
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developed, which suggests that genomic imprinting serves to control the nutrient flow 
from the mother to the progeny, with maternally and paternally expressed genes having 
different roles in nutrient allocation (Haig and Westoby, 1989; Trivers and Burt, 1999). 
Whereas paternally expressed imprinted genes are suggested to promote nutrient flow to 
the embryo, maternally expressed imprinted genes reduce nutrient flow to the embryo, 
preserving nutrition for the mother. 
In the three groups of living mammals, monotremes, marsupials and eutherians, there 
is a correlation between complexities of the extraembryonic tissues and levels of genomic 
imprinting (Renfree et al., 2009). The egg-laying monotremes have a simple 
extraembryonic structure that is similar to the reptiles and birds. The monotremes lay 
eggs after a brief period of intrauterine growth supported by the uterine secretions 
transferred across the yolk sac (Renfree et al., 2009). Marsupials have a brief intrauterine 
life and are born tiny and altricial, but have sophisticated lactation that supports the 
young. The marsupial placenta has a vascularized yolk-sac, secretes hormones, and is 
essential for fetal development. However, it is short lived and does not support the full 
term of development (Freyer et al., 2003). Young eutherians are nurtured in utero for an 
extended period of time and most are delivered highly developed. The eutherian placenta 
has various adaptations of the chorionic membrane, which is vascularized by the allantois 
to form the chorioallantoic placenta. The eutherian placenta not only contributes to the 
nutrient and gas exchange between mother and fetus, but is also able to mediate immune 
responses (Renfree et al., 2009). Genomic imprinting is present in eutherians and 
marsupials, but has not yet been identified in monotremes. Marsupials generally have 
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fewer imprinted genes than eutherians [reviewed in (Renfree et al., 2009)]. Furthermore, 
many imprinted genes play important roles in embryonic and extraembryonic 
development, as well as maternal nursing behaviors (Barlow DP and Bartolomei MS, 
2007). A recent report showed functional dominance of maternally methylated DMRs (as 
compared with the paternally methylated DMRs) at the time of chorioallantoic placenta 
formation (Schulz et al., 2010). By comparison of 15 DMRs in 16 eutherian species, the 
authors showed that paternally methylated DMRs tend to lose CpGs, whereas maternally 
methylated DMRs tend to gain CpGs during evolution. The authors concluded that 
functional dominance of maternally methylated DMRs is the consequence of the selective 
pressure to tightly regulate the expression of genes affecting the fetal-maternal interface 
once the placenta had evolved, therefore supporting the parent conflict theory.  
Taken together, in favor of the parental conflict theory, evolution of genomic 
imprinting correlates well with viviparity and placenta. 
1.1.1.2. The defense theory 
In contrast, imprinting might have evolved as a by-product of a defense mechanism 
destined to silence invading foreign DNA in the gametes and the embryos (the defense 
theory) (Barlow, 1993). Recent studies in both mammals and flowering plants provide 
substantial evidence for the defense theory. Paternal expressed 10 (Peg10) is a 
retrotransposon-derived imprinted gene that has an essential role for the mouse placenta 
(Ono et al., 2003). In the common ancestors of eutherians and marsupials, Peg10 was 
inserted next to the Sarcoglycan epsilon (Sgce) gene (Suzuki et al., 2007). Suzuki et al. 
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showed that Peg10 is imprinted in marsupials and identified a DMR that covers the 
Peg10 promoter. DMRs are also found in many other imprinted loci and a subset of 
DMRs is required for imprinting control (see 1.1.3). Importantly, the Peg10 DMR 
extends to the neighboring Sgce promoter in eutherians and Sgce is imprinted in 
eutherians but not in marsupials. Therefore, imprinted expression of Peg10 and Sgce 
correlates well with the repression of exogenous DNA sequences by DNA methylation. 
Moreover, comparison of repeat elements in imprinted loci revealed significant difference 
between monotremes and therians, that monotremes have fewer repeats of certain classes 
than marsupials and eutherians (Pask et al., 2009). In addition, imprinted genes in plants 
are located in the vicinity of transposons or repeat sequences, suggesting that the 
insertion of transposon or repeat sequences was a prerequisite for imprinting evolution 
(Gehring et al., 2009; Hsieh et al., 2009).  
Taken together, the parental conflict theory may explain why genomic imprinting is 
important in evolution, while the defense theory may explain how imprinting is 
manifested. 
1.1.2. Genomic imprinting and human diseases 
Imprinted genes are expressed from only one parental allele. Such imprinted 
expression is tightly regulated by a number of different cis-regulatory elements, as well 
as epigenetic marks such as DNA methylation. Therefore, mutations or changes in the 
epigenome that occur in imprinted loci may be deleterious. Indeed, a number of human 
diseases and syndromes are associated with imprinted genes. These include human 
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cancers [reviewed in (Lim and Maher, 2010)], as well as genetic disorders such as: 
Beckwith-Wiedemann Syndrome (BWS), Silver-Russell Syndrome (SRS), Prader-Willi 
Syndrome (PWS), Angelman Syndrome (AS), Albright hereditary osteodystrophy and 
uniparental disomy 14 [reviewed in (Butler, 2009)]. Typically, these imprinting-related 
diseases are associated with DNA methylation abnormalities at imprinted loci, which are 
caused by DNA duplications, inversions, insertions, micro-deletions and translocations. 
For example, many BWS patients have abnormal methylation of genes in the 
Chromosome (Chr) 11p15.5 region, specifically at the H19/IGF2 and 
KCNQ1/KCNQ1OT1 imprinting loci. Biallelic expression of INSULIN LIKE GROWTH 
FACTOR 2 (IGF2), KCNQ1 OVERLAPPING TRANSCRIPT 1 (KCNQ1OT1) and reduced 
expression of CYCLIN-DEPENDENT KNASE INHIBITOR 1 (CDKN1C) are common in 
BWS patients.  
In addition, increased numbers of imprinting disorders (especially BWS and AS) 
have also been associated with children conceived through Assisted Reproductive 
Technologies (ART) (Owen and Segars, 2009). ART involves superovulation of the 
mother, in vitro fertilizations (IVF), intracytoplasmic sperm injections (ICSI) and in vitro 
culture of eggs and/or embryos. A number of ART studies in human and mouse have 
discovered gain or loss of DNA methylation in imprinted loci of ART mouse embryos 
and patients (Mann et al., 2004; Rivera et al., 2008; Owen and Segars, 2009; 
Market-Velker et al., 2010a, b). Therefore, investigating the mechanisms of genomic 
imprinting, especially DNA methylation-dependent mechanisms, will provide important 
knowledge for human health.  
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1.1.3. Imprinted regulation in mammals 
In mammals, approximately 100 imprinted genes have been identified and many are 
located within about 1 megabase (Mb) clusters that harbor DMRs [reviewed in 
(Bartolomei, 2009)]. Within a cluster, imprinted gene expression is co-regulated by a 
cis-acting element, designated imprinting control region (ICR), which is also a DMR. 
The ICR, typically a few kilobase (kb) pairs in length, acquires parental allele-specific 
DNA methylation in the germline and exhibits posttranslational histone modifications. 
Deletion of ICRs results in loss of imprinting of linked genes (Wutz et al., 1997; 
Thorvaldsen et al., 1998; Fitzpatrick et al., 2002; Lin et al., 2003; Williamson et al., 2006; 
Mancini-Dinardo et al., 2006). In addition to the ICR, many imprinted loci harbor DMRs 
that are not required for the imprinting control. These DMRs do not acquire differential 
methylation during gametogenesis and/or do not survive the genome-wide 
reprogramming after fertilization (Bartolomei, 2009). For example, the promoters of 
Cdkn1c (Bhogal et al., 2004) and Insulin like growth factor 2 receptor (Igf2r) (Stöger et 
al., 1993) obtain DNA methylation after fertilization and are likely a consequence of 
transcriptional silencing of the repressed allele. Additionally, the Igf2 DMR2 is 
methylated during spermatogenesis, then demethylated together with other paternal 
sequences immediately after fertilization, and is subsequently remethylated during 
post-implantation development (Oswald et al., 2000). 
Two major mechanisms that regulate imprinted gene clusters have been characterized 
in mammals (Bartolomei, 2009). One employs allele-specific insulation mediated by the 
insulator protein CTCF. The second mechanism requires the transcription of a long 
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non-coding RNA (ncRNA), which silences genes in cis, allowing the alternate allele to be 
expressed. Some clusters employ aspects of both mechanisms. Recently, a new 
mechanism employing allele-specific alternative polyadenylation sites has also been 
described (Wood et al., 2008). 
1.1.3.1. The insulator mechanism 
The insulator mechanism of imprinted regulation has been well described at the 
H19/Igf2 locus (Fig. 1.1). In this context, an insulator is a DNA element that blocks 
enhancer-promoter interaction when placed between the gene and enhancer element 
(Chung et al., 1993). The H19/Igf2 locus is located on human Chr 11p15.5 and mouse 
Chr 7F. H19 encodes a ~2.2 kb ncRNA expressed from the maternal chromosome 
(Bartolomei et al., 1991), and is a primary microRNA precursor for miR-675 (Mineno et 
al., 2006; Cai and Cullen, 2007). The Igf2 gene encodes a fetal growth factor expressed 
from the paternal chromosome (DeChiara et al., 1990, 1991). The imprinted expression 
of the mouse locus, which is largely conserved in humans, is controlled by two elements, 
the ICR located 2 kb upstream of H19 but still downstream of Igf2 (Thorvaldsen et al., 
1998, 2002), and the shared enhancers located downstream of H19 (Leighton et al., 1995; 
Ishihara et al., 2000; Kaffer et al., 2000, 2001). The ICR, 2 kb in length, is methylated on 
the paternal chromosome. This methylation is established in the gametes and maintained 
throughout development (Tremblay et al., 1995, 1997). When the ICR is deleted from the 
maternal chromosome, H19 expression is reduced and Igf2 is expressed biallelically; 
conversely, when the ICR is deleted from the paternal chromosome, H19 is expressed on 
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Figure 1.1 The mouse H19/Igf2 imprinting locus 
Schematic showing the mouse H19/Igf2 locus. Igf2 is located about 85 kb upstream of H19. The 
endodermal enhancers are shown (the mesodermal enhancers are located further downstream of 
H19). On the maternal chromosome, the ICR recruits CTCF through four binding sites. A 
CTCF-dependent insulator is formed on the ICR, blocking interaction between the Igf2 promoter 
and 3’ shared enhancers. On the paternal chromosome, DNA methylation on the ICR repels 
CTCF binding, allowing Igf2 activation by the enhancers. In addition, paternal ICR methylation 
spreads to the H19 promoter and therefore silences H19. 
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both alleles and Igf2 expression is reduced (Thorvaldsen et al., 1998, 2002). Furthermore, 
when an extra set of the endodermal enhancers are inserted between the ICR and Igf2, 
Igf2 is expressed from both alleles (in endodermal tissues) while H19 expression is not 
affected (Webber et al., 1998). These observations led to a model that the unmethylated 
maternal ICR serves as an enhancer blocker to insulate Igf2 from shared enhancers, 
whereas the methylated paternal ICR does not have this insulator activity but functions as 
a silencer of H19 on the paternal allele. Therefore, expression of H19 and Igf2 is 
dependent on the accessibility of these genes to the enhancers. This model is further 
supported by the discovery that the ICR binds to CTCF (Bell and Felsenfeld, 2000; Hark 
et al., 2000; Kanduri et al., 2000; Szabó et al., 2000), a protein that mediates insulator 
activity at other loci including the β-globin locus (Bell et al., 1999). Importantly, CTCF 
binds to the H19/Igf2 ICR in a DNA methylation-sensitive manner (Szabó et al., 2000; 
Bell and Felsenfeld, 2000; Hark et al., 2000; Kanduri et al., 2000), through four 
21-basepair (bp) repeats (Stadnick et al., 1999). 
Consistent with the insulator model, when a mutant allele that harbors deletion or 
mutation of the CTCF binding sites in the ICR is inherited from the maternal 
chromosome, Igf2 exhibits biallelic expression and H19 expression is reduced (Fig. 1.2) 
(Schoenherr et al., 2003; Pant et al., 2003, 2004; Szabo et al., 2004; Engel et al., 2006). 
Moreover, in a mutant that ectopically attracts CTCF to the paternal allele, forming the 
insulator on both alleles, Igf2 expression is reduced and H19 is expressed biallelically 
(Fig. 1.3) (Engel et al., 2004). 
To date, the insulator mechanism of imprinted regulation has only been described for 
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Figure 1.2 CTCF binding sites are required for the insulator activity at the H19/Igf2 locus 
Schematic showing the maternal transmission of the ∆R (deletion of repeats) allele, in which four 
CTCF binding sites are deleted from the endogenous locus. Upon maternal transmission of the 
mutant allele, the insulator activity is lost because CTCF cannot bind to the ICR, Igf2 exhibits 
biallelic expression and H19 expression is reduced. Moreover, the maternal ICR ectopically 
acquires DNA methylation in postimplantation tissues (Engel et al., 2006). 
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Figure 1.3 Ectopic binding of CTCF to the paternal ICR causes loss of imprinting at the 
H19/Igf2 locus 
Schematic showing the paternal transmission of the 9CG allele, in which nine CpGs are mutated 
in the CTCF binding sites while retaining CTCF binding. Upon paternal transmission of the mutant 
allele, the paternal ICR loses DNA methylation and forms an insulator due to binding of CTCF. 
Igf2 expression is reduced and H19 exhibits biallelic expression (Engel et al., 2004). 
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the H19/Igf2 locus, despite the fact that CTCF also binds to many other imprinted loci, 
including the Dlk1-Dio3, Kcnq1/Kcnq1ot1, Growth factor receptor bound protein 10 
(Grb10) and RAS protein-specific guanine nucleotide-releasing factor 1 (Rasgrf1) loci 
(Hikichi et al., 2003; Yoon et al., 2005; Fitzpatrick et al., 2007; Kernohan et al., 2010). At 
the Rasgrf1 locus, there is also evidence suggesting a CTCF-dependent insulator 
mechanism (Yoon et al., 2005). However, it is unclear whether the presence of CTCF is 
always associated with insulator activity at these other loci, and further evidence, such as 
the presence of cis-regulatory elements is required to assess the suitability of an insulator 
model at these loci.  
1.1.3.2. The long ncRNA mechanism 
In contrast to the seemingly limited use of the insulator mechanism at imprinted loci, 
a number of imprinted loci appear to use the long ncRNA mechanism to regulate 
imprinting. These loci contain at least one long ncRNA, transcription of which is required 
for silencing of other imprinted genes in cis. The best characterized example is the Igf2r 
imprinting locus (Fig. 1.4). This locus resides on mouse Chr 17 and contains three 
maternally expressed imprinted genes, Igf2r, solute carrier family 22 member 3 (Slc22a3) 
and Slc22a2, and one paternally expressed imprinted gene, Antisense Igf2r RNA (Airn). 
Additionally, three non-imprinted genes, including Plasminogen (Plg), Slc22a1 and Mas1 
oncogene (Mas1), also reside at the locus. This locus has two DMRs, DMR1 and DMR2, 
which encompass the promoters of Igf2r and Airn, respectively. DMR1 is methylated on 
the paternal Igf2r allele. The DNA methylation is acquired progressively during 
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embryogenesis and is a consequence of silencing of the paternal allele (Stöger et al., 
1993). DMR2, which is maternally methylated, is the ICR of this imprinted locus because 
the DNA methylation on DMR2 is obtained in oocytes but not sperm, and persists during 
embryonic development (Stöger et al., 1993; Brandeis et al., 1993; Lucifero et al., 2002). 
In addition, deletion of DMR2 causes loss of imprinting of all three maternally expressed 
genes in the locus (Wutz et al., 1997; Zwart et al., 2001). The Airn transcript, which is not 
spliced, initiates at the second intron of Igf2r and is antisense to Igf2r (Wutz et al., 1997). 
The Airn transcript extends more than 100 kb and its 3’ end overlaps the 5’ end of Mas1 
(Lyle et al., 2000). Transcription of the full-length paternal Airn is required for repression 
of the paternal allele of Igf2r, as well as Slc22a3 and Slc22a2, which do not overlap with 
the Airn gene (Sleutels et al., 2002). Therefore, the full-length paternal Airn transcript, or 
transcription through the region, is required for the silencing of imprinted genes on the 
paternal allele at the Igf2r imprinted locus. 
The Kcnq1/Kcnq1ot1 locus exhibits features of both the long ncRNA silencing and 
the CTCF-related mechanisms; the former serves as the primary mechanism. Similar to 
the Igf2r locus, the imprinted expression of genes in the Kcnq1/Kcnq1ot1 locus requires 
transcription of a full-length long ncRNA, Kcnq1ot1. The Kcnq1/Kcnq1ot1 imprinted 
locus is located in proximity to the H19/Igf2 locus in both human and mouse. However, 
the imprinted regulation in the Kcnq1/Kcnq1ot1 is independent of the H19 ICR (Caspary 
et al., 1998; Ainscough et al., 1998). The Kcnq1/Kcnq1ot1 locus (Fig. 1.5) contains 
eleven maternally-expressed genes, including Oxysterol binding protein-like 5 (Osbpl5), 
Tumor necrosis factor receptor superfamily member 23 (Tnfrsf23), Nucleosome assembly 
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protein 1-like 4 (Nap1l4), Pleckstrin homology-like domain family A member2 (Phlda2), 
Slc22a18, Cdkn1c, Potassium voltage-gated channel subfamily Q member 1 (Kcnq1), 
Tumor-suppressing subchromosomal transferable fragment 4 (Tssc4), CD81 antigen 
(Cd81), Tetraspanin 32 (Tspan32) and Achaete-scute complex homolog 2 (Ascl2); as well 
as one paternally-expressed long ncRNA, Kcnq1ot1, which is an antisense transcript of 
Kcnq1. The locus also contains five genes that appear to not be imprinted, including 
Tnfrsf22, Tnfrsf26, Cysteinyl-tRNA synthetase (Cars), Transient receptor potential cation 
channel subfamily M member 5 (Trpm5) and Tyrosine hydroxylase (Th). Two DMRs, 
KvDMR1 and the Cdkn1c DMR, are located in the Kcnq1/Kcnq1ot1 locus. As mentioned 
earlier, the Cdkn1c DMR becomes methylated after fertilization, which is likely a 
consequence of transcriptional silencing of the repressed allele (Bhogal et al., 2004) and 
thus is not likely an ICR. The maternally methylated KvDMR1, which covers the 
Kcnq1ot1 promoter, is the ICR of the locus (Smilinich et al., 1999). On the paternal allele, 
where KvDMR1 is unmethylated, Kcnq1ot1 is expressed, which results in silencing the 
adjacent genes. Paternal deletion of the KvDMR1 causes loss of expression of Kcnq1ot1 
and results in activation of genes in cis in embryonic and extra-embryonic tissues 
(Fitzpatrick et al., 2002; Lewis et al., 2004). Transcription of the intact Kcnq1ot1 RNA is 
required for imprinted expression of the entire locus (Thakur et al., 2004; 
Mancini-Dinardo et al., 2006; Shin et al., 2008). An exception to this is that in several 
fetal and neonatal tissues, Cdkn1c imprinting was maintained on a Kcnq1ot1 truncation 
allele (Shin et al., 2008). Moreover, two CTCF binding sites were identified in the 
KvDMR1 (Fitzpatrick et al., 2007). These data, together with the evidence that the 
KvDMR1 has enhancer-blocking and silencer activities in vitro (Fitzpatrick et al., 2007; 
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Mancini-DiNardo et al., 2003; Thakur et al., 2003), indicate that CTCF may form an 
insulator at the KvDMR1 as a secondary mechanism in the Kcnq1/Kcnq1ot1 imprinted 
locus. Further characterization of enhancer elements is required to determine the 
involvement of CTCF in imprinted regulation at this locus. 
1.2. DNA methylation and reprogramming in mammals 
1.2.1. DNA methylation 
DNA methylation of cytosine within CpG dinucleotides is an important epigenetic 
modification that is involved in genomic imprinting. In general, DNA methylation is 
correlated with gene repression (Bird and Wolffe, 1999), and the proper establishment 
and maintenance of methylation is required for normal development (Chen and Li, 2006). 
In mammals, DNA methylation occurs predominantly at the 5’ carbon of cytosines in 
CpG dinucleotides. For both genome-wide methylation and imprinting associated 
methylation, DNA methyltransferase 3A (DNMT3A) and DNMT3B are responsible for 
the major de novo methylation in gametes and during early development, while DNMT1 
is responsible for maintenance of methylation patterns at each cell division, by 
recognizing hemi-methylated CpGs and adding methyl groups to the newly synthesized 
daughter strand (Bestor et al., 1988; Okano et al., 1998, 1999). DNMT3-like (DNMT3L) 
is a member of the DNMT3 family that lacks the catalytic domain but stimulates the 
activity of DNMT3A and DNMT3B through direct interactions (Suetake et al., 2004). 
DNMT3L recognizes and binds to the tail of histone H3 and can thereby recruit 
DNMT3A to chromatin and to its target DNA sequences (Ooi et al., 2007).  
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Proper DNA methylation is essential for imprinted expression because mutations in 
the Dnmt genes exhibit loss of methylation of the ICRs and loss of imprinted gene 
expression (Li et al., 1993; Bourc'his et al., 2001; Hata et al., 2002; Kaneda et al., 2004, 
2010; Bourc'his and Bestor, 2004; Weaver et al., 2010). Moreover, DNMT3L cannot bind 
to H3 tails when H3 lysine 4 (H3K4) is methylated, suggesting H3K4 methylation is 
inhibitory to DNA methylation (Ooi et al., 2007). When histone H3K4 demethylase 
KDM1B (lysine-specific demethylase 1B) is depleted from mouse oocytes, a number of 
imprinted DMRs fail to establish maternal-specific methylation, and embryos derived 
from KDM1B-deficient oocytes have biallelic expression of related imprinted genes 
(Ciccone et al., 2009), presumably because of disruption in binding of DNMT3L to H3 
tails. These results provide a nice example of crosstalk between histone modifications and 
DNA methylation in regulation of imprinted gene regulation. 
1.2.2. DNA methylation reprogramming in mammals 
Two waves of genome-wide reprogramming of DNA methylation occur during the 
mammalian life cycle (Fig. 1.6) (Reik et al., 2001). During gametogenesis, genome-wide 
methylation is erased and a new methylation pattern is set at sex-specific times by de 
novo methylation, which includes the setting of methylation imprints. Mammalian germ 
cells are derived from a small population of extraembryonic mesoderm cells of the 
epiblast, as a consequence of signaling from adjacent tissues [reviewed in (Kota and Feil, 
2010)]. The founder population of germ cells, called primordial germ cells (PGCs), which 
give rise to either spermatozoa or oocytes, is formed around embryonic day (E) 7.25 in 
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Figure 1.6 DNA methylation reprogramming during mammalian development 
(Modified from Reik et al., 2001) Schematic showing DNA methylation changes during 
mammalian development. The vertical line separates gametogenesis and embryogenesis. PGCs 
in the mouse become demethylated early in development. Remethylation (including remethylation 
at the germline DMRs) begins in E16 male germ cells, and after birth in growing oocytes. DNA 
methylation of some DMRs is reset in a sex-specific manner in the germ lines. Following 
fertilization, the paternal genome is demethylated by an active mechanism, whereas the maternal 
genome is demethylated by a passive mechanism that depends on DNA replication. The DNA 
methylation level reaches its lowest extent around the blastocyst stage. Both genomes are 
remethylated after implantation. The embryonic lineages (Em) display higher levels of DNA 
methylation than the extraembryonic lineages (Ex) (Santos et al., 2002). Throughout the 
reprogramming during embryogenesis, methylated germline DMRs in imprinted loci and some 
repeats sequences remain methylated; whereas unmethylated germline DMRs remain 
unmethylated. 
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the mouse (Ginsburg et al., 1990). The PGCs proliferate and migrate toward the genital 
ridges that they colonize (at around E10.5 in the mouse), after which the gonads form. 
During and after the migration, PGCs undergo global epigenetic reprogramming 
including DNA demethylation and changes in histone modifications (Seki et al., 2005). 
Demethylation of DNA in PGCs depends partially upon the cytidine deaminase AID 
(Popp et al., 2010), but the mechanism is not fully understood. Subsequently, DNA 
methylation, including differential methylation at germline ICRs, is re-established during 
gametogenesis. Remethylation begins in prospermatogonia in E16 male germ cells, and 
after birth in growing oocytes. In both germlines, the acquisition of DNA methylation at 
imprinted DMRs involves the DNMT3A-DNMT3L complex (Bourc'his et al., 2001; 
Kaneda et al., 2004; Kato et al., 2007). In addition, at the Guanine nucleotide binding 
protein alpha stimulating complex locus (Gnas) imprinted locus, transcription through the 
DMRs is required for remethylation in oocytes (Chotalia et al., 2009). 
Mature spermatozoa and oocytes remain highly methylated until fertilization, soon 
after which a second wave of demethylation takes place. The paternal genome undergoes 
DNA demethylation by an active mechanism (Mayer et al., 2000; Oswald et al., 2000), 
whereas DNA replication-dependent demethylation occurs on the maternal genome by a 
passive mechanism (Rougier et al., 1998). The mechanism that actively demethylates the 
paternal genome is still under debate and remains largely unknown (Ooi and Bestor, 
2008). Genome-wide DNA methylation reaches its lowest level at the blastocyst stage 
and recovers to its approximately final methylation level around gastrulation [reviewed in 
(Mann and Bartolomei, 2002; Li, 2002)]. The de novo methylation was observed 
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specifically in the inner cell mass (ICM), but not in the trophoectoderm of the blastocyst, 
consistent with higher methylation levels in the embryonic lineages than in the 
extraembryonic lineages (Santos et al., 2002).  
The differential methylation patterns established at germ-line DMRs during 
gametogenesis are resistant to the genome-wide demethylation process after fertilization 
(Weaver et al., 2009). One possibility is that these DMRs can survive the massive 
genome-wide reprogramming, which would require specific recognition and protection of 
these DMRs from the demethylation. Alternatively, active methylation may also play a 
role. It is suggested that DNA methylation is maintained in the preimplantation embryos 
by a combination of DNMT1 and the oocyte-specific form of DNMT1 (DNMT1o) 
(Howell et al., 2001; Hirasawa et al., 2008; Cirio et al., 2008). In addition, DNMT3A and 
DNMT3B are also required for the maintenance of CpG methylation at some loci (Chen 
et al., 2003).  
In addition to the DNMTs, a number of proteins appear involved in maintenance of 
DNA methylation at imprinted DMRs. For instance, two proteins encoded by AT-rich 
interaction domain (Arid) family genes, ARID4A/RBBP1 and ARID4B/RBBP1L1 are 
involved in maintenance of the maternal methylation at the Small nuclear 
ribonucleoprotein N (Snrpn) locus (Wu et al., 2006b). Moreover, the maternally 
deposited protein DPPA3 (Developmental pluripotency-associated 3)/STELLA is 
required at multiple maternally and paternally methylated loci (Nakamura et al., 2007). 
Furthermore, loss of DNA methylation in DMRs has been observed in both human and 
mouse when a KRAB zinc finger protein, ZFP57 (Zinc finger protein 57) is mutated or 
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deleted (Mackay et al., 2008; Li et al., 2008). 
In summary, it is apparent that multiple proteins maintain methylation at different 
DMRs, and it is likely that other proteins involved in histone modifications and 
transcriptional regulation are also involved. However, the underlying mechanism by 
which the imprinted ICRs are specifically recognized and subsequently protected from 
demethylation remains to be uncovered. A group of DNA binding proteins that 
specifically bind to methylated DNA may be the missing link. 
1.3. Methyl-CpG binding proteins 
The Methyl-CpG-Binding-Domain (MBD) protein family and the Kaiso zinc finger 
protein family, which both have methyl-CpG binding activity, bind preferentially to 
methylated DNA and to recruit repressor complexes [reviewed in (Klose and Bird, 2006)]. 
In addition, proteins from both families bind to imprinted loci (Fujita et al., 1999; 
Prokhortchouk et al., 2001; Drewell et al., 2002; Fournier et al., 2002; Samaco et al., 
2005; Makedonski et al., 2005; Filion et al., 2006) (see below). These activities make the 
MBDs exciting candidates that can specifically recognize imprinted DMRs and silence 
linked genes. 
1.3.1. The MBD family 
The mammalian MBD family includes five members (Fig. 1.7 A): MeCP2 (Methyl 
CpG binding protein 2), MBD1, MBD2, MBD3 and MBD4 (Hendrich and Bird, 1998). 
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Figure 1.7 The MBD and Kaiso families of methylated DNA binding proteins 
Schematic showing the MBD and Kaiso families of methylated DNA binding proteins in the 
mouse. The abbreviations are defined as follows: methyl-CpG binding domain (MBD), 
transcription repression domain (TRD), the CxxC zinc finger domain (CxxC), glycine & arginine 
repeats (GR), glutamic acid-rich region (E-rich) and zinc finger (ZF). (A) The MBD family shares a 
conserved MBD. The MBD and TRD of MBD2 overlap. The MBD of MBD3 harbors mutations 
(black bar), causing the inability of MBD3 to bind to methylated CpG (Saito and Ishikawa, 2002). 
(B) The Kaiso family proteins share an N-terminus POZ/BTB domain and three ZFs that bind to 
methylated DNA. ZBTB4 and ZBTB38 contain additional ZFs that are not homologous among the 
three proteins. 
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All MBD family proteins contain the MBD, which binds methylated DNA in vitro (Nan 
et al., 1993). Moreover, all members are associated with histone deacetylase 
(HDAC)-containing repressor complexes and transcriptional repression (Klose and Bird, 
2006). 
MeCP2 was the first member of the MBD family identified. Heterozygous mutations 
in the human X-linked MECP2 gene cause a severe and progressive neurodevelopmental 
disorder called Rett syndrome (RS), almost exclusively in girls (Gonzales and LaSalle, 
2010). Besides the MBD, MeCP2 also contains a transcriptional repression domain (TRD) 
(Nan et al., 1997). MeCP2 has both methyl-CpG binding activity and sequence-specific 
binding activity (Weitzel et al., 1997; Bowen et al., 2004a), and can mediate 
transcriptional repression by two independent mechanisms. The enzymatic mechanism 
involves interactions between the TRD and Sin3A, a co-repressor that exists in a complex 
with HDACs (Jørgensen and Bird, 2002; Bowen et al., 2004a). The HDAC-independent 
structural mechanism is indicated by the ability of MeCP2 to mediate chromatin 
compaction regardless of the methylation state of DNA (Jørgensen and Bird, 2002; 
Georgel et al., 2003; Bowen et al., 2004a). Besides its transcriptional repression roles, 
MeCP2 can participate in activation of transcription, nuclear organization and splicing 
(Bogdanović and Veenstra, 2009). Interestingly, MeCP2 binds to a number of imprinted 
loci, including the H19 ICR (Drewell et al., 2002), the methylated maternal Snrpn DMR 
(Samaco et al., 2005; Makedonski et al., 2005), and the maternal allele of the Zinc finger 
(CCCH type) RNA binding motif and serine/arginine rich 1 (Zrsr1) DMR, which is 
maternally methylated (Fournier et al., 2002; Georgel et al., 2003). The binding of 
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MeCP2 in the Snrpn DMR has been correlated to imprinted regulation of a neighbor 
imprinted gene, Ubiquitin protein ligase E3A (Ube3a) (Makedonski et al., 2005). 
However, it is unclear if MeCP2 functions to regulate imprinted expression at these loci 
because two reports show that mutations in MeCP2 cause changes in expression levels 
but not loss of imprinting (Balmer et al., 2002; Samaco et al., 2005). 
MBD1 binds to both methyl-CpG and nonmethylated-CpG sites via its MBD and 
two or three cysteine-rich (CxxC) motifs, respectively (Jørgensen and Bird, 2002; 
Jørgensen et al., 2004). In addition, MBD1 has a TRD, which has no sequence similarity 
to the TRD of MeCP2 (Ng et al., 2000). Both the CxxC motifs and the TRD confer the 
transcriptional repression activity of MBD1 (Cross et al., 1997; Fujita et al., 1999, 2003; 
Ng et al., 2000). MBD1 recruits the Suv39h1-HP1 complex and HDACs (Fujita et al., 
2003), as well as the H3 lysine 9 (H3K9) methyltransferase SETDB1 (Sarraf and 
Stancheva, 2004) to enhance DNA methylation-mediated transcriptional repression. 
Mbd1-null mice have normal life-span without obvious developmental defects, but have 
deficits in adult neurogenesis and hippocampal function (Zhao et al., 2003). Similar to 
MeCP2, MBD1 also binds to the maternal allele of the Zrsr1 DMR (Fournier et al., 2002). 
In addition, human MBD1 associates with and suppresses expression of the human 
SNRPN gene in vitro (Fujita et al., 1999). Further characterization is required to 
understand MBD1’s role in imprinted loci. 
MBD2 and MBD3 are closely related to each other, not only in the MBD but also in 
the sequence outside the MBD (Hendrich and Bird, 1998). The shared region of MBD2 
and MBD3 contains a coiled-coil domain, which might be responsible for formation of 
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hetero- and homo-dimers of MBD2 and MBD3 (Tatematsu et al., 2000). MBD2 binds 
methylated DNA and confers DNA methylation-mediated transcriptional silencing 
through its TRD, which overlaps with the MBD and is not homologous to either the 
MeCP2 or MBD1 TRDs (Boeke et al., 2000). The Mbd2-null mice are fertile with subtle 
immune system defects and impaired maternal behavior (Hendrich et al., 2001). A 
number of imprinted genes, including H19, Igf2, Igf2r, Snrpn, and Paternally expressed 
gene 3 (Peg3), were tested in adult tissues from the Mbd2-null mice. None of these genes 
were affected by depletion of MBD2 (Hendrich et al., 2001). Therefore, MBD2 seems to 
be dispensable for imprinted gene regulation. 
MBD3 is the only member of the MBD family proteins that lacks the capacity to 
selectively recognize methylated DNA in vitro, which is due to two amino changes in the 
conserved residues of the MBD (Hendrich and Bird, 1998; Saito and Ishikawa, 2002). As 
stated above, it is suggested that MBD2 and MBD3 form heterodimers though the 
coiled-coil domain (Tatematsu et al., 2000). Therefore, MBD3 may be recruited to 
methylated DNA elements by MBD2. However, unlike the mild phenotype observed in 
Mbd2-null mice, Mbd3-null mice are embryonic lethal, indicating that MBD3 has 
essential functions during embryonic development that is MBD2 independent (Hendrich 
et al., 2001). MBD3 is required for the pluripotency of mouse embryonic stem (ES) cells 
(Kaji et al., 2006), and is required for development of the ICM of preimplantation 
embryo to epiblast (Kaji et al., 2007), likely by repressing the expression of trophoblast 
lineage genes (Zhu et al., 2009). Similar to MeCP2 and MBD1, MBD3 also binds to the 
Zrsr1 DMR (Fournier et al., 2002). Cofactors of MBD3, likely MBD2, may be involved 
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in this interaction. 
Both MBD2 and MBD3 are components of the nucleosome remodeling and histone 
deacetylation (NuRD) repressor complex (Zhang et al., 1999; Wade et al., 1999; 
Brackertz et al., 2002; Le Guezennec et al., 2006). Depletion of MBD3 from mouse ES 
cells causes disassembly of the NuRD complex, suggesting MBD3 is a core component 
of the NuRD complex (Kaji et al., 2006). MBD2- and MBD3-containing NuRD 
complexes are suggested to be distinct protein complexes with different biochemical and 
functional properties (Le Guezennec et al., 2006). 
Unlike other members of the MBD family, MBD4 has a DNA glycosylase domain 
that targets sites of cytosine deamination, where MBD4 acts as a thymine DNA 
glycosylase and is involved in DNA break repair (Hendrich et al., 1999). MBD4 deficient 
mice have an increased rate of CpG to TpG mutations (Millar et al., 2002; Wong et al., 
2002). MBD4 is also suggested to be associated with transcriptional repression in a DNA 
methylation- and HDAC-dependent manner (Kondo et al., 2005). 
As already stated, MeCP2, MBD1 and MBD3 bind to a variety of imprinted loci 
(Drewell et al., 2002; Fournier et al., 2002; Samaco et al., 2005; Makedonski et al., 2005), 
indicating involvement of these proteins in imprinted regulation. Further investigation is 
required to identify potential interactions between MBD proteins and imprinted loci, as 
well as consequences of such interactions. 
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1.3.2. The Kaiso family 
Another family of proteins, the Kaiso family, also binds to methylated DNA. The 
three members of the family, Kaiso, ZBTB4 (Zinc finger and BTB domain containing 4) 
and ZBTB38, share three homologous zinc finger domains and an N-terminal POZ/BTB 
[poxvirus and zinc finger (POZ) or Broad complex, Tramtrack, Bric-a-brac (BTB)] 
domain (Collins et al., 2001; Filion et al., 2006) (Fig. 1.7 B). The POZ/BTB domain is an 
evolutionarily conserved protein-protein interaction domain that belongs to the C2H2 
class of zinc fingers (Collins et al., 2001). In the Kaiso family, the homologous zinc 
finger domains are responsible for the methylated-CpG-binding activity (Prokhortchouk 
et al., 2001). Similar to the MBD family proteins, Kaiso family proteins act as 
transcription repressors in a DNA methylation-dependent manner. Kaiso interacts with 
CTCF, and thereby negatively regulates CTCF insulator activity (Defossez et al., 2005). 
Kaiso-deficient mice are viable and fertile, with no detectable defects in development 
(Prokhortchouk et al., 2006). Interestingly, these mice show resistance to intestinal cancer 
when crossed with tumor-susceptible mice, suggesting a role for Kaiso in suppressing 
intestinal cancer (Prokhortchouk et al., 2006). The other Kaiso family members, ZBTB38 
and ZBTB4, preferentially bind to the methylated paternal ICR of H19/Igf2 locus, 
whereas Kaiso interacts with both alleles with a bias towards the paternal allele (Filion et 
al., 2006). The association of MBD and Kaiso families of proteins with imprinted loci 
prompted our interest in testing the potential role of methyl-CpG binding proteins in 
genomic imprinting.  
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1.4. CTCF 
The methyl-CpG binding proteins may function to establish and/or maintain 
parental-specific methylation at ICRs. In contrast, the insulator protein, CTCF, may 
function to establish and/or maintain parental-specific hypomethylation at ICRs 
[reviewed in (Filippova, 2008)]. CTCF is an eleven-zinc finger protein with multiple 
functions (discussed later in 1.4.2). The role of CTCF in imprinted gene expression has 
been best characterized at the H19/Igf2 locus. CTCF binds to the unmethylated allele of 
the H19 ICR and plays important roles in the imprinted regulation of the H19/Igf2 locus 
(see 1.1.1.1). Mutations or deletions of CTCF binding sites on the maternal H19 ICR 
result in gain of DNA methylation in the ICR during development, indicating CTCF 
binding is required for maintenance of hypomethylation at the maternal H19 ICR 
(Schoenherr et al., 2003; Pant et al., 2003, 2004; Szabo et al., 2004; Engel et al., 2006). 
Indeed, CTCF binding sites are enriched in DNA methylation-free regions genome-wide 
(Mukhopadhyay et al., 2004). In addition to the H19 ICR, CTCF binds to DMRs at a 
number of other imprinted loci including Dlk1-Dio3, Kcnq1/Kcnq1ot1, Grb10 and 
Rasgrf1 (Hikichi et al., 2003; Yoon et al., 2005; Fitzpatrick et al., 2007; Kernohan et al., 
2010). Moreover, CTCF binding appears to be methylation-sensitive at the 
Kcnq1/Kcnq1ot1, Grb10 and Rasgrf1 loci (Hikichi et al., 2003; Yoon et al., 2005; 
Fitzpatrick et al., 2007), and depletion of CTCF in mouse oocytes led to reduction in two 
imprinted transcripts: Grb10 and Gene trap locus 2 (Gtl2) / Maternally expressed 3 
(Meg3), which is located in the Dlk1-Dio3 locus (Wan et al., 2008). Interestingly, the 
Kcnq1/Kcnq1ot1 locus (see 1.1.1.2) and possibly the Dlk1-Dio3 locus (Lin et al., 2003; 
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Tierling et al., 2006) use the ncRNA mechanism to regulate imprinted expression. It is 
intriguing that CTCF is present and may possibly function at imprinted loci that are 
regulated by different imprinting control mechanisms (insulator versus ncRNA). 
However, how CTCF manifests its functions at the H19/Igf2 locus and whether it has 
similar roles at other imprinted loci remains to be fully elucidated. 
1.4.1. Models for insulator function 
The insulator function of CTCF has been well-characterized. However, the 
mechanism of insulation is still hotly debated (Ohlsson et al., 2010). The looping model 
proposes that CTCF facilitates the formation of three-dimensional structures around the 
insulator element, resulting in different domains of transcriptional activity. This model is 
supported by the following evidence: CTCF interacts with itself (Pant et al., 2004), and 
therefore it can mediate interactions between distal binding sites; CTCF binds to the 
nucleolar protein nucleophosmin (B23) and tethers a transgenic insulator element to 
subnuclear sites (Yusufzai et al., 2004); CTCF binding sites are enriched at boundaries 
between genes that undergo and escape X chromosome inactivation (Filippova et al., 
2005), as well as boundaries of histone methylation domains (Kim et al., 2007; Xie et al., 
2007; Barski et al., 2007; Xi et al., 2007); CTCF is related to nucleosome positioning 
(Kanduri et al., 2002; Fu et al., 2008), and is enriched at nuclear lamina-associated 
domains (Guelen et al., 2008); and moreover, CTCF mediates inter- and 
intra-chromosomal interactions [reviewed in (Williams and Flavell, 2008)]. These 
observations suggest that CTCF can provide anchor points and tether remote regions in 
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the genome together, supporting the looping model. Indeed, a study of the β-globin locus 
suggests that functional insulator elements form loops whereas non-functional insulator 
elements seem to have a linear conformation, by chromatin conformation capture (3C) 
experiments (Tolhuis et al., 2002). At the H19/Igf2 locus, 3C experiments have revealed 
association of the ICR with the Igf2 promoters and DMRs (Murrell et al., 2004; Ling et 
al., 2006; Kurukuti et al., 2006), suggesting that maternal Igf2 is isolated in a loop that 
has a silencing environment, apart from the active domain where H19 and the enhancers 
are located [Fig. 1.8 A shows interaction of the ICR with the Igf2 DMR1, which is 
maternally methylated and was shown to function as a mesodermal silencer element to 
repress Igf2 maternal expression (Constância et al., 2000)]. In addition, the ICR has also 
been found to be associated with the endodermal enhancers (Yoon et al., 2007; Qiu et al., 
2008) (Fig. 1.8 B), suggesting a competition mechanism: the ICR binds to the enhancers, 
preventing possible interactions between these enhancers and the Igf2 promoter.  
Alternatively, a tracking model suggests that RNA polymerase II (Pol II) and other 
activating factors bind to an enhancer and track along the chromatin until they contact an 
insulator or a promoter that has high binding affinity with the enhancer. The chromatin 
loops are formed by the intervening region between the enhancer and the scanned 
elements. This model is supported by the observation that histone acetylations are 
associated with increased chromatin mobility and flexibility, and therefore impacts 
formation of chromatin loops and further determines the interaction between enhancers 
and genes (Li et al., 2006). Consistently, it has been shown that CTCF binding sites at the 
chicken β-globin insulator 5’HS4 stall Pol II and inhibit enhancer-induced histone 
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Figure 1.8 The looping model for insulator function at the H19/Igf2 locus 
Schematic showing two alternatives for the looping model at the H19/Igf2 locus. The maternal 
chromosome is shown. (A) ICR associates with Igf2 DMR1, isolating Igf2 to a silencing 
environment (gray area). (B) ICR associates with the 3’ shared enhancers, blocking possible 
interaction between the Igf2 promoter and the enhancers. H19 is located in an active chromatin 
domain (orange area). (A) and (B) together suggest a competition mechanism: ICR interacts with 
both Igf2 and the enhancers, preventing possible interactions between Igf2 and the enhancers 
(Yoon et al., 2007; Qiu et al., 2008). 
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acetylation (Zhao and Dean, 2004). Moreover, despite the fact that some CTCF binding 
sites also have Pol II occupancy, most of these sites are not transcribed (Chernukhin et al., 
2007), which can result from tracking Pol II being stalled by CTCF-bound DNA elements. 
At the H19/Igf2 locus, the tracking model is supported by 3C experiments demonstrating 
that the enhancers associate with Igf2 and the entire intervening region between Igf2 and 
H19 on the paternal chromosome, whereas the enhancers do not associate with regions 
upstream of the ICR on the maternal chromosome (Engel et al., 2008) (Fig. 1.9). The 
tracking process of an enhancer and its associated activating proteins may result in 
clustering of a transcriptional factory, which may serve as a subnuclear domain to which 
CTCF tethers chromatin (Cook, 2003). 
1.4.2. Discovery and multifunctionality of CTCF 
It remains unclear if imprinted loci other than the H19/Igf2 locus use CTCF binding 
sites as insulators. Instead, CTCF may play distinct functions at these loci, as it has been 
shown to be multifunctional. CTCF was initially identified as a CCCTC binding factor in 
the chicken V-myc Myelocytomatosis viral oncogene homolog (Myc) locus where in vitro 
studies indicated that it suppressed Myc expression (Lobanenkov et al., 1990). After its 
discovery, CTCF was found associated with the 5’ end of the chicken β-globin locus 
(5’HS4) (Bell et al., 1999), which functions as an insulator that blocks enhancer-promoter 
interactions (Chung et al., 1993). The CTCF binding site at 5’HS4 is necessary and 
sufficient for the insulator activity (Bell et al., 1999). Further studies of the H19/Igf2 and 
Myc sequences also demonstrated requirement of CTCF binding sites for insulator 
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Figure 1.9 The tracking model for insulator function at the H19/Igf2 locus 
Schematic showing the tracking model. Enhancers and active factors (not shown) track along the 
chromosome (arrows). On the maternal chromosome, the enhancers are blocked by the 
CTCF-bound ICR. On the paternal chromosome, an insulator is not formed because CTCF 
cannot bind to the ICR, and the enhancers are able to activate Igf2 expression. 
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activities (Gombert et al., 2003; Wan and Bartolomei, 2008). 
The CTCF protein has eleven zinc fingers and is conserved from fruit fly to human 
(Moon et al., 2005). Among vertebrates, the CTCF proteins from zebrafish, Xenopus and 
human have 98% identical amino acids within the zinc fingers (Burke et al., 2002; 
Pugacheva et al., 2006), whereas the avian CTCF zinc fingers are 100% identical to the 
human counterpart (Filippova et al., 1996). Surprisingly, despite the strict conservation in 
the primary sequence of the CTCF protein, CTCF binding sites are somewhat divergent 
among different species and target genes, suggesting that the zinc fingers are flexible 
[reviewed in (Filippova, 2008)]. Consistently, CTCF was found to be multi-functional. 
Besides the insulator activity, CTCF is associated with transcriptional activation and 
repression of a number of target genes. CTCF binding sites are involved in transcriptional 
repression in the Myc locus (Klenova et al., 1993; Filippova et al., 1996), the composite 
thyroid response element of the lysozyme gene (Burcin et al., 1997), the 
microsatellite-containing silencer of the HLA-DRB1 gene (Arnold et al., 2000), Paired 
box gene 6 (Li et al., 2004; Wu et al., 2006a), and others. In contrast, CTCF binding sites 
positively regulate transcription in the amyloid β-protein precursor promoter (Vostrov 
and Quitschke, 1997; Yang et al., 1999), the Interleukin 1 receptor associated protein 
kinase 2 gene (Kuzmin et al., 2005), Retinoblastoma promoter (De La Rosa-Velázquez et 
al., 2007), and others. Furthermore, clusters of CTCF binding sites are identified at the X 
inactivation center, likely having a role in X chromosome inactivation (Chao et al., 2002; 
Pugacheva et al., 2005; Boumil et al., 2006; Navarro et al., 2006; Xu et al., 2007; 
Donohoe et al., 2009). In conclusion, these data suggest that CTCF has multiple functions 
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in transcriptional regulation. 
1.4.3. CTCF binding sites 
It is hypothesized that CTCF binds to different DNA sequences through different 
combinations of zinc fingers (Filippova et al., 1996). Indeed, various zinc finger 
truncations cause loss of CTCF binding to different binding sites in vitro [reviewed in 
(Ohlsson et al., 2001)]. However, the changes in CTCF binding affinity may be due to 
structural changes in the protein conformation, and/or due to the interdependence of 
DNA-binding properties of individual zinc fingers. In addition, these mutations can also 
affect interactions between CTCF and cofactors. 
In order to understand the mechanisms by which CTCF manifests its multiple 
functions, significant efforts have been made to map CTCF binding sites. In the past few 
years, genome-wide mapping of CTCF binding sites by chromatin immunoprecipitation 
(ChIP) technologies (ChIP-on-chip and ChIP-sequencing) has identified thousands of 
CTCF binding sites (e.g., ~26,000 sites in the human genome) (Kim et al., 2007; 
Chernukhin et al., 2007; Xie et al., 2007; Barski et al., 2007; Xi et al., 2007; Chen et al., 
2008; Heintzman et al., 2009; Goren et al., 2009; Cuddapah et al., 2009; Kang et al., 2009; 
Kunarso et al., 2010). Computational analysis of these datasets has provided insights into 
the functions of CTCF. For example, CTCF is enriched at boundaries of histone 
modification domains, suggesting CTCF’s role in formation of chromatin domains. 
Analysis by Essien et al. identified three classes of CTCF binding sites according to their 
sequence similarity to a common consensus sequence (Essien et al., 2009). These classes 
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of CTCF sites, termed LowOc, MedOc and HighOc for low-, medium- and 
high-occupancy, have distinct properties. The majority of CTCF binding sites in 
imprinted loci belong to the LowOc and MedOc classes, which seem to have lower 
binding affinity to CTCF, and tend to be more cell-type specific than the HighOc class. 
Interestingly, the LowOc sites also tend to cluster (e.g., the CTCF binding sites in the 
H19 ICR), suggesting another level of regulation by recruiting multiple CTCF proteins to 
compensate for individual low affinity binding sites. The authors hypothesized that the 
low affinity may be important for the allele-specific binding of CTCF at imprinted loci. 
Moreover, the LowOc sites are not as conserved as the HighOc sites. Consistently, 
imprinted genes evolved recently in mammals (see 1.1.1), whereas some HighOc sites, 
such as the CTCF binding sites in the β-globin locus, are conserved between avian and 
mammalian species (Farrell et al., 2002).  
1.4.4. CTCF cofactors 
In addition to binding at different target sites, CTCF interacts with various protein 
partners. For instance, its insulator function has been correlated with binding of 
nucleophosmin (B23) (Yusufzai et al., 2004), Kaiso (Defossez et al., 2005), the 
SNF2-like chromodomain helicase DNA binding protein 8 (CHD8) (Ishihara et al., 2006) 
and Pol II (Chernukhin et al., 2007). The repression function of CTCF may be attributed 
to the interaction between CTCF and the Sin3A corepressor complex (Lutz et al., 2000). 
Furthermore, CTCF interacts with the Y-box DNA/RNA-binding factor YB-1, which is 
also multifunctional and involved in transcription, replication and RNA processing 
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(Chernukhin et al., 2000). The transcriptional repressor protein YY1 often binds to DNA 
in proximity to CTCF sites (Kim, 2008; Kang et al., 2009). YY1 and POU domain class 5 
transcription factor 1(POUF51)/OCT4, a transcription factor required for pluripotency, 
were found to be important CTCF cofactors in X-inactivation (Donohoe et al., 2007, 
2009).  
1.4.5. CTCF interacts with cohesins 
In addition to the protein cofactors mentioned above, CTCF interacts with cohesin 
complex subunits (Stedman et al., 2008). The cohesin complex is highly conserved in 
eukaryotes, and is required for sister chromatid cohesion and chromosome segregation 
during cell division [reviewed in (Bose and Gerton, 2010)]. The mitotic cohesin complex 
consists of four subunits, including RAD21/Sister chromatid cohesion protein 1 (SCC1), 
SCC3 (SA1/SA2), and two members of the structural maintenance of chromosomes 
(SMC) family, SMC1/SMC1A and SMC3. The cohesin complex is proposed to form a 
ring-like structure and hold the sister chromatids together during mitosis (Fig. 1.10) 
(Gruber et al., 2003; Ivanov and Nasmyth, 2005; Haering et al., 2008). In vertebrates, 
cohesins are loaded to the chromatin during late telophase (Sumara et al., 2000), with the 
assistance of the SCC2/SCC4 adherin complex (Ciosk et al., 2000; Watrin et al., 2006). 
The bulk of cohesin complex dissociates at the prophase/metaphase transition, while a 
small portion of the complex persists at centromeres and dissociates at the onset of 
anaphase, due to the activity of separase [reviewed in (Barbero, 2009)]. As part of its 
mitotic function, the cohesin complex also participates in post-replication DNA break 
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Figure 1.10 The mitotic cohesin complex 
Schematic showing the four subunits of the mitotic cohesin complex. SMC1 and SMC3 dimerize 
through the hinge domains and embrace the DNA (grey lines) by the coiled-coil arms. The N- and 
C-terminus of SMC1 and SMC3 form the head domains, which contain the ATPase motifs. The 
head domains of SMC1 and SMC3 interact with C- and N-terminus of RAD21, respectively, to 
close the ring. SCC3 binds to RAD21 to stabilize the ring [reviewed in (Bose and Gerton, 2010)]. 
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repair (Watrin and Peters, 2006) and heterochromatin formation (Gullerova and 
Proudfoot, 2008). 
Cohesin and cohesin-related genes are associated with human diseases. Mutations in 
the NIPBL gene (the human ortholog of Scc2), and subsequently, in the SMC1A and 
SMC3 genes, were described in Cornelia de Lange syndrome (CdLS) patients (Krantz et 
al., 2004; Tonkin et al., 2004; Deardorff et al., 2007). Surprisingly, some CdLS 
individuals do not have severe defects in sister chromatid cohesion (Kaur et al., 2005), 
suggesting that cohesins are involved in gene regulation and development independent of 
their mitotic role. Following this discovery, a number of studies revealed that cohesins 
are expressed in post-mitotic cells, involved in transcriptional regulation and chromatin 
structure, and required in neuronal morphogenesis and embryonic development [reviewed 
in (Dorsett, 2007; Barbero, 2009)], likely through their ability to interact with 
chromosomes. Importantly, Drosophila SMC1, RAD21 and SCC3 are postulated to 
prevent enhancer-promoter interactions at the cut locus (Rollins et al., 2004; Dorsett et al., 
2005), indicating that cohesins function as insulator proteins. Thus, cohesins may 
function in concert with CTCF at insulator elements. 
In my dissertation, I have investigated the role of protein factors in genomic 
imprinting. I have studied the function of methyl-CpG binding proteins, CTCF and 
cohesins at imprinted loci. In Chapter 2, I show that MBD and its NuRD complex 
cofactor Metastasis tumor antigen 2 (MTA2) are required for maintenance of differential 
methylation and imprinted expression at the H19/Igf2 locus. Depletion of both MBD3 
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and MTA2 from preimplantation embryos causes hypomethylation of the paternal H19 
ICR, as well as biallelic expression of H19. Furthermore, depletion of only MTA2 but not 
MBD3 causes biallelic expression of the Peg3 gene. In Chapter 3, I have identified 
cohesins as general cofactors of CTCF at three imprinted loci: the H19/Igf2, 
Kcnq1/Kcnq1ot1 and Dlk1-Dio3 loci. RNA interference (RNAi) experiments targeting 
CTCF and two cohesin subunits, SMC1 and RAD21, causes elevated expression of 
imprinted genes in mouse embryonic fibroblast cells (MEFs). However, imprinted 
expression is maintained, suggesting a non-allelic role of CTCF and cohesins in genomic 
imprinting. Furthermore, in order to study cell-type specific functions of CTCF and 
cohesins. I have derived F1 hybrid trophoblast stem (TS) cell lines that can be used as a 
model cell line.  
This dissertation provides important knowledge about the regulation of imprinted 
gene expression: 1) how DNA methylation marks at imprinted loci are interpreted and 
maintained during mammalian preimplantation development; and 2) how the insulator 
protein CTCF and its cofactor, the cohesin complex, are involved in non-allelic 
regulation of imprinted genes. This knowledge will be critical as an increasing number of 
epimutations at imprinted loci are reported in individuals with BWS, AS, SRS, PWS, 
many types of human cancers and other human diseases. A greater comprehension of the 
mechanisms regulating imprinted gene expression will contribute to the understanding of 
the etiology of these diseases. Furthermore, the incidence of these diseases is increased in 
babies conceived with ART such as in vitro fertilization, so understanding imprinting 
takes on added importance. 
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Chapter 2. Roles of methylated DNA binding proteins in genomic 
imprinting 
45 
 
Germline DMRs are resistant to the genome-wide DNA demethylation during 
preimplantation development (see 1.2.2 and Fig. 1.6). Therefore, an important question is 
the identity of proteins that maintain DMR methylation. The methylated DNA binding 
proteins, including the MBD and Kaiso families, bind specifically to methylated DNA, 
and are associated with transcriptional repression (see 1.3). Thus, these proteins are 
candidates for the dual activities of recognizing DNA methylation at imprinted 
ICRs/DMRs and silencing transcription from the imprinted locus. We proposed that the 
MBD and Kaiso families of proteins may bind to germline DMRs and prevent their 
demethylation during preimplantation development. Moreover, as part of the exquisite 
regulation of imprinted gene regulation, DNA methylation at these DMRs is maintained 
through each cell division in somatic tissues. To assist the regulation of imprinted gene 
expression, the MBD and Kaiso families of proteins may bind to imprinted DMRs before 
and after implantation to 1) maintain the methylation memory; and 2) assist the 
transcriptional repression of silenced imprinted genes. 
Indeed, another methylated DNA binding protein that does not belong to the MBD or 
the Kaiso families, NP95, is associated with the inheritance of DNA methylation after 
each cell cycle (Sharif et al., 2007). The study by Sharif et al. (Sharif et al., 2007) 
suggested that a complex containing NP95 and DNMT1 is localized to replicating foci in 
dividing cells and methylates the newly synthesized DNA strand. NP95 deficient mouse 
embryos exhibit lethality around E10.5, similar to Dnmt1-null embryos, and have global 
loss of DNA methylation (Li et al., 1992; Sharif et al., 2007). Importantly, DNA 
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methylation is lost in the H19 ICR, KvDMR1 and the ICR of the Dlk1-Dio3 locus 
[Intergenic DMR (IG-DMR)], which results in misexpression of linked imprinted genes 
(Sharif et al., 2007). Thus, NP95 functions as a general cofactor of DNMT1 and is 
important for maintenance of DNA methylation at imprinted loci, repetitive elements and 
heterochromatin regions (Sharif et al., 2007). In contrast, the MBD and Kaiso families of 
proteins, except MeCP2 and MBD3, are not essential in development (see 1.3), and 
therefore may function to maintain DNA methylation in a locus-specific manner. 
To test the hypothesis that methylated-CpG binding proteins participate in regulation 
of genomic imprinting, I have used three approaches. First I have used ChIP assays of ES 
cells and mouse embryonic fibroblasts (MEFs) chromatin to investigate the binding of 
methylated DNA binding proteins at five imprinted loci: the H19/Igf2, Dlk1-Dio3, Snrpn, 
Peg3 and Kcnq1/Kcnq1ot1 loci. Second, in collaboration with Dr. Kimberly Reese, a 
former member of the Bartolomei laboratory, I have studied function of MBD3 using 
RNAi to deplete MBD3 in mouse preimplantation embryos and then assay DNA 
methylation and gene expression at imprinted loci. Finally, in collaboration with Drs. 
Pengpeng Ma and Richard Schultz, I have studied the involvement of a MBD3 cofactor, 
MTA2, in genomic imprinting by RNAi experiments.  
2.1. Methylated DNA binding proteins are associated with imprinted loci 
To investigate potential physical interactions between the MBD and Kaiso families 
and imprinted loci, ChIP assays employing antibodies against MBD3, MBD1 and Kaiso 
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were performed. Two model cell lines, F1 hybrid mouse ES cells (Thorvaldsen et al., 
unpublished) and F1 hybrid MEFs were used. ES cells are derived from the ICM of the 
mouse blastocysts (E3.5) (Evans and Kaufman, 1981; Martin, 1981), representing the 
preimplantation embryonic lineage. MEFs are derived from E12.5-14.5 mouse embryos, 
representing embryonic lineage in a later developmental stage. The F1 hybrid cells are 
derived from crosses between two different mouse strains that harbor polymorphisms at 
imprinted loci (see Chapter 5), which allows the distinction between parental alleles. The 
parent-of-origin of imprinted loci can be recognized by restriction enzyme digestion of 
PCR products, which result in strain-specific fragment sizes. I have studied associations 
of MBD3, MBD1 and Kaiso at five imprinted loci (H19/Igf2, Dlk1-Dio3, Snrpn, Peg3, 
and Kcnq1/Kcnq1ot1) in ES cells and MEFs.  
2.1.1. MBD3 binds preferentially to the paternal H19 ICR in ES cells 
Because Mbd3-null embryos die right after implantation (Hendrich et al., 2001), we 
chose MBD3 as the first candidate and tested occupancy of MBD3 at imprinted loci. 
With help from Drs. Kimberly Reese and Raluca Verona, I performed ChIP experiments 
utilizing an antibody against MBD3 and found that MBD3 was enriched at the paternal 
H19 ICR but not other imprinted loci. Some data from the MBD3 ChIP assays was 
published in (Reese et al., 2007).  
Differential histone modifications between two parental alleles, including acetylated 
histone H3 (AcH3) and dimethyl-histone H3 lysine 4 (H3K4me2), are known to be 
associated with imprinted loci including the H19 ICR, IG-DMR, Snrpn DMR and 
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KvDMR1 [(Lewis et al., 2004; Carr et al., 2007; Verona et al., 2008); Verona et al. 
unpublished]. Therefore, an antibody against AcH3 was included as a positive control in 
the ChIP assays. In ES cells, the AcH3 antibody precipitated significantly more 
chromatin (p<0.01) than the no antibody negative control (No-Ab) at the H19 ICR and 
the Snrpn DMR (Fig. 2.1 A). In contrast, an antibody against MBD3 precipitated 
significantly more chromatin (p<0.05) than No-Ab at the H19 ICR but not the Snrpn 
DMR (p=0.24) (Fig. 2.1 A) (Reese et al., 2007). Therefore, MBD3 is associated with the 
H19 ICR but not the Snrpn DMR in ES cells, suggesting a role of MBD3 at the H19 ICR 
during preimplantation development. 
To determine if MBD3 localization at the H19 ICR is enriched on the methylated 
allele, and if MBD3 localizes at other imprinted loci allele-specifically, we performed 
allele-specific PCR analysis of DNA isolated from ChIP experiments. Five imprinted 
regions were analyzed, including two paternally methylated DMRs (the H19 ICR and 
IG-DMR) (Tremblay et al., 1997; Lin et al., 2003) and two maternally methylated DMRs 
(Snrpn DMR and KvDMR1) (Glenn et al., 1996; Smilinich et al., 1999), as well as the 
H19 promoter. The AcH3 antibody was included as a positive control because it is 
enriched to the transcribed allele at imprinted loci in multiple cell types (Verona et al., 
2008). At the H19 ICR, AcH3 is preferentially enriched the unmethylated maternal allele: 
69% of the total DNA that is ChIPed using the AcH3 antibody is from the maternal allele 
(Fig. 2.1 B). In contrast to AcH3, MBD3 is associated preferentially with the methylated 
paternal allele (23% of ChIPed DNA is maternal) (Fig. 2.1 B). We tested four other 
imprinted regions, including the H19 promoter, IG-DMR, Snrpn DMR and KvDMR1 
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Figure 2.1 MBD3 preferentially localizes to the paternal H19 ICR 
(A) ChIPs followed by real-time PCRs showing that MBD3 is associated with the H19 ICR but not 
the Snrpn DMR. *: p<0.05, **: p<0.01. p values show differences between No-Ab control and 
antibodies against AcH3 and MBD3. The data are normalized to AcH3. Error bars indicate 
standard deviation of at least three biological replicates. (B) to (F) Allele-specific ChIP PCRs 
showing that MBD3 is enriched allele-specifically at the paternal H19 ICR but not other imprinted 
loci. PCR primers specific for (B) the H19 ICR, (C) H19 promoter, (D) IG-DMR, (E) Snrpn DMR 
and (F) KvDMR1 were used. In: Input; B: maternal allele; C: paternal allele. The percentage of 
protein binding on the B allele over total binding (B+C) is indicated at the bottom. At least three 
experiments were performed and similar results were obtained. 
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(Fig. 2.1 C-E). At all four regions, no enrichment of MBD3 was observed and the 
background levels of MBD3 binding are around 50% maternal (Fig. 2.1 C-G). 
Furthermore, consistent with the maternal expression of H19, AcH3 is enriched at the 
maternal H19 promoter (60%) (Fig. 2.1 C). AcH3 is also enriched on the maternal allele 
of IG-DMR (70%), which is paternally methylated (Fig. 2.1 D). At two maternally 
methylated DMRs, the Snrpn DMR and KvDMR1, AcH3 is enriched on the paternal 
allele (23% maternal and 4% maternal, respectively) (Fig. 2.1 E and F). Therefore, in ES 
cells, MBD3 is localized preferentially at the paternal H19 ICR, but not the H19 promoter, 
nor other imprinted loci tested. In contrast, in MEFs, preliminary data indicates that 
MBD3 is not enriched at the H19 ICR (data not shown). Altogether, these observations 
suggest that MBD3 play a role in the maintenance of DNA methylation at the H19/Igf2 
locus during the preimplantation period but not after implantation.  
MBD3, in contrast to other MBD proteins, does not bind directly to DNA in vitro 
because two amino acid residues are mutated in the MBD (Fig. 1.7) (Hendrich and Bird, 
1998; Saito and Ishikawa, 2002). Consistently, the association of MBD3 with the H19 
ICR is largely variable between different ChIP experiments (Fig. 2.1 A). MBD3 may bind 
to the H19 ICR indirectly through the interaction with other proteins such as MBD2 or 
other NuRD complex components (see 1.3.1). Furthermore, MBD3 only recognizes the 
H19 ICR but not other imprinted loci tested (Fig. 2.1), suggesting different methylated 
DNA binding proteins may bind to distinct imprinted loci. 
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2.1.2. A survey for occupancy of MBD1 and Kaiso at imprinted loci 
In order to test if other methylated DNA binding proteins are recruited to imprinted 
loci, I performed ChIP assays using antibodies against MBD1 and Kaiso in both F1 
hybrid ES cells and MEFs. MBD2 was not included in the analysis because the MBD2 
antibody I used (see Chapter 5) was not suitable for ChIP experiments (data not shown). 
Four imprinted DMRs, including two paternally methylated loci (the H19 ICR and 
IG-DMR) (Tremblay et al., 1997; Lin et al., 2003) and two maternally methylated loci 
(the Snrpn DMR and Peg3 DMR) (Glenn et al., 1996; Li et al., 2000) are included in this 
survey.  
In ES cells, no significant enrichment of MBD1 or Kaiso was seen at the H19 ICR 
(Fig. 2.2A). At the Snrpn DMR, the antibody against Kaiso precipitated significantly 
more chromatin (p<0.05) than the No-Ab control (Fig. 2.2 A). Consistent with a previous 
report that MBD1 associates with the human SNRPN gene in vitro (Fournier et al., 2002), 
the antibody against MBD1 precipitated more chromatin than No-Ab (Fig. 2.2 A). 
However, it remains uncertain that if this enrichment is statistically significant because 
only two biological repeats were obtained. No statistically significant enrichment of 
MBD1 and Kaiso was detected at the Peg3 DMR (n=3), although the average binding 
signals for MBD1 and Kaiso were higher than No-Ab at the Peg3 DMR (p=0.24 for 
MBD1, p=0.17 for Kaiso). However, allele-specific PCRs showed maternal-specific 
enrichment of MBD1 and Kaiso at the Snrpn DMR and Peg3 DMR (Fig. 2.2 B), which 
are both methylated on the maternal allele (Glenn et al., 1996; Li et al., 2000). As shown 
in Fig. 2.2 B, at the Snrpn DMR, the active histone mark AcH3 is enriched on the 
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Figure 2.2 MBD1 and Kaiso binding to methylated DMRs in ES cells 
ChIPs showing MBD1 and Kaiso occupancy at imprinted loci in ES cells. (A) ChIPs followed by 
real-time PCRs. *: p<0.05. p value shows differences between No-Ab control and antibodies 
against Kaiso. Error bars indicate standard deviation of two or three biological replicates. (B, C) 
Allele-specific ChIP PCRs using primers specific to (B) Snrpn DMR and (C) Peg3 DMR. MBD1 
and Kaiso bind preferentially to the maternal alleles. In: Input; B: maternal allele; C: paternal 
allele. The percentage of protein binding on the B allele over total binding (B+C) is indicated at the 
bottom. 
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unmethylated paternal allele (24% maternal), whereas MBD1 and Kaiso are enriched on 
the methylated maternal allele (97% and 70%, respectively). At the Peg3 DMR, two 
positive histone modifications, AcH3 and H3K4me2, are enriched on the unmethylated 
paternal allele (32% and 33% maternal, respectively). In contrast, MBD1 and Kaiso are 
enriched on the methylated maternal allele (68% and 63%, respectively). Taken together, 
these data suggest that in ES cells, MBD1 and Kaiso bind to the methylated alleles of the 
Snrpn DMR and Peg3 DMR. 
To investigate roles of methylated DNA binding proteins at a different developmental 
stage, MEFs, which represent a postimplantation stage, were used for ChIP assays. Two 
paternally methylated DMRs (the H19 ICR and IG-DMR) (Tremblay et al., 1997; 
Smilinich et al., 1999) were examined for occupancy of MBD1 and Kaiso in MEFs. As 
shown in Fig. 2.3 A, a significant enrichment was seen at the H19 ICR with the antibody 
against Kaiso (p<0.01). Moreover, Kaiso is enriched at the paternal allele of the H19 ICR 
(34% maternal) (Fig. 2.3 B). This observation was consistent with a previous study that 
Kaiso binds to both alleles of the H19 ICR with a bias towards the paternal allele, in adult 
mouse brain (Filion et al., 2006). Although not statistically significant, the antibody 
against MBD1 precipitates more chromatin than the No-Ab at both DMRs in average 
(Fig. 2.3 A). Interestingly, allele-specific analysis suggests that MBD1 is enriched at the 
paternal alleles of H19 ICR and IG-DMR (28% maternal and 31% maternal, respectively) 
(Fig. 2.3 B and C), suggesting possible involvement of MBD1 at these two loci after 
implantation. AcH3 was included as a positive control and was enriched on the 
unmethylated alleles (Fig. 2.3 B and C). 
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Figure 2.3 MBD1 and Kaiso binding to methylated DMRs in MEFs 
ChIPs showing MBD1 and Kaiso occupancy at imprinted loci in MEFs. (A) ChIPs followed by 
real-time PCRs. **: p<0.01. p value shows differences between No-Ab control and antibodies 
against Kaiso. Error bars indicate standard deviation of two or three biological replicates. (B, C) 
Allele-specific ChIP PCRs using primers specific to (B) the H19 ICR and (C) IG-DMR. In: Input; B: 
maternal allele; C: paternal allele. The percentage of protein binding on the B allele over total 
binding (B+C) is indicated at the bottom. 
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I hypothesized that distinct imprinted loci use different protein factors to maintain the 
differential DNA methylation. Consistent with this idea, the ChIP survey provides 
evidence suggesting that methylated-CpG binding proteins are associated with various 
imprinted loci. In ES cells, MBD3 is localized at the methylated paternal H19 ICR, and 
Kaiso binds to the methylated maternal Peg3 DMR. In addition, at the H19 ICR, MBD3 
is associated with the methylated paternal allele in ES cells, whereas Kaiso binds to the 
same allele in MEFs. These results suggest that imprinted loci require different 
methylated DNA binding proteins at distinct developmental time and there is a functional 
difference between these proteins. At other loci tested, these data also indicate association 
of MBD1 and Kaiso with the methylated DMRs. Further characterization is required to 
determine if MBD1 and Kaiso are functionally required at these loci.  
2.2. MBD3 is required for the H19/Igf2 locus in preimplantation embryos 
We have shown that MBD3 is associated with the paternal H19 ICR in ES cells but 
not MEFs (see 2.1.1), suggesting that MBD3 is involved in maintenance of DNA 
methylation at the H19 ICR during preimplantation development. Because the Mbd3-null 
mice die right after implantation (Hendrich et al., 2001), we employed an RNA 
interference (RNAi) approach targeting MBD3 to generate hypomorphic alleles. This 
work was done in collaboration with Dr. Kimberly Reese and published in (Reese et al., 
2007). Two independent RNAi methods (injection and transgenic RNAi) targeting the 
same sequence of the Mbd3 mRNA were used to deplete MBD3 in preimplantation 
embryos (Fig. 2.4). In the first method, in vitro transcribed double stranded RNA (dsRNA) 
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Figure 2.4 Two independent RNAi approaches to deplete MBD3 
Schematic showing the injection RNAi (A) and transgenic RNAi (B) methods targeting MBD3 in 
preimplantation embryos. (A) F1 hybrid (see Chapter 5) 1-cell embryos are injected with dsMbd3 
or dsGfp RNA and cultured in vitro to the blastocyst stage. (B) Transgenic females carrying the 
transgene are mated with males that come from a different strain (see Chapter 5). For both 
methods, blastocysts are collected and analyzed for DNA methylation and imprinted gene 
expression. 
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[dsMbd3 or a dsRNA against Green fluorescent protein (Gfp)] was injected into one-cell 
embryos. Embryos were then cultured in vitro to the blastocyst stage and collected for 
analysis. The second method utilized a Zona pellucida 3 (Zp3) promoter-driven transgene, 
which is expressed in growing oocytes (Fedoriw et al., 2004; Reese et al., 2007). The 
transgene, termed Zp3-dsMbd3 contains an Mbd3 inverted repeat and generates a dsRNA 
identical to the in vitro transcribed dsRNA, targeting the first 510 bp of the Mbd3 mRNA 
(Fig. 2.4). Because the transgene is transcribed in growing oocytes, all embryos from a 
transgenic mother have maternal stores of dsMbd3, regardless of the genotypes of the 
embryos. In RNAi blastocysts generated by both the injection RNAi and the transgenic 
RNAi, the Mbd3 RNA and protein levels were reduced, whereas Mbd2 RNA levels were 
not affected (Reese et al., 2007). As previously stated (see 1.3.1), MBD2 and MBD3 are 
the most closely related members of the MBD family. Because Mbd2 RNA levels were 
unaffected, the RNAi approaches used to target knock-down of MBD3 were both 
effective and specific.  
2.2.1. MBD3 is required for the maintenance of DNA methylation at the H19 ICR 
in preimplantation embryos 
To test if MBD3 depletion causes a loss of DNA methylation at imprinted loci, we 
employed bisulfite mutagenesis and DNA sequencing to screen the DNA methylation 
patterns of ICRs/DMRs in several pools of RNAi and control embryos. Because MBD3 
localizes at the H19 ICR but not Snrpn DMR in ES cells (see 2.1.1), we first tested the 
effects of MBD3 depletion at the H19 ICR. The 5’ portion of the H19 ICR (Fig. 2.5 A) 
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Figure 2.5 Depletion of MBD3 causes loss of DNA methylation at the H19 ICR 
(A) Schematic showing the paternal H19/Igf2 locus. 17 CpGs were assayed in the 5’ portion of the 
H19 ICR as indicated by the black line below the diagram. (B) Bisulfite mutagenesis of RNAi 
treated embryos and control embryos. Percentages of hypomethylated strands are indicated on 
top of each group. Each line of circles represents a single DNA strand with the number to the left 
of the line corresponding to the number of times this pattern was seen. Each circle represents a 
single CpG. If the CpG was methylated, the circle is filled. Those strands with less than half of the 
CpGs methylated are considered hypomethylated. Only the paternal strands are shown. 
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was analyzed by cloning and sequencing of the bisulfite treated DNA. We could 
distinguish the maternal and paternal strands by using single nucleotide polymorphisms 
(SNPs) between the two alleles in our F1 hybrid embryos (see Chapter 5). Fig. 2.5 B 
shows the paternal strands of H19 ICR, as all sequenced maternal strands were 
unmethylated as expected (data not shown). Strands with less than half of the CpGs 
methylated are considered hypomethylated. In control embryos, only a few 
hypomethylated strands are identified (13% and 22% for uninjected and dsGfp-injected 
blastocysts, respectively), but in dsMbd3-injected embryos, 42% of the paternal strands 
are hypomethylated. Zp3-dsMbd3 transgenic blastocysts showed similar results with 42% 
of the paternal strands hypomethylated compared with 16% of the strands in 
non-transgenic embryos. Similar analysis was also performed at the Snrpn DMR, but the 
normally methylated maternal alleles from RNAi embryos did not differ from controls 
(data not shown), consistent with the result the absence of MBD3 binding (see 2.1.1). 
These results indicate that MBD3 is required to maintain the paternal DNA methylation 
at the H19 ICR during the preimplantation period. In addition, they indicate that other 
imprinted DMRs utilize different protein factors to maintain differential DNA 
methylation during preimplantation development. Consistently, MBD1 and Kaiso are 
suggested to be associated with the methylated allele of Snrpn DMR and Peg3 DMR in 
ES cells, whereas no binding of MBD1 or Kaiso was observed in the H19 ICR in ES cells 
(see 2.1.2 and Fig. 2.2). 
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2.2.2. MBD3 is required for the imprinted expression of H19 in preimplantation 
embryos 
Loss of DNA methylation of the H19 paternal ICR is associated with activation of 
H19 expression from the paternal allele (Engel et al., 2004). Therefore H19 allelic 
expression may be affected by MBD3 depletion, together with loss of DNA methylation 
at the H19 ICR. To investigate whether MBD3 is required for imprinted expression of 
H19, we performed allele-specific reverse-transcription (RT) PCR analysis of single 
blastocysts (Mann et al., 2003). In blastocysts derived from injection of one-cell embryos 
with dsMbd3, 26% (9/35) of the embryos showed biallelic H19 expression whereas only 
4% (2/26) of uninjected blastocysts and no dsGfp-injected blastocysts (0/28) exhibited 
biallelic H19 expression (Fig. 2.6A). The numbers of dsMbd3 embryos that exhibit 
biallelic H19 expression are significantly different from the numbers of control embryos 
(p<0.01, Chi-square) (Fig. 2.6 A). Similarly, 39% (15/38) of blastocysts derived from 
Zp3-dsMbd3 transgenic mothers exhibited biallelic H19 expression, whereas none of the 
non-transgenic blastocysts (0/5) showed biallelic expression (Fig. 2.6 B). Although allelic 
expression of H19 is closely coordinated with Igf2 (see 1.1.3.1), Igf2 is not expressed in 
early embryos until after implantation. Thus, we cannot use this approach to assess the 
role of MBD3 in the regulation of Igf2 expression. Nevertheless, these experiments 
demonstrate that MBD3 is required for proper imprinted expression of H19 in 
preimplantation embryos. 
RNAi treated embryos were also assayed for the other imprinted genes expressed at 
this early stage, including Snrpn, Peg3, Gtl2 and ATPase Cu++ transporting alpha 
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Figure 2.6 Depletion of MBD3 causes biallelic expression of H19 in preimplantation 
embryos 
(A) H19 is biallelically expressed in 26% (9/35) of dsMbd3-injected embryos. This is statistically 
significant different from controls [p<0.01 compared with uninjected (2/46) and p<0.01 compared 
with dsGfp-injected (0/28)]. (B) H19 is biallelically expressed in 39% (15/38) of transgenic 
embryos. None (0/5) of the non-transgenic controls showed biallelic expression. 
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polypeptide (Atp7a). Atp7a is located on the X chromosome and is silenced on the 
paternal allele due to imprinted X-inactivation in the preimplantation embryo (Huynh and 
Lee, 2003). Female embryos were tested for Atp7a and all embryos were tested for Snrpn, 
Peg3 and Gtl2 expression. No change in allelic expression was detected for any of these 
genes in MBD3-depleted embryos (data no shown). These results suggest that MBD3 
may be only required for H19 at the blastocyst stage. 
By using two independent RNAi methods (injection RNAi and transgenic RNAi), we 
observed the same effects on the imprinted expression and DNA methylation of H19, 
demonstrating that MBD3 is required for maintenance of the DNA methylation and 
repression of the paternal H19, but not at other imprinted loci tested. These results 
indicate that the silent alleles at imprinted loci other than the H19/Igf2 locus employ other 
MBD or Kaiso families of proteins to confer silencing of the inactive allele. 
However, the paternal H19 ICR is totally demethylated on some strands but not on 
others (Fig. 2.5). Similarly, not all RNAi embryos exhibited biallelic expression of H19 
(Fig. 2.6). The variable phenotypes between embryos are probably due to incomplete 
depletion of the MBD3 protein from these embryos because detectable amounts of Mbd3 
RNA and protein remained in the RNAi embryos (Reese et al., 2007). Furthermore, 
several other methylated DNA binding proteins, including MBD1 and Kaiso, are also 
expressed in preimplantation embryos and may contribute to the maintenance of paternal 
H19 ICR methylation [(Zeng et al., 2004); Reese and Bartolomei, unpublished]. 
Consistently, our preliminary ChIP data suggest that MBD1 and Kaiso bind to the 
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paternal H19 ICR, in both ES cells and MEFs (see 2.1.2 and Fig. 2.2, 2.3).  
We examined expression of four other imprinted genes in MBD3-depleted embryos, 
but none showed activation of the silent allele. One explanation is that residual amount of 
MBD3 is sufficient to maintain appropriate monoallelic expression of these genes. 
Alternatively, MBD3 is not involved in the repression of these genes. In this case, other 
proteins or protein complexes, such as ZFP57 (Mackay et al., 2008; Li et al., 2008), 
MBD1 and Kaiso, may be required for their imprinted expression. Alternatively, other 
methylated DNA binding proteins that are expressed in preimplantation embryos might 
be sufficient to compensate for the reduction of MBD3 at these loci, but not at H19. By 
reducing several methylated DNA binding proteins in concert by RNAi, such 
compensatory mechanisms might be uncovered.  
Our analysis has been focused on the preimplantation stage because it is the period 
when genome-wide reprogramming takes place. In addition, our RNAi methods only 
provide transient depletion of MBD3. The MBD3 protein level is presumably recovered 
later as the dsRNAs are diluted during embryonic growth after implantation, and the 
dsRNAs are degraded. For the dsMbd3 RNAi experiments, despite the early phenotypes 
described above, mice from Zp3-dsMbd3 transgenic mothers can be developed full term 
and are healthy and fertile. This suggests that the RNAi effect is only brief and does not 
affect the viability. Alternatively, all the embryos that did not have sufficient amount of 
MBD3 died before birth. In embryos that survived, temporary depletion of MBD3 may 
still impact later development in a subtle way. To test if MBD3 knock-down has a 
long-existing effect in genomic imprinting, embryos from later developmental stages 
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need to be analyzed for DNA methylation status and imprinted expression of imprinted 
loci. Reese et al. recovered seven E7.5 embryos from a Zp3-dsMbd3 transgenic female. 
In all embryos, expression of H19 was monoallelic (Reese et al., 2007). This suggests 
that either the active paternal H19 expression observed in Zp3-dsMbd3 blastocysts is 
repressed during/after implantation or the embryos have biallelic H19 expression did not 
survive. Analysis of both H19 expression and DNA methylation at the H19 ICR in 
additional postimplantation Zp3-dsMbd3 embryos (e.g., E6.5 embryos) was therefore of 
interest. I have conducted several experiments using E6.5 embryos, but that transgene 
was unfortunately repressed. Based on experience of others using a transgenic technique 
in the B6 mice (Bartolomei and Weaver, personal communications), such transgene 
repression is not rare because B6 mice are prone to high levels of DNA methylation 
(Sapienza et al., 1989). To resolve this problem, I introduced the Zp3-dsMbd3 transgene 
into a different strain, DBA/2J (The Jackson laboratory), which has less DNA 
methylation activity (Sapienza et al., 1989; Allen et al., 1990). Similar experiments were 
performed in mice with a different transgene by Jamie Weaver, a graduate student in the 
Bartolomei laboratory. Successful reactivation of the transgene was observed after it was 
crossed into DBA/2J mice for 5-6 generations (Weaver et al. unpublished). I have 
successfully derived the DBA/2J Zp3-dsMbd3 mice, now allowing examination of the 
knock-down efficiency, as well as further analysis of the long-term effects of MBD3 
depletion. 
2.3. MTA2 is required for imprinted expression at the H19/Igf2 and Peg3 loci in 
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preimplantation embryos 
MBD3 is a component of the NuRD complex, which can remodel nucleosomes and 
deacetylate histones, and thereby is associated with transcriptional repressions [reviewed 
in (McDonel et al., 2009)]. The NuRD complex is composed of at least seven proteins in 
mammals and shares four components, HDAC1, HDAC2 and two histone-binding 
proteins (Retinoblastoma binding protein 4 (RBBP4) and RBBP), with the Sin3A histone 
deacetylase complex (McDonel et al., 2009). The other three proteins, Chromodomain 
helicase DNA binding protein (CHD)/Mi-2 (CHD3/Mi-2α or CHD4/Mi-2β), MBD 
(MBD2 or MBD3), and MTA (MTA1, MTA2 or MTA3), appear to be unique to the 
NuRD complex (McDonel et al., 2009). 
HDAC1 and 2 are histone deacetylases that catalyze removal of lysine residues in 
histone tails (Thiagalingam et al., 2003), a process associated with epigenetic silencing. 
CHD3/4 is the largest subunit of the NuRD complex, and has a chromodomain that 
exhibits ATP-dependent nucleosome-remodeling activity (Zhang et al., 1998).  
MTA proteins (MTA1, 2, and 3) are the last characterized components of the NuRD 
complex (Manavathi and Kumar, 2007). It is suggested that only one MTA protein is 
present in a given NuRD complex (Yao and Yang, 2003; Bowen et al., 2004b; Fujita et al., 
2004; Manavathi and Kumar, 2007; Wang et al., 2009), presumably contributing to target 
specificity. The founding member of the MTA family, MTA1, was first described in rat 
metastatic breast tumors (Toh et al., 1997). Since then, MTAs have been implicated in 
numerous biological processes [e.g., estrogen receptor α (ERα)-associated signaling] 
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(Manavathi and Kumar, 2007). MTA2 deficient mice exhibit multiple phenotypes, 
including partial embryonic and perinatal lethality, female infertility, abnormal T cell 
activation, and lupus-like autoimmune disease (Lu et al., 2008). Although it is likely that 
the three MTAs form different NuRD complexes with distinct functions (Yao and Yang, 
2003; Bowen et al., 2004b; Fujita et al., 2004; Manavathi and Kumar, 2007; Wang et al., 
2009), the role of MTA proteins in the function of NuRD complexes remains elusive. 
MBD3 is an integral member of the NuRD complex because depletion of MBD3 
causes disassembly of the NuRD complex and degradation of some NuRD complex 
components in ES cells (Kaji et al., 2006). Consistently, in our MBD3-depleted 
blastocysts, MTA2 protein levels were reduced by 53% in the nuclei (Reese et al., 2007). 
The requirement for MBD3 at the H19/Igf2 locus and the accompanying reduction in 
MTA2 levels strongly implicates a role for the NuRD complex in genomic imprinting. 
In this section, I will present experiments done in collaboration with Drs. Pengpeng 
Ma and Richard Schultz, investigating requirements of MTA2 for genomic imprinting in 
preimplantation embryos. We have shown that: 1) MTA2 is required for the imprinted 
expression of two genes, H19 and Peg3; and 2) similar to MBD3, MTA2 is required for 
maintenance of the paternal methylation at the H19 ICR. This work was published in (Ma 
et al., 2010). 
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2.3.1. MTA2 is required for the imprinted expression of H19 and Peg3 in 
preimplantation embryos 
We demonstrated that MBD3 is required for maintenance of the paternal DNA 
methylation in the H19 ICR, and is required for imprinted expression of H19 in 
preimplantation embryos (see 2.2). MTA2 protein levels were reduced in the nuclei of 
MBD3-depleted embryos (Reese et al., 2007), indicating involvement of the NuRD 
complex in regulating H19 expression. To define further the function of the NuRD 
complex in genomic imprinting, and in particular the function of MTA2, we used an 
injection RNAi approach to deplete selectively MTA2 in mouse preimplantation embryos. 
Similar to the injection RNAi approach used to target MBD3 (Fig. 2.4 A), 1-cell embryos 
were injected with in vitro transcribed dsMta2 or dsGfp RNA. The embryos were then 
cultured to the blastocyst stage and collected for analysis. MTA2 protein was largely 
depleted (less than 10% of the dsGfp-injected control) in these embryos as determined by 
immunocytochemistry and western blot (Ma et al., 2010). 
To determine the effect of directly depleting MTA2 on imprinted genes, 
allele-specific RT PCR was performed, allowing examination of allelic expression of H19 
in MTA2-depleted blastocysts (Fig. 2.7 A). Consistent with the phenotypes observed in 
MBD3-depleted embryos (Fig. 2.6), we found that H19 expression was biallelic in 32% 
of the dsMta2-injected embryos (16/50) whereas only 10% (4/39) of the dsGfp-injected 
embryos exhibited biallelic H19 expression (p<0.05, Chi-square). Moreover, no 
difference was observed in the expression of Snrpn between dsMta2- and dsGfp-injected 
embryos [0% (0/36) biallelic and 1% (1/21) biallelic, respectively] (Fig. 2.7 B); as well as 
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Figure 2.7 Depletion of MTA2 causes biallelic expression of H19 and Peg3 in 
preimplantation embryos 
Shown are percentages of embryos that biallelically express (A) H19, (B) Snrpn and (C) Peg3. *: 
p<0.05. p values show difference between RNAi embryos and control embryos. (A) H19 is 
biallelically expressed in 32% (16/50) of dsMta2-injected embryos. This is statistically significantly 
different from dsGfp-injected [10% (4/39)]. (B) Monoallelic expression of Snrpn is maintained in 
both dsGfp- [1% (1/21) biallelic] and dsMta2-injected embryos [0% (0/36) biallelic] (p>0.05). (C) 
Monoallelic expression of Kcnq1ot1 is maintained in both dsGfp- [0% (0/3) biallelic] and 
dsMta2-injected embryos [0% (0/5) biallelic]. (D) Peg3 is biallelically expressed in 32% (12/38) of 
dsMta2-injected embryos. This is statistically significantly different from dsGfp-injected [7% 
(2/28)]. 
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in the expression of Kcnq1ot1 (3 dsGfp-injected embryos and 5 dsMta2-injected embryos 
were analyzed, and all of them showed monoallelic expression of the paternal allele) (Fig. 
2.7 C). In contrast, a different phenotype between the dsMbd3 embryos and dsMta2 
embryos was seen at the Peg3 locus: 32% (12/38) of the MTA2-injected embryos 
exhibited biallelic Peg3 expression when compared with dsGfp-injected embryos [7% 
(2/28)] (Fig. 2.7 D), whereas Peg3 remained imprinted in the dsMbd3 embryos (see 
2.2.2). These results suggest that MBD3 and MTA2 function in concert to regulate 
imprinted expression of H19, but not Snrpn, in preimplantation embryos, and that MTA2 
functions independently of MBD3 at the Peg3 locus.  
2.3.2. MTA2 is required for the maintenance of DNA methylation at the H19 ICR 
in preimplantation embryos 
The H19 ICR is hypomethylated in MBD3-depleted embryos (Fig. 2.5), whereas 
Snrpn DMR is not affected (see 2.2.1). To investigate the effects of MTA2 depletion in 
DNA methylation at imprinted loci, we performed bisulfite mutagenesis and DNA 
sequencing using pools of dsMta2- and dsGfp-injected embryos (Fig. 2.8). The normally 
unmethylated maternal H19 ICR, paternal Snrpn DMR and paternal Peg3 DMR were all 
hypomethylated as expected (data not shown). DNA methylation profiles of the paternal 
H19 ICR, maternal Snrpn DMR and maternal Peg3 DMR are shown in Fig. 2.8. We 
observed a significant increase (p<0.01, Chi-square) in the number of DNA 
hypomethylated strands in MTA2-depleted embryos (43%) compared with controls (12%)  
(Fig. 2.8 A). These results strongly suggest that MTA2 is necessary for both the proper 
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Figure 2.8 Depletion of MTA2 causes hypomethylation at the H19 ICR 
Bisulfite mutagenesis of RNAi treated embryos and control embryos. Percentages of 
hypomethylated strands are indicated on top of each group. Strands with less than half of the 
CpGs methylated are considered hypomethylated. 17, 16 and 24 CpGs were analyzed for (A) 
H19 ICR, (B) Snrpn DMR, (C) Peg3 DMR, respectively. Only the normally methylated strands are 
shown. (A) The dsMta2-injected embryos have significantly more hypomethylated strands 
compared with the dsGfp-injected embryos (p<0.01). (B, C) The RNAi embryos are not different 
from the controls (p>0.05). 
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imprinted gene expression of H19 and the maintenance of H19 paternal methylation in 
mouse preimplantation embryos. In contrast, no changes in DNA methylation were 
detected at the Snrpn DMR (Fig. 2.8 B), consistent with the monoallelic expression of 
Snrpn in both RNAi embryos and controls (Fig. 2.7 B). However, although the 
dsMta2-injected embryos had more strains that were hypomethylated than the 
dsGfp-injected embryos (40% versus 22%) (Fig. 2.8 C), the difference was not 
statistically significant (p>0.05, Chi-square). Effects of MBD3- and MTA2-depletions at 
imprinted loci are summarized in Table 1. 
In the dsMta2-injected embryos analyzed, roughly equal percentages of embryos 
exhibited biallelic expression of Peg3 and H19 (Fig. 2.7 A and D), suggesting that these 
two imprinted loci require similar amounts of MTA2 protein and/or MTA2-containing 
complexes. However, only the DNA methylation in the paternal H19 ICR was 
significantly affected. These data suggest that cis elements other than the Peg3 DMR may 
be required for imprinted expression of Peg3. Consistently, the Peg3 DMR has not been 
demonstrated to function as an ICR by deficiency studies. Szeto et al. (Szeto et al., 2004) 
analyzed three different lines of transgenic mice that carry a bacterial artificial 
chromosome (BAC) covering 120 kb around the Peg3 locus. Although all BACs included 
the Peg3 DMR sequence, only one out of three lines of transgenic mice exhibited partial 
imprinted expression of Peg3 and differential methylation in the Peg3 DMR. These 
results suggest that the Peg3 DMR alone is not sufficient to control the imprinted 
expression of Peg3 and our data indicate that MTA2 functions through an unknown 
element, in addition to the Peg3 DMR, to repress the maternal Peg3. 
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Table 1 Effects of MBD3- and MTA2-depletion at imprinted loci in preimplantation embryos 
Imprinted locus (DNA methylation and/or gene 
expression) 
MBD3-depleted 
embryos 
MTA2-depleted 
embryos 
H19/Igf2 
Paternal H19 ICR methylation Reduced Reduced 
H19 expression Biallelic Biallelic 
Snrpn 
Maternal Snrpn DMR 
methylation 
No effect No effect 
Snrpn expression Monoallelic Monoallelic 
Peg3 
Maternal Peg3 DMR 
methylation 
N/A No effect 
Peg3 expression Monoallelic Biallelic 
Kcnq1/Kcnq1ot1 Kcnq1ot1 expression Monoallelic Monoallelic 
Dlk1-Dio3 Gtl2 expression Monoallelic N/A 
X-Chromosome Atp7a Monoallelic N/A 
N/A: data not available. The phenotypes that are different from control embryos are underlined. 
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During mammalian preimplantation development, genome-wide DNA demethylation 
occurs at most methylated sequences except at some repeats and germline imprinted 
DMRs (see 1.2.2 and Fig. 1.6). The paternally methylated H19 ICR must survive the 
active DNA demethylation on the paternal genome and then stay methylated in 
subsequent stages during passive demethylation (Tremblay et al., 1995, 1997), whereas 
the maternally methylated Peg3 DMR must survive the maternal-specific passive 
demethylation (Li et al., 2000). How these processes occur has remained largely 
unknown. We proposed that methylated DNA binding proteins are involved in these 
processes, and that maternally- and paternally-methylated DMRs require protection from 
different proteins. We have shown that MBD3, as well as its NuRD complex cofactor 
MTA2, are intimately involved at the maintenance of DNA methylation at the H19 ICR 
during preimplantation development.  
We found that depletion of MTA2, but not MBD3, led to biallelic expression of Peg3, 
suggesting an independent function of MTA2 that is not related to MBD3. Because 
MTA1 is translocated from the nucleus to the cytoplasm in MTA2-depleted embryos as 
shown by western blot and immunocytochemistry experiments performed by Dr. 
Pengpeng Ma (Ma et al., 2010), MTA1-containing NuRD complexes may be the actual 
functioning complexes at the Peg3 locus, whereas MTA2- and MBD3-cotaining NuRD 
complexes control the H19 locus.  
In conclusion, data presented in Chapter 2 have provided the first link between 
MBD3- and MTA2-containing NuRD complex and genomic imprinting. It remains 
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elusive how loss of MBD3 and MTA2 is mechanistically linked to biallelic expression of 
H19 and Peg3, and linked to loss of DNA methylation at the H19 ICR. Although MBD3 
localizes at the H19 ICR, no binding of MTA2 at the H19 ICR and Peg3 DMR was 
observed in ChIP experiments using multiple MTA2 antibodies (data not shown). This 
could be because the MTA2 antibodies were not suitable for ChIP experiments. 
Nevertheless, our results uncover essential roles for MBD3, MTA2 and the NuRD 
complex in maintaining differential DNA methylation and controlling allelic expression 
at imprinted loci. 
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Chapter 3. Roles of CTCF and the cohesin complex in genomic 
imprinting 
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CTCF is a multi-functional protein that plays important roles in chromosomal 
organization (see 1.4). CTCF binds to a number of imprinted loci, including H19/Igf2¸ 
Dlk1/Dio3, Kcnq1/Kcnq1ot1, Grb10 and Rasgrf1 (see 1.1.3.1 and 1.4). As previously 
mentioned, CTCF binding sites are required for the insulator activity of the H19 ICR. 
Deletion of these binding sites from the maternal chromosome leads to biallelic 
expression of Igf2 and reduced H19 expression (Schoenherr et al., 2003; Pant et al., 2003, 
2004; Szabo et al., 2004; Engel et al., 2006). In contrast, CTCF may play other functions 
such as transcriptional activation or repression at other imprinted loci.  
It remains largely unknown how CTCF can manifest multiple functions in the 
nucleus. One hypothesis is that CTCF recruits disparate protein cofactors to distinct 
binding sites and therefore functions differently. Indeed, a number of CTCF cofactors are 
associated with various functions of CTCF (see 1.4.4). The cohesin complex plays 
important roles in chromosome biology and transcriptional regulation (Barbero, 2009), 
and was recently found to interact with CTCF (Stedman et al., 2008). Lieberman and 
colleagues described colocalization of CTCF and cohesins at the major latency control 
region of the Kaposi’s sarcoma-associated herpesvirus (KSHV). Deletion of the CTCF 
binding site from the viral genome disrupted cohesins binding and caused derepression of 
two lytic transcripts (Stedman et al., 2008). The authors additionally showed 
colocalization of CTCF and cohesins at the cellular Myc locus. These data prompted our 
interest to investigate possible involvement of cohesins at imprinted loci. 
In Chapter 3, I tested the hypothesis that CTCF and cohesins function together for 
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regulation of imprinted gene expression, by conducting the following experiments: 1) 
Using ChIP assays, I studied colocalization of CTCF and two cohesin subunits, SMC1 
and RAD21, at five imprinted regions: the H19 ICR, conserved sequence at the 
intervening region (IVR) between H19 and Igf2, a CTCF binding site upstream of Igf2, 
Gtl2 DMR and KvDMR1. 2) I further analyzed the functional requirement of CTCF and 
cohesins at these imprinted loci by small interfering RNA (siRNA) treatments to 
knock-down CTCF, SMCI and RAD21 in F1 hybrid primary MEFs. MEF was chosen as 
a model cell line because it exhibits monoallelic expression of imprinted genes that are 
linked to CTCF binding sites. Furthermore, another model cell line, TS cells were derived 
to study cell-type specific functions of CTCF and cohesins.  
3.1. CTCF and cohesins colocalize at three imprinted loci 
To investigate potential physical interactions between cohesins and imprinted loci, 
ChIP assays employing antibodies against two cohesins subunits, SMC1 and RAD21, as 
well as CTCF were performed. Three imprinted loci, the H19/Igf2, Dlk1-Dio3 and 
Kcnq1/Kcnq1ot1 loci, were included in the study. The H19/Igf2 locus employs an 
insulator mechanism to regulate imprinted gene expression in a CTCF binding 
sites-dependent manner (see 1.1.3.1 and 1.4.1), whereas both the Dlk1-Dio3 (see 3.1.2) 
and Kcnq1/Kcnq1ot1 loci (see 1.1.3.2) are suggested to use the long ncRNA mechanism. 
There are CTCF binding sites located in these loci that employs different mechanisms to 
regulate imprinting (Szabó et al., 2000; Bell and Felsenfeld, 2000; Hark et al., 2000; 
Kanduri et al., 2000; Fitzpatrick et al., 2007; Kernohan et al., 2010), suggesting that 
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CTCF may manifest multiple functions in genomic imprinting. 
3.1.1. CTCF and cohesins colocalize at the H19/Igf2 locus 
The four CTCF binding sites located in the H19 ICR have been well characterized 
(see 1.1.3.1). In addition to the H19 ICR, there are a number of other CTCF binding sites 
at the IVR (Chen et al., 2008) and the Igf2 gene (Du et al., 2003; Kurukuti et al., 2006; 
Yoon et al., 2007; Chen et al., 2008; Li et al., 2008). CTCF’s role at the IVR remains 
largely unknown. Some CTCF binding sites around the Igf2 gene recruit CTCF in a 
maternal-specific manner, and were hypothesized to be required for maternal repression 
of Igf2 expression (Kurukuti et al., 2006; Li et al., 2008) (see 3.2.1.2). I have examined 
colocalization of CTCF and cohesins in the H19 ICR and the IVR (see below). 
3.1.1.1. CTCF and cohesins colocalize at the maternal H19 ICR 
To investigate cohesins’ presence at imprinted loci, ChIP experiments using 
antibodies against CTCF and two cohesin subunits, SMC1 and RAD21, were carried out 
in MEFs (Fig. 3.1 B and Fig. 3.2 B). Consistent with the colocalization of CTCF and 
cohesins in the KSHV genome (Stedman et al., 2008), both SMC1 and RAD21 colocalize 
with CTCF at the H19 ICR (Fig. 3.1 B), but not at three other H19 regions analyzed, 
including a region upstream of the ICR (DMD_UP), H19 promoter (Prom) and Exon 5 
(Ex5) (Fig. 3.1 A, B) (Verona et al., 2008). In addition, PCRs of ChIPed DNA using 
primers specific for the c-Myc CTCF binding site was also included as a positive control 
(Fig. 3.1 A). These data demonstrate that cohesins bind specifically to the H19 ICR 
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Figure 3.1 Cohesins colocalize with CTCF at the H19 ICR, in a CTCF binding 
sites-dependent manner 
(A) Schematic showing the H19/Igf2 locus. The white bars indicate four CTCF binding sites that 
are deleted in the H19∆R/+ mutant. The regions analyzed in (B, C) are indicated by black bars 
below the diagram. DMD_UP: upstream of ICR; Rep1&2: CTCF binding sites 1&2 in the ICR; 
Prom: H19 promoter; Ex5: H19 Exon 5. (B, C) ChIPs followed by real-time PCRs. *: p<0.05; **: 
p<0.01. p value shows differences between No-Ab control and antibodies against CTCF, SMCI 
and RAD21. Error bars indicate standard deviation of at least three biological replicates. (B) 
CTCF and cohesins colocalize at the H19 ICR but not other regions (DMD_UP, Prom and Ex5) in 
the H19/Igf2 locus. The Myc promoter was included as a positive control. (C) Shown are binding 
of CTCF and cohesins in wild-type (WT) MEFs and neonatal liver from the H19∆R/+ mutant at 
Rep1&2 region. Cohesins binding is lost in the H19∆R/+ mutant. 
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which has four CTCF binding sites, but do not bind to other regions assayed at the H19 
locus. 
The binding of cohesins at the KSHV latency control region is dependent on the 
CTCF binding sites (Stedman et al., 2008). In order to test if the same dependence is also 
true at the H19 ICR, I performed ChIP assays targeting CTCF and cohesins in the 
H19∆R/+ mutant, which has maternal transmission of the H19∆R mutant allele, an allele 
that lacks the four CTCF binding sites at the H19 ICR (Fig. 1.2) (Engel et al., 2006). As 
expected, CTCF no longer binds to the H19 ICR in the mutant, and the same is true for 
cohesins (Fig. 3.1 C). These data demonstrate that the maternal CTCF binding sites are 
required for cohesins binding at the H19 ICR. In addition, because cohesin binding is 
completely abolished in H19∆R/+ mutant, cohesins likely only bind to the wild-type 
maternal allele. Indeed, allele-specific PCRs of ChIPed DNA from F1 hybrid MEFs 
suggest that both cohesin subunits preferentially bind to the maternal allele of H19 ICR 
(Fig. 3.2 B). In contrast, at the Ex5 region where cohesins are not enriched (Fig. 3.1 B), 
the background levels of ChIP signals are equal between maternal and paternal alleles, 
similar to signals from the No-Ab control (Fig. 3.2 D). Similarly, in neonatal liver from 
the H19∆R/+ mutant, ~50% of background signals at the H19 ICR are from either parental 
allele (Fig. 3.2 C). In conclusion, cohesins colocalize with CTCF at the maternal H19 
ICR, in a CTCF binding site-dependent manner. These results were published together 
with the KSHV data in (Stedman et al., 2008). 
81 
 
 
Figure 3.2 Cohesins colocalize with CTCF at the maternal H19 ICR 
(A) Schematic showing the H19/Igf2 locus. The white bars indicate the four CTCF binding sites 
that are deleted in the H19∆R/+ mutant. The regions analyzed in (B) to (D) are indicated by black 
bars below the diagram. Rep3: CTCF binding sites 3 in the ICR; Ex5: H19 Exon 5. (B-D) 
Allele-specific ChIP PCRs. (B) CTCF and cohesins are enriched on the maternal allele at Rep3 in 
wild-type (WT) cells. (C) The allelic binding of CTCF and cohesins is lost in the H19∆R/+ mutant. 
(D) No allelic binding of CTCF and cohesins is seen at Ex5 in WT. In: Input; B: maternal allele; C: 
paternal allele. The percentage of protein binding on the B allele over total binding (B+C) is 
indicated at the bottom.  
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3.1.1.2. CTCF and cohesins colocalize at the intervening region between H19 and 
Igf2 
A DNase I hypersensitivity site (HSS) intergenic to H19 and Igf2 (~40 kb from either 
gene) that colocalizes to a conserved sequence between human and mouse has previously 
been described (Fig. 3.3 A) (Koide et al., 1994; Ainscough et al., 2000). Other studies 
have suggested that this HSS region contains an Igf2 muscle specific repressor and/or 
brain specific enhancer (Ainscough et al., 2000; Jones et al., 2001). Interestingly, a CTCF 
binding site was reported to be located in the conserved sequence within the HSS (Chen 
et al., 2008). Recently, using a mouse imprinting region tiling array (MIRTA) of 
embryonic tissues, Huang and Barlow have identified an abundant transcript adjacent to 
the intergenic HSS and nearer to Igf2 (Ru Huang and Denise Barlow, Research Center for 
Molecular Medicine of the Austrian Academy of Sciences, unpublished). This transcript 
is called the intervening region (IVR) transcript. The IVR transcript is ~8 kb long and its 
transcription start site is 1.5 kb distal to the CTCF binding site within the HSS (Fig. 3.3 
A). Allele-specific expression analysis of the IVR transcript in wild-type embryonic 
tissues demonstrated it is preferentially expressed from the paternal allele (75% to 85% 
bias) (Thorvaldsen and Bartolomei, unpublished). When this analysis was performed in 
embryonic tissues inheriting deletion of the H19 maternal ICR (Thorvaldsen et al., 1998), 
preferential expression of the paternal IVR transcript is no longer detected (Thorvaldsen 
and Bartolomei, unpublished). These data demonstrate that imprinted expression of the 
IVR transcript is dependent upon the H19 ICR. I set out to determine if CTCF and 
cohesins bound to the conserved sequence adjacent to the IVR transcription start site, 
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Figure 3.3 Cohesins colocalize with CTCF at the CTCF binding site in the IVR 
(A) Schematic showing the IVR region which is ~40 kb from H19 and Igf2. The direction of the IVR 
transcript is shown with the arrow. The green boxes represent two conserved regions, one of 
which overlaps with a HSS and contains a CTCF binding site (Koide et al., 1994; Ainscough et al., 
2000; Chen et al. 2008). The regions analyzed in (B, C) are indicated by black bars below the 
diagram. Ctrl1 & 2: control 1 & 2; IVR CBS: IVR CTCF binding site. (B) ChIPs followed by 
real-time PCRs show that CTCF and cohesins bind to the IVR CBS but not Ctrl1 & 2. The H19 
ICR is included as a positive control. *: p<0.05; **: p<0.01. p value shows differences between 
No-Ab control and antibodies against CTCF, SMCI and RAD21. Error bars indicate standard 
deviation of at least three biological replicates. (C) Allele-specific ChIP PCRs show that CTCF 
and cohesins bind to both alleles of IVR CBS in MEFs. In: Input; B: maternal allele; C: paternal 
allele. The percentage of protein binding on the B allele over total binding (B+C) is indicated at the 
bottom. At least three experiments were performed and similar results were obtained. 
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where a CTCF binding site had been identified (Fig. 3.3 A) (Chen et al., 2008). 
To investigate potential interactions of cohesins at the IVR locus, I performed ChIP 
experiments in F1 hybrid MEFs using antibodies targeting CTCF, SMCI and RAD21. 
Real-time PCRs of ChIPed DNA showed that CTCF and cohesins colocalize at the IVR 
CTCF binding site (CBS), but not in two control regions, Ctrl1 and Ctrl2 (Fig. 3.3 A, B). 
Ctrl1 is located ~2.1 kb proximal to the CBS, whereas Ctrl2 resides at the 5’ end of the 
IVR transcript Exon 2 (Fig. 3.3 A) (Thorvaldsen and Bartolomei, unpublished). Because 
the IVR transcript is partially imprinted and expresses from mostly the paternal allele 
(Thorvaldsen and Bartolomei unpublished), I tested if CTCF and cohesins binding was 
enriched at one particular allele by allele-specific PCRs. As shown in Fig. 3.4 C, CTCF 
and cohesins bind to both alleles of the IVR CBS. Two histone modifications, AcH3 and 
H3K4me2 are associated equally with both alleles. The binding of CTCF, SMCI and 
RAD21 are slightly biased to the paternal allele (48%, 40% and 43% maternal, 
respectively), whereas the input DNA is 59% maternal. The same bias was seen in three 
independent experiments but was not statistically different from the input (data not 
shown). Consistent with our data that CTCF and cohesins bind to both alleles at the IVR 
CBS in MEFs, an approximately 1 kb region around the IVR CBS is hypomethylated on 
both parental alleles in embryos (Koide et al., 1994).  
These data show that CTCF and cohesins bind to both alleles of the IVR CBS, 
indicating non-allelic function of CTCF and cohesins at this region. This may be because 
the IVR transcript is not detectable in MEFs (Thorvaldsen and Bartolomei, unpublished), 
CTCF and cohesins may not have allele-specific functions at the IVR in MEFs. Therefore, 
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the biallelic binding of CTCF and cohesins may be a consequence of the silencing of the 
IVR transcript. Given that a consistent small bias of CTCF and cohesins binding towards 
the paternal allele, they may bind to this site at a paternal-specific manner in tissues that 
express the IVR transcript. ChIP experiments of such tissues will provide information to 
distinguish allelic versus non-allelic functions of CTCF and cohesins at this region. 
3.1.2. CTCF and cohesins colocalize at the Gtl2 DMR and KvDMR1 
As previously mentioned, a number of imprinted loci other than the H19/Igf2 locus 
contain CTCF binding sites. To examine if cohesins are general cofactors of CTCF at 
imprinted loci, I expanded the investigation to two more CTCF-associated imprinted loci: 
the Dlk1-Dio3 and Kcnq1/Kcnq1ot1 loci (Fitzpatrick et al., 2007; Kernohan et al., 2010). 
I showed that CTCF and cohesins colocalize at these two loci, with a maternal bias at the 
Gtl2 DMR and biallelic binding at KvDMR1. 
3.1.2.1. CTCF and cohesins colocalize to the unmethylated allele of Gtl2 DMR 
The Dlk1-Dio3 imprinting cluster was initially identified in uniparental disomy 
(UPD) of distal mouse Chr 12 deficiencies (Takada et al., 2000), and UPDs of the 
orthologous human Chr 14q32 (Kagami et al., 2005). The locus contains three paternally 
expressed protein-coding genes: Delta-like 1 homolog (Dlk1), Retrotransposon-like 1 
(Rtl1) and Deiodinase iodothyronine type III (Dio3) and a number of 
maternally-expressed ncRNAs, including Gtl2, an antisense transcript of Rtl1 (Rtl1as), a 
number of genes encoding small nucleolar RNAs (snoRNAs), Micro RNA containing 
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gene (Mirg) and numerous microRNAs (Fig. 3.4). Gtl2 encodes a long ncRNA with 
multiple spliced forms of unknown function (Schuster-Gossler et al., 1998; Paulsen et al., 
2001). It was proposed that these ncRNAs can make up a large polycistronic transcription 
unit that represses the protein-coding genes on the maternal chromosome, suggesting a 
ncRNA-dependent mechanism of imprinting control. In human and mouse, the paternally 
methylated germline DMR, Intergenic DMR (IG-DMR), functions as the ICR of the 
cluster (Lin et al., 2003, 2007; Kagami et al., 2008). Deletions or mutations of IG-DMR 
cause loss of imprinting across the entire locus. There is a second 
postfertilization-derived paternally methylated Gtl2 DMR, spanning the promoter, exon 1 
and part of the intron 1 of Gtl2 (Takada et al., 2000) (Fig. 3.4). Maternal deletion of the 
Gtl2 DMR in human results in regional silencing of imprinted genes (Kagami et al., 
2010). The Gtl2 DMR contains a CTCF binding site [(Paulsen et al., 2001; Kernohan et 
al., 2010); Takada and Ferguson-Smith, unpublished], raising the possibility that cohesins 
bind to the region. 
To test if cohesins colocalize with CTCF at the Gtl2 DMR, ChIP experiments were 
performed in MEFs. At the Gtl2 DMR, the antibodies against CTCF and cohesins 
precipitated significantly more chromatin (p<0.01) than a No-Ab control. However, no 
enrichment of CTCF and cohesins was seen at the IG-DMR (Fig. 3.5 A), consistent with 
the absence of CTCF binding sites (Paulsen et al., 2001). CTCF binds to the Gtl2 DMR at 
a similar level compared with the H19 ICR, whereas less SMC1 and RAD21 bound to the 
Gtl2 DMR as bound to the H19 ICR (Fig. 3.5 A), indicating that the affinity of cohesins 
differ between the Gtl2 DMR and the H19 ICR. Therefore, cohesins may interact with 
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Figure 3.5 Cohesins colocalize with CTCF at the maternal allele of Gtl2 DMR 
(A) ChIPs followed by real-time PCRs show that CTCF and cohesins bind to the Gtl2 DMR but not 
IG-DMR. The H19 ICR is included as a positive control. *: p<0.05; **: p<0.01. p value shows 
differences between No-Ab control and antibodies against CTCF, SMCI and RAD21. Error bars 
indicate standard deviation of at least three biological replicates. (B) Allele-specific ChIP PCRs 
show that CTCF and cohesins preferentially bind to the maternal allele of Gtl2 DMR in MEFs. In: 
Input; B: maternal allele; C: paternal allele. The percentage of protein binding on the B allele over 
total binding (B+C) is indicated at the bottom. At least three experiments were performed and 
similar results were obtained. 
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CTCF differently and exhibit disparate functions at these two loci. 
To determine if the binding of CTCF and cohesins is exclusive to one parental allele, 
we performed allele-specific PCR analysis of DNA isolated from ChIP experiments. 
Because the CTCF binding site resides near the Gtl2 promoter, and histone modifications 
that are associated with active transcription were reported to be enriched at maternal 
allele at this region (Carr et al., 2007), we included AcH3 and H3K4me2 as controls. 
AcH3 and H3K4me2 are preferentially associated with the transcribed, maternal allele 
(Fig. 3.5 B), as do CTCF and the two cohesin complex subunits (Fig. 3.5 B). Binding of 
CTCF on the unmethylated maternal allele is consistent with results of experiments 
showing a methylation-sensitive binding pattern (Filippova, 2008). In conclusion, CTCF 
and cohesins colocalize in an allele-specific manner at the Gtl2 DMR, similar to the H19 
ICR. This result suggests that CTCF, as well as cohesins, are involved in the imprinted 
regulation of the Dlk1-Dio3 locus. 
3.1.2.2. CTCF and cohesins colocalize to both alleles of the KvDMR1 
At the Kcnq1/Kcnq1ot1 locus (see 1.1.3.2 and Fig. 1.5), allelic silencing of linked 
imprinted genes is regulated by expression of the long ncRNA Kcnq1ot1. This locus also 
harbors two CTCF binding sites (Fitzpatrick et al., 2007). These two CTCF binding sites, 
CTCF BS1 and 2, reside in one of the two CpG islands within KvDMR1 (Fig. 3.6 A). 
To determine if cohesins colocalize with CTCF at ICR of the Kcnq1/Kncq1ot1 locus, 
I analyzed chromatin from F1 hybrid MEFs (see Chapter 5) (Verona et al., 2008). 
Following ChIP, real-time PCRs showed that CTCF, SMC1 and RAD21 associated with 
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Figure 3.6 Cohesins colocalize with CTCF at KvDMR1 
(A) Schematic showing the KvDMR1 (Black box), which is enlarged at the bottom. The striped 
boxes represent two CpG islands in the KvDMR1. The regions analyzed in (B) are indicated 
below the diagram. (B) ChIPs followed by real-time PCRs show that CTCF and cohesins bind to 
both CTCF binding sites (BS) 1&2. *: p<0.05; **: p<0.01. p values show differences between 
No-Ab controls and antibodies against CTCF, SMC1 and RAD21. The data are normalized to the 
No-Ab controls of each PCR. Error bars indicate standard deviation of at least three biological 
replicates.  
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both CTCF BS1 and 2, but not the control region (Ctrl) (Fig. 3.6 B). Allele-specific 
analysis revealed that the allelic bias of CTCF binding at KvDMR1 in MEFs was very 
weak, in contrast to AcH3 and H3K4me2, which were strongly biased to the paternal 
allele. Compared with the input DNA, the CTCF antibody precipitated 5-20% KvDMR1 
DNA from of the paternal allele than the maternal allele. Similarly, the two cohesin 
complex subunits showed a small bias (~5%) towards the paternal allele (Fig. 3.7 B, C). 
Furthermore, the No-Ab controls showed a background signal that were biased towards 
the maternal allele (Fig. 3.7 B, C), suggesting the small maternal enrichments observed in 
CTCF and cohesins ChIPed DNA may be a consequence of a PCR bias. My results 
contrast those of Fitzpatrick et al., who showed that CTCF binding at the KvDMR1 was 
exclusively on the paternal allele in C57BL/6 X SD7 F1 hybrid MEFs (Fitzpatrick et al., 
2007). Because I used different mouse strains to generate MEFs [C57BL/6 X 
B6(CAST7P12X), see Chapter 5], the contrasting results could reflect mouse strain 
differences. 
In summary, I have shown that CTCF and cohesins colocalize to four imprinted 
regions, including two ICRs (H19 ICR and KvDMR1), a non-ICR DMR (Gtl2 DMR), 
and the IVR region between H19 and Igf2. The allele-specific analysis revealed three 
patterns of CTCF and cohesins binding at DMRs: 1) they bind allele-specifically to the 
H19 ICR; 2) they bind biallelically to the KvDMR1 (ICR); 3) they bind 
allele-specifically to the Gtl2 DMR (which is not an ICR). These results suggest that 
CTCF and cohesins play distinct functions at different imprinted loci. Interestingly, 
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Figure 3.7 Cohesins colocalize with CTCF at both alleles of KvDMR1 
(A) Schematic showing the KvDMR1 (Black box), which is enlarged at the bottom. The striped 
boxes represent two CpG islands in the KvDMR1. The regions analyzed in (B, C) are indicated 
below the diagram. (B, C) Allele-specific ChIP PCRs showing biallelic binding of CTCF and 
cohesins in (B) CTCF BS1 and (C) CTCF BS-2. AcH3 and H3K4me2 are included as controls. B: 
maternal allele; C: paternal allele. The percentage of protein binding on the B allele over total 
binding (B+C) is indicated at the bottom. At least three experiments were performed and similar 
results were obtained. 
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CTCF and cohesins always behave the same at these sites. When they are bound to one 
specific allele, they always bind to the unmethylated allele. At the IVR, cell types or 
tissues that express the IVR transcript need to be included in future analysis. If CTCF and 
cohesins still bind to both alleles, they may play non-allelic functions such as 
transcription activation or repression at this region. In contrast, if CTCF and cohesins 
bind to one parental allele specifically, they could play important roles in the imprinted 
expression of this transcript. In conclusion, the data presented in 3.1 suggest that cohesins 
are general cofactors of CTCF, and may play important functions in concert with CTCF 
at imprinted loci. 
3.2. Functional analysis of CTCF and cohesins in MEFs 
The results described above demonstrated that CTCF and cohesins colocalize at four 
imprinted regions. To assess the functional significance of CTCF and cohesins binding in 
regulating expression of imprinted genes, I performed RNAi experiments to knock-down 
levels of CTCF and/or cohesins. F1 hybrid MEFs (see Chapter 5) were treated with 
siRNAs targeting Ctcf, Smc1 and Rad21. An siRNA that does not target any known 
transcript in mouse was included as a control (Ctrl siRNA). I first determined conditions 
to achieve the best knock-down efficiency and then demonstrated that CTCF and 
cohesins were specifically depleted. 
To achieve the best knock-down efficiency, I performed sequential siRNA treatments 
by treating the cells every 48 h. Maximum depletion (~75% to 90%) of targeted proteins 
94 
occurred around 72 h and was maintained through 144 h, with two to three treatments of 
siRNAs (Fig. 3.8 A shows examples of CTCF and SMC1 knock-down at various time 
points). Consequently, I conducted most of the experiments with two or three sequential 
siRNA treatments and harvested cells at 96h and 144h. Because no obvious growth or 
proliferation defects were observed in the siRNA treated cells, any changes in these cells 
were likely due to the altered function of CTCF and cohesin complex subunits in 
transcriptional regulation, rather than cell division.  
The RNAi approach using two or three sequential treatments of one siRNA against 
each transcript successfully reduced the amount of the protein encoded by the targeted 
mRNA (Fig. 3.8 B). Around 75%~90% depletion of target proteins are achieved (Fig. 3.8 
B). When compared with the amount of a control protein, αTUBULIN, the residual 
amounts of CTCF, SMC1 and RAD21 are 17%, 25% and 10%, respectively (Fig. 3.8 B). 
Among the three siRNAs that target CTCF and cohesins, the Ctcf siRNA and Rad21 
siRNA usually had stronger knock-down efficiency than the Smc1 siRNA (data not 
shown). In addition, because there are thousands of CTCF binding sites in the genome 
(Kim et al., 2007; Chernukhin et al., 2007; Xie et al., 2007; Barski et al., 2007; Xi et al., 
2007; Chen et al., 2008; Heintzman et al., 2009; Goren et al., 2009; Cuddapah et al., 2009; 
Kang et al., 2009; Kunarso et al., 2010), and cohesins are associated with many regions in 
the genome [reviewed in (Barbero, 2009)], it is possible that depletion of CTCF and 
cohesins would affect housekeeping genes. Therefore, I examined the relative RNA levels 
of target RNAs compared with RNA levels of three housekeeping genes [β-actin (Actb), 
Glyceraldehyde-3-phosphate dehydrogenase (Gapdh) and Ribosomal protein large P0 
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Figure 3.8 Successful depletion of CTCF, SMC1 and RAD21 from MEFs 
(A) Western blots showing knock-down effects achieved by Ctcf siRNA (Ctcf-si) and Smc1-si 
treatments for various time lengths. (B) Western blots showing 75% to 98% depletion of CTCF 
and cohesin subunits by siRNA treatments after 96 h of treatments. For both (A) and (B), 
anti-αTUBULIN is used as a control. The residual amounts of target proteins are indicated below 
the gels. (C) RT PCRs showing relative Ctcf, Smc1 and Rad21 mRNA levels compared with three 
housekeeping genes, Actb, Gapdh and Rplp0 in target siRNA treated cells. No difference of 
relative target mRNA levels are seen, indicating that these housekeeping genes are not affected 
by RNAi. Target mRNA levels are normalized to the housekeeping genes. Relative value of the 
control siRNA treatment is set to 1.  
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(Rplp0)] in the siRNA-treated cells (Fig. 3.8 C) and found no effect on the relative 
transcript abundance of target RNAs when compared with different housekeeping genes. 
In general, 65%-85% reduction of target RNAs was achieved compared with the control 
siRNA treated cells. Thus, for all subsequent experiments, only Rplp0 was used as the 
control. 
3.2.1. Depletion of CTCF and cohesins in MEFs lead to increased Igf2 expression 
from the normally expressed paternal allele 
I first characterized the effect of CTCF and cohesins depletion at the H19/Igf2 locus. 
I hypothesized that by depleting CTCF and/or cohesin complex subunits, insulator 
activity at the H19 ICR would be reduced, resulting in increased Igf2 transcription due to 
expression from the normally repressed maternal allele, as well as decreased H19 
expression due to competition of H19 and Igf2 for the shared enhancers on the maternal 
chromosome. Of note, because the IVR transcript is not expressed in MEFs (Thorvaldsen 
and Bartolomei, unpublished), it is not included in the following experiments. 
3.2.1.1. Depletion of CTCF and cohesins lead to increased expression of Igf2 
To test the hypothesis mentioned above, I treated MEFs with individual siRNAs 
against CTCF and cohesins, as well as with different combinations of siRNAs (Fig. 3.9 
A). As expected, Ctcf siRNA-treated cells had elevated Igf2 expression (p<0.01), 
approximately three-fold relative to control siRNA-treated cells. Rad21 siRNA treatments 
also led to increased Igf2 expression (p<0.05), whereas Smc1 siRNA had no significant 
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Figure 3.9 CTCF and cohesins depletion associate with elevated expression, but not loss 
of imprinted expression of Igf2 
(A) Real-time PCRs showing H19 and Igf2 relative RNA levels in siRNA-treated wild-type (WT) 
MEFs. CTCF- and RAD21-depleted WT MEFs have elevated expression of Igf2. Ctrl: control; C: 
Ctcf; S: Smc1; R: Rad21 siRNAs. *: p<0.05, **: p<0.01. p values show differences between CTCF 
or cohesins siRNA treatments and the Ctrl siRNA treatments. H19 and Igf2 RNA levels are 
normalized to Rplp0. Relative value of the control siRNA treatment is set to 1. Error bars indicate 
standard deviation. (B) Allele-specific analysis of Igf2 expression in WT MEFs. CTCF- and 
cohesins-depleted MEFs have monoallelic expression of Igf2 B: maternal allele; C: paternal allele. 
Samples were collected at 144 h after three or two sequential treatments of siRNAs. Only the 
second lane (Ctcf siRNA) has a low level of maternal Igf2 expression detected (arrow head).  
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effect (p>0.05), probably due to insufficient depletion of SMC1 proteins (Fig. 3.8 B). 
Surprisingly, H19 levels were mostly unaffected by siRNA treatments and, in Ctcf siRNA 
treatments, elevated (Fig. 3.9 A). Next, I examined allelic expression of Igf2 and H19. 
Unexpectedly, most cells maintained imprinted Igf2 and H19 expression (Fig. 3.9 B). 
When biallelic Igf2 expression was observed, it was always in the Ctcf siRNA treated 
cells. This is consistent with the insulator function of CTCF at the H19 ICR. However, 
such maternal expression of Igf2 upon CTCF depletion was very low (Fig. 3.9 B, arrow 
head). Because Igf2 levels were increased about three-fold compared with controls, I 
concluded that the enrichment was not from the normally silent maternal allele but rather 
from the normally active paternal allele. The low maternal expression of Igf2 could be a 
result of activation on both alleles. The residual amount of CTCF is likely sufficient to 
maintain imprinting. CTCF and Rad21 may function as repressors of Igf2. 
3.2.1.2. Depletion of CTCF in H19∆R/+ MEFs lead to increased expression of Igf2 
To test whether the above phenotype (expression changes of Igf2 and H19) depends 
on the CTCF binding sites in the H19 ICR, I conducted siRNA treatments in MEFs that 
have maternal transmission of the H19∆R mutation (Engel et al., 2006). In these MEFs, 
the insulator function at the maternal H19 ICR is disrupted due to deletion of the four 
CTCF binding sites at the endogenous locus (see 1.1.3.1 and Fig. 1.2), leading to biallelic 
Igf2 expression (Fig. 3.10 B, Ctrl siRNA-treated sample) (Engel et al., 2006). If the 
phenotype in the wild-type cells (Fig. 3.9 A, B) depended on the CTCF binding sites in 
the H19 ICR, I would expect to see no changes in H19 and Igf2 expression in the H19∆R/+ 
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Figure 3.10 CTCF depletion in H19∆R/+ MEFs associate with elevated expression of Igf2  
(A) Real-time PCRs showing H19 and Igf2 relative RNA levels in siRNA-treated H19∆R/+ MEFs. 
CTCF-depleted H19∆R/+ MEFs have elevated expression of Igf2. Ctrl: control; C: Ctcf; S: Smc1; R: 
Rad21 siRNAs. *: p<0.05. p value shows differences between CTCF siRNA treatments and the 
Ctrl siRNA treatments. H19 and Igf2 RNA levels are normalized to Rplp0. Relative value of the 
control siRNA treatment is set to 1. Error bars indicate standard deviation. (B) Allele-specific 
analysis of Igf2 expression in H19∆R/+ MEFs. B: maternal allele; C: paternal allele. Samples were 
collected at 96 h after two sequential treatments of siRNAs. (B) CTCF- and cohesins-depleted 
H19∆R/+ MEFs have similar amounts of two parental alleles of Igf2, similar to the Ctrl siRNA treated 
MEFs. 
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cells. Contrary to this expectation, depleting CTCF resulted in increased Igf2 expression 
in CTCF knock-down H19∆R/+ MEFs (Fig. 3.10 A). Furthermore, allele-specific analysis 
showed that Igf2 was expressed equally from both parental alleles in both control siRNA- 
and target siRNA-treated MEFs. Thus, the elevated expression of Igf2 was from both 
alleles in the H19∆R/+ MEFs. I concluded that CTCF and cohesins repress Igf2 expression, 
independent of the CTCF binding sites in the H19 ICR. 
One explanation for these phenotypes is that CTCF may function as a transcriptional 
repressor of Igf2, independent of the insulator function at the H19 ICR. Such repressor 
function may be more sensitive to the levels of CTCF protein than the insulator function 
at the H19 ICR, and was affected by our siRNA experiments, whereas occupancy of 
CTCF at the H19 ICR was not affected. Igf2 has four alternative promoters, P0, 1, 2 and 
3, which are suggested to exhibit tissue specificity (Engström et al., 1998). There are 
three DMRs around the Igf2 gene, DMR 1 and 2, as well as DMR0, which may be 
placenta-specific (Sasaki et al., 1992; Feil et al., 1994; Moore et al., 1997) (Fig. 3.11 A). 
Other than the CTCF binding sites in the H19 ICR, ChIP assays in various human and 
mouse tissues have revealed multiple CTCF binding sites at the Igf2 locus (Du et al., 
2003; Kurukuti et al., 2006; Yoon et al., 2007; Chen et al., 2008; Li et al., 2008) and 
CTCF appears preferentially bound to the maternal allele of Igf2 DMR1 and the P2 and 
P3 promoters (Kurukuti et al., 2006; Li et al., 2008). These observations suggest that 
CTCF is involved in the maternal-specific repression of Igf2. Therefore, the non-allelic 
repressive effect I observed at Igf2 is not likely dependent on these CTCF binding sites. 
Nonetheless, CTCF binding at the Igf2 DMR0 is on both alleles (Li et al., 2008), whereas 
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Figure 3.11 CTCF and cohesins colocalize at a CTCF binding site 5.2 kb upstream of Igf2 
DMR0 
(A) Schematic showing the H19/Igf2 locus. The transcriptional and methylation status of the 
maternal and paternal chromosomes are represented on the top and bottom of the DNA strand, 
respectively. Three Igf2 DMRs are shown. IUCBS1 & 2 are located 1.7 and 5.2 kb upstream of 
DMR0, respectively, and are indicated by the arrows below the diagram. (B) ChIPs followed by 
real-time PCRs show that CTCF and cohesins bind to the IUCBS2 and CTCF also binds to 
IUCBS1. The H19 ICR is included as a positive control. *: p<0.05; **: p<0.01. p value shows 
differences between No-Ab control and antibodies against CTCF, SMCI and RAD21. Error bars 
indicate standard deviation of at least three biological replicates. 
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other sites (1.7 kb and 5.2kb upstream of the Igf2 DMR0) have not been tested allelically 
(Yoon et al., 2007; Chen et al., 2008). It is possible that CTCF binds to both parental 
alleles at these sites and functions as a transcriptional repressor. In support of this idea, 
SMC1 binds to two of these CTCF binding sites (1.7 kb and 5.2 kb upstream of the Igf2 
DMR0) in MEFs (GEO accession: GSM560355) (Kagey et al., 2010). In addition, CTCF 
and SMC3 colocalize at the upstream of human Igf2 DMR0 on both parental alleles 
(Nativio et al., 2009). 
To test if CTCF and cohesins bind to the two CTCF binding sites upstream of Igf2 
DMR0, I designed primers specific for the -1.7 kb and -5.2 kb regions, termed IUCBS1 
and 2 for Igf2 upstream CTCF binding site 1 and 2, respectively. Real-time PCR 
following ChIP assays showed that CTCF and cohesins colocalize at the IUCBS2 site 
(Fig. 3.11 B). Moreover, CTCF also binds to IUCBS1 (p<0.05), and preliminary data 
showed that the two cohesin subunits precipitated more chromatin than the No-Ab 
control (Figure 3.11 B), suggesting cohesins colocalize with CTCF at this site. However, 
no polymorphisms are available at these sites in our F1 hybrid cells, precluding 
identification what allele is aoosicated with CTCF and cohesins. Further characterization 
of CTCF and cohesins binding at Igf2 will help to clarify how they repress its 
transcription. 
3.2.2. Depletion of CTCF and cohesins in MEFs lead to non-allelic changes of 
expression levels at the Dlk1-Dio3 locus, but not at the Kcnq1/Kcnq1ot1 locus 
CTCF and cohesins colocalize to two additional imprinted loci, the Dlk1-Dio3 and 
103 
the Kcnq1/Kcnq1ot1 loci (see 3.1.2 and Fig. 3.5, 3.6, 3.7). To investigate effects of CTCF 
and cohesins depletion at these loci, I examined five imprinted genes in the Dlk1-Dio3 
and the Kcnq1/Kcnq1ot1 loci in the CTCF knock-down and cohesins knock-down MEFs. 
Imprinted expression of Dlk1, Gtl2, Kcnq1, Kcnq1ot1 and Cdkn1c did not seem to be 
affected by siRNA treatments (data not shown). Although the expression levels of Dlk1 
and Gtl2 were not affected in most siRNA treatments, when a difference was observed, it 
was always an increase (Fig. 3.12 A). No significant difference in Kcnq1ot1 expression 
level was observed (Fig. 3.12 B). My data suggest that CTCF and cohesins function as 
transcriptional repressors at the Dlk1-Dio3 locus but not the Kcnq1/Kcnq1ot1 locus, 
which is similar to Igf2 in CTCF- and cohesins-depleted MEFs (Fig. 3.9). Importantly, 
the repressor roles of these proteins do not affect allele-specific expression of imprinted 
genes analyzed. 
3.2.3. Using TS cell as a new model cell line to study roles of CTCF and cohesins 
in genomic imprinting 
The aforementioned results have uncovered unappreciated roles of CTCF and 
cohesins in non-allelic regulation of imprinted genes. However, we were not able to show 
disruption of the insulator function at the H19/Igf2 locus by CTCF siRNA treatments in 
MEFs. This suggests that the H19 ICR may require low levels of CTCF protein to 
maintain imprinting in MEFs. Although MEFs exhibit monoallelic expression of 
imprinted genes from the three loci that contain CTCF binding sites, they do not express 
H19 and Igf2 at high levels (see below). I hypothesized that imprinting regulation in a 
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Figure 3.12 CTCF and cohesins depletion lead to changes in Gtl2 and Dlk1 RNA levels, but 
not in Kcnq1ot1 RNA levels 
(A) Gtl2 and Dlk1 relative RNA levels in siRNA treated MEFs. *: p<0.05, **: p<0.01. p values 
reflect the differences between CTCF or cohesin siRNA treatments and the control siRNA 
treatment. (B) Kcnq1ot relative RNA levels in siRNA treated MEFs. No significant change is seen 
between CTCF or cohesins siRNA treatments and the control siRNA treatment. For both panels, 
the levels of imprinted gene RNA are normalized to Rplp0. Relative value of the control siRNA 
treatment is set to 1. Error bars indicate standard deviation. 
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cell type that expresses high levels of H19 and Igf2 may be more sensitive to protein 
levels of CTCF and cohesins, compared with MEFs. Likewise, if cohesins participate in 
the insulator function at the H19 ICR, depletion of cohesins in such a cell type will lead 
to biallelic expression of Igf2 and reduction in H19 expression. In addition, to show that 
the binding profiles of CTCF and cohesins differ from that of MEFs, ChIP assays may 
also be performed in this cell type. Because H19 is only expressed in the trophoectoderm 
layer in mouse blastocysts (Poirier et al., 1991), and Igf2 is expressed later at high levels 
in extraembryonic tissues (Lee et al., 1990), I decided to use TS cells as another model 
cell line to study functions of CTCF and cohesins. Mouse TS cells are derived from the 
trophoectoderm layer of E3.5 mouse blastocysts and thus represent the extraembryonic 
lineage (Tanaka et al., 1998). I did not choose ES cells, which have been well-established 
in our lab as a model cell line, for two reasons: 1) ES cells are derived from the ICM 
(Evans and Kaufman, 1981; Martin, 1981), which does not express H19 (Poirier et al., 
1991). 2) Our F1 hybrid ES cell lines exhibit biallelic expression of H19 (Thorvaldsen 
and Lin, unpublished), probably because only low levels of H19 are expressed and basal 
levels of expression may come from both alleles. Alternatively, the conditions for ES cell 
culture may lead to biallelic expression of H19. 
3.2.3.1 Derivation of F1 hybrid TS cells 
In collaboration with Dr. Winifred Mak, I derived six F1 hybrid TS cell lines from 
crosses between 129/S1 females and B6(CAST7) or B6(CAST7P12X) males (see 
Chapter 5). We used the 129/S1 strain rather than the C57BL/6 (B6) strain because 
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deriving TS cells from B6 mice has been shown to be inefficient (Tanaka, 2006; Himeno 
et al., 2008). In fact, we were not able to establish TS cells from B6 females after 
multiple attempts (Mak and Lin, unpublished). Three TS cell lines from crosses between 
a 129/S1 mother and a B6(CAST7P12X) father, designated P12X-f, P12X-a and P12X-c, 
were tested for expression of TS marker genes, including Estrogen related receptor beta 
(Esrrb), Eomesodermin homolog (Eomes), Caudal type homeobox 2 (Cdx2) and 
Fibroblast growth factor receptor 2 (Fgfr2) (Tanaka et al., 1998). All three lines, as well 
as a positive control TS cell line, A2 (Mak et al., 2002), expressed these marker genes 
(Fig. 3.13 A), indicating that the derivations were successful. 
I tested expression levels of H19 and Igf2 in these F1 hybrid TS cells. Fig. 3.13 B 
shows the relative levels of H19 and Igf2 RNAs in MEFs, ES cells and two lines of F1 
hybrid TS cells (P12X-f and P12X-a). TS cells express both genes at a much higher level 
(~6 to 7 fold) compared with the levels in MEFs and ES cells. In addition, ChIP assays 
using antibodies against SMC1 and RAD21 showed enrichment of both cohesin subunits 
at the H19 ICR, Gtl2 DMR and KvDMR1 CTCF BS1 (Fig. 3.13 C). Therefore, cohesins 
likely play a role at these imprinted loci in TS cells. CTCF is not included in these 
experiments because a new batch of CTCF antibody did not work for ChIP experiments. 
I was able to recover one F1 hybrid TS cell line (P12X-c) that expresses monoallelic 
H19, Snrpn, Peg3, Kcnq1ot1 and Cdkn1c (data not shown). However, all TS cell lines 
tested exhibited biallelic expression of Igf2 (data not shown), probably because Igf2 is 
either not expressed at the blastocyst stage (Lee et al., 1990) or is expressed at very low 
levels biallelically (Latham et al., 1994; Thorvaldsen et al., 2006). The imprinted 
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Figure 3.13 Characterization of F1 TS cell lines 
(A) Three lines of F1 hybrid TS cells, P12X-f, P12X-a and P12X-c express TS cell marker genes. 
An established TS cell line, A2 (Mak et al., 2002), is included as a positive control. (B) H19 and 
Igf2 relative RNA levels in MEF, ES and TS cells. Shown are average expression levels from two 
TS cell lines (P12X-f and P12X-a). The levels of imprinted gene RNA are normalized to Rplp0. 
Relative values of the expression levels in MEFs are set to 1. Error bars indicate standard 
deviation. (C) ChIPs followed by real-time PCRs using primers specific for the H19 ICR, Gtl2 
DMR and KvDMR1 CTCF BS1 in F1 hybrid TS cells. SMC1 and RAD21 may bind to these 
regions in TS cells. Error bars show standard deviation of two biological replicates. 
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expression is not fully established until a later developmental stage (after E6.5) 
(Thorvaldsen et al., 2006). Despite the biallelic expression of Igf2, the TS cell lines can 
still be useful because they express a number of other imprinted genes (e.g., Kcnq1ot1 
and Cdkn1c) and can be differentiated to multiple extraembryonic lineages (Tanaka et al., 
1998) and thus are extremely useful in studying placenta-specific imprinted genes. 
Particular loci of interest include the Kcnq1/Kcnq1ot1 locus that contains a number of 
placenta-specific imprinted genes in mouse (e.g., Osbpl5, Nap1l4, Tssc4 and Ascl2) 
(Tanaka et al., 1999; Paulsen et al., 2000; Engemann et al., 2000), as well as two CTCF 
binding sites that also recruit cohesins in MEFs (see 3.1.2). Therefore, TS cells can be a 
useful model cell line for studying the functional requirements of CTCF and cohesins at 
the Kcnq1/Kcnq1ot1 locus. 
3.2.3.1 Depletion of CTCF and cohesins in TS cells requires lentiviruses-based 
RNAi 
To study the roles of CTCF and cohesins in TS cells, I first conducted siRNA 
treatments targeting CTCF, SMC1 and RAD21 in TS cells using lipofectamine 
(lipofectamine 2000, Invitrogen, see Chapter 5) that was also used to introduce siRNAs 
into MEFs. However, very limited knock-down of target proteins, if any, was achieved by 
these siRNA treatments in TS cells (Fig. 3.14 A). Furthermore, TS cells differentiated 
upon lipofectamine treatment and it was very difficult to recover enough cells for analysis. 
Differentiated TS cells usually have multiple lineages, including tetraploid giant cells 
(Tanaka et al., 1998). Because these cell types may exhibit different patterns of imprinted 
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Figure 3.14 RNAi in TS cells 
(A) Western blot showing that no CTCF and RAD21 knock-down was achieved by siRNA 
treatments of TS cells. TS cells are treated with siRNAs (si) for 54 h and harvested for analysis. 
(B) Western blot showing that RAD21 is reduced in lentiviruses-infected TS cells, compared with 
non affected (No-V) cells. Two lines of lentiviruses carrying shRNA sequences targeting RAD21, 
Rad21-9 and Rad21-12 (see Chapter 5), are used. Another lentivirus line carrying a scrambled 
shRNA (see Chapter 5) is included as a negative control. TS cells are infected with lentiviruses 
and drug-selected for about two weeks. For both (A) and (B), anti-TUBULIN is used as a control. 
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gene expression, we would like to study functions of CTCF and cohesins in a 
homogeneous cell type. Therefore, another way to deliver siRNA or shRNAs into TS 
cells that does not lead to differentiation is required.  
Lentivirus-based RNAi technologies have been shown to be effective in primary cell 
lines, including ES cells. I had conducted lentivirus RNAi experiments using 
commercially available lentiviruses targeting MBD3 in ES cells (Lin, Reese and 
Bartolomei, unpublished). I was able to deplete MBD3 protein levels in ES cells by 
~75% (Lin, unpublished). However, because wild-type ES cells exhibit biallelic H19 
expression (Thorvaldsen and Lin, unpublished), we didn’t use this system to study 
MBD3’s functions. To investigate the roles of CTCF and cohesins at genomic imprinting 
in TS cells, I applied a similar lentivirus approach to knock down these proteins in TS 
cells. I cloned siRNA sequences that were used in siRNA treatments of MEFs into a 
lentivirus vector (see Chapter 5) and infected TS cells with lentiviruses to knock-down 
CTCF and cohesins. Preliminary data suggest that the lentiviruses targeting RAD21, were 
able to infect TS cells and knock-down target proteins (Fig. 3.14 B). Further experiments 
will be conducted to test the expression of TS marker genes to be assured that 
virus-infected TS cells have not differentiated, and to confirm the knock-down of CTCF 
and SMC1. Subsequently, expression of imprinted genes will be examined in CTCF- and 
cohesins-depleted TS cells. 
In summary, these data presented in Chapter 3 have shown colocalization of CTCF 
and cohesins at three imprinted loci, H19/Igf2, Dlk1-Dio3 and Kcnq1/Kcnq1ot1. CTCF 
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and cohesins preferentially bind to the H19 ICR and Gtl2 DMR on the unmethylated 
maternal allele. Functional analysis of CTCF and cohesins has been performed in MEFs 
by siRNA treatment, and monoallelic expression of imprinted genes at these three loci 
was maintained. The mRNA levels for these genes were typically increased; for H19 and 
Igf2 the increased expression was independent of the CTCF binding sites in the H19 ICR. 
Depletion of CTCF and RAD21 by siRNA treatments increased the levels of Igf2 and 
Gtl2 expression (Fig. 3.9 and 3.12). However, depletion of SMC1 did not show such 
effect. Given that no evidence is available to indicate independent function of RAD21 
from the cohesin complex, this result is probably due to the relatively lower efficiency of 
SMC1 knock-down (Fig. 3.8 B). 
In conclusion, my results have provided a systematic view of the colocalization of 
CTCF and cohesins at imprinted gene loci. Distinct binding profiles of CTCF and 
cohesins at different imprinted DMRs indicate locus-specific functions. Furthermore, by 
performing allele-specific analysis, we have uncovered new roles for CTCF and cohesins 
in the transcriptional regulation of the active allele of imprinted genes. In addition, I have 
derived F1 hybrid TS cell lines that can be used as a model cell line for imprinted gene 
regulation, as well as extraembryonic development. 
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Chapter 4. Discussion and future directions 
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In my dissertation, I have investigated roles of protein factors in genomic imprinting. 
I have established that NuRD complex components MBD3 and MTA2 are required at the 
H19/Igf2 imprinted locus during preimplantation development (Fig. 4.1). MTA2, but not 
MBD3, is also required at the Peg3 locus. I have also shown association of two more 
methylated DNA binding proteins, MBD1 and Kaiso, with various imprinted loci in ES 
cells and MEFs. Taken together, these methylated DNA binding proteins and their 
cofactors may participate in the regulation of genomic imprinting with various degrees of 
locus- and tissue-specificity, and they may either function alone or in concert with each 
other.  
The second major focus of my thesis was to investigate more systematically the 
colocalization and function of CTCF and the cohesin complex at imprinted loci. I showed 
that CTCF and cohesins were bound at three imprinted loci. Depletion of CTCF and 
cohesins in MEFs led to changes in the total expression levels of several imprinted genes, 
but monoallelic expression was maintained. Therefore, my thesis work has uncovered a 
non-allelic role of CTCF and cohesins in the regulation of imprinted loci. Whereas 
numerous studies have shown the importance of allele-specific regulation of imprinted 
genes, my work suggests the non-allelic control of expression levels could be as well 
critical for imprinted gene functions.  
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Figure 4.1 Protein factors are required for regulation of imprinted gene expression 
Schematic showing the H19/Igf2 locus. On the maternal allele, the ICR recruits CTCF and forms 
an insulator that blocks maternal Igf2 expression, whereas H19 is active. Cohesins are found at 
the ICR, but may not be required for the insulator function (shown by the question mark). On the 
paternal allele, the ICR is methylated, preventing insulator activity. The methylation spreads to the 
H19 promoter, therefore H19 is silenced. Igf2 is activated on the paternal allele. MBD3 and MTA2 
are required for maintaining the methylation at the paternal ICR, as well as repression of the 
paternal H19. CTCF and cohesins bind to a region upstream of Igf2, and may repress Igf2 
expression on both alleles. 
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4.1. The NuRD complex and genomic imprinting in preimplantation embryos 
The lethality of Mbd3-null embryos (Hendrich et al., 2001) suggests that the NuRD 
complex has important functions in preimplantation embryos. However, due to the low 
amount of material available for biochemical experiments, there is limited information on 
the composition and functions of the NuRD complex in mouse preimplantation embryos. 
By performing RNAi experiments targeting individual NuRD complex components, we 
found that MBD3 and MTA2 are required at imprinted loci, providing the first link 
between the NuRD complex and genomic imprinting, as well as a mechanism for 
maintenance of differential methylation at ICRs. 
Furthermore, although the H19/Igf2 locus was affected when either MBD3 or MTA2 
was depleted, the Peg3 locus was only affected in the MTA2-depleted embryos. These 
results suggested that MTA2-containing NuRD complexes did not totally overlap with the 
MBD3-containing NuRD complexes. Because the imprinted expression of Peg3 was not 
affected in Mbd2-null mice (Hendrich et al., 2001), MBD2 and MBD3 may have 
redundant functions, in contrast to the indispensable role of MTA2 for the Peg3 locus. 
Further functional analysis of a double mutant that lacks both MBD2 and MBD3 is 
required to verify the involvement of MBD2 at the Peg3 locus.  
It is worth noting that the nuclear levels of MTA1 were reduced in MTA2-depleted 
embryos (Ma et al., 2010), suggesting that MTA1-containing NuRD complexes may be 
the actual functioning complexes at the Peg3 locus. Examination of MTA1 levels in 
MBD3-depleted embryos could provide evidence for this idea. However, because MTA1 
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proteins are largely reduced in Mbd3-null ES cells (Kaji et al., 2006), it is likely that 
MTA1 levels may also be reduced by depletion of MBD3 in blastocysts. If so, neither 
MTA1 nor MBD3 is required for imprinted expression of Peg3. 
4.2 Possible mechanisms for incomplete penetrance in MBD3- or MTA2-depleted 
embryos  
The DNA methylation and allele-specific expression of imprinted genes vary among 
the MBD3 or MTA2 RNAi embryos tested (see 2.2, 2.3 and Fig. 2.5, 2.6, 2.7). Because 
the Zp3-dsMbd3 transgene is transcribed in growing oocytes (Fedoriw et al., 2004; Reese 
et al., 2007), the embryos from transgenic females likely receive similar amounts of the 
dsRNA from the maternal deposit. Both the dsRNA injection and transgenic RNAi 
exhibit similar variations in phenotype severity (see 2.2 and Fig. 2.5, 2.6), suggesting that 
the phenotypic variations among RNAi embryos is not due to technical differences in 
dsRNA injections. As briefly discussed in 2.2.2, one explanation is that knock-down of 
MBD3 and MTA2 has inherent limitations of not being able to ablate the targeted protein 
completely. Because the Mbd3-null mice are lethal, and the Mta2-null females are 
infertile (Hendrich et al., 2001; Lu et al., 2008), complete depletion of MBD3 and MTA2 
from preimplantation embryos is essentially technically impossible. However, it is 
possible to further knock-down MBD3 in preimplantation embryos, by crossing our 
Zp3-dsMbd3 mice with the heterozygous mice carrying the Mbd3-null allele. Functions 
of MBD3 at other imprinted loci will be observed if such embryos exhibit phenotypes at 
other loci besides the H19/Igf2. 
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In addition, another explanation for such incomplete penentrance is that the 
time-window of the RNAi treatment is not long enough. Earlier depletion of MBD3 and 
MTA2 may be required to completely ablate the functions of these proteins at imprinted 
loci. The transgenic RNAi utilizes the Zp3 promoter that is expressed in growing oocytes 
(Fedoriw et al., 2004; Reese et al., 2007), providing a longer time-window than the 
dsRNA injection at the 1-cell stage. The latter does not introduce the dsRNAs into 
embryos until after fertilization. Supporting the idea that longer exposure to dsRNAs is 
required for higher penetrance, more MBD3-depleted embryos generated by the 
transgenic RNAi than by dsRNA injection had biallelic expression of H19 (40% and 26%, 
respectively).  
Alternatively, other protein factors could compensate for the loss of MBD3 and 
MTA2 in preimplantation embryos. For example, mutations and deletions of Zfp57 are 
associated with hypomethylation of the Peg3 DMR in both human and mouse (Mackay et 
al., 2008; Li et al., 2008). For the H19 ICR, it is unknown whether factors other than 
PGC7/STELLA, DNMT1 and its cofactors are required for maintaining its paternal 
methylation. My ChIP data suggest that MBD1 and Kaiso do not bind to the H19 ICR in 
ES cells (Fig. 2.2). It is worth testing binding of MBD2 at the H19 ICR because 
MBD2-containing and MBD3-containing NuRD complexes may have redundant 
functions. Moreover, possible redundancy between MBD2 and MBD3 can be examined 
by crossing our Zp3-dsMbd3 mice with Mbd2-null mice.  
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4.3. Establishment versus maintenance roles of MBD3 and MTA2 at imprinted loci 
In the dsMbd3- and dsMta2-injected embryos, the dsRNAs were introduced after 
fertilization, when the maternal DNA methylation at imprinted loci has already been 
established. Because the DNA methylation is lost at the paternal H19 ICR in these 
embryos, MBD3 and MTA2 are required for the maintenance of differential DNA 
methylation. However, because the Zp3-Mbd3 transgene is expressed in growing oocytes, 
where the maternal DNA methylation imprints are established (Reik et al., 2001), it is 
unclear whether the phenotypes observed in the Zp3-Mbd3 transgenic embryos were due 
to MBD3 and MTA2’s functions in the maintenance or both the maintenance and 
establishment of imprinting marks. Analysis of DNA methylation patterns in the female 
germ-line of the Mta2-null mice, which exhibit female infertility (Lu et al., 2008), as well 
as analysis of mice that have MBD3 conditionally deleted from the female germ-line, 
may provide information to distinguish between these two possibilities. 
4.4. Various requirements for protein cofactors at different developmental stages 
and at distinct imprinted loci 
An intriguing result from my ChIP survey of MBD proteins and Kaiso is that while 
MBD3 binds to the paternal H19 ICR in ES cells but not in MEFs (see 2.1.1 and Fig. 2.1), 
Kaiso binds to the same locus in MEFs but not ES cells (Fig. 2.3). In addition, Kaiso, as 
well as the other two Kaiso family members, ZBTB4 and ZBTB38, bind to the H19 ICR 
in a paternal allele-biased (or paternal-specific) manner in adult mouse brain (Filion et al., 
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2006). Taken together, these results strongly suggest that imprinted loci utilize distinct 
proteins or protein complexes at different developmental stages: whereas MBD3 is 
required for the maintenance of DNA methylation in the H19 ICR and repression of the 
H19 paternal allele in preimplantation embryos, Kaiso family proteins may be required 
for repression of the H19 paternal allele after implantation, when protection from 
genome-wide DNA demethylation is not required. 
In addition, multiple proteins of MBD and Kaiso families may play redundant roles 
for a given imprinted locus, at a particular developmental stage. My ChIP survey suggests 
that MBD1 and Kaiso colocalize to the maternal Snrpn DMR and Peg3 DMR in ES cells, 
as well as the paternal H19 ICR and IG-DMR in MEFs (Fig. 2.2 and 2.3). The three 
aforementioned Kaiso family proteins all bind to the H19 ICR in adult mouse brain 
(Filion et al., 2006). Moreover, MBD1, MBD3 and MeCP2 bind to the methylated allele 
of the Zrsr1 DMR in adult mouse liver (Fournier et al., 2002). These observations 
support the idea that MBD and Kaiso families of proteins have compensatory functions at 
imprinted loci. Consistently, MBD1 and Kaiso are dispensable from embryonic 
development (Zhao et al., 2003; Prokhortchouk et al., 2006). The possible redundancy 
between these proteins can be examined by generating mice carrying two or more 
deletion alleles for these proteins.  
In contrast to the MBD and Kaiso families of proteins, which seem to have locus- 
and stage-specific functions, two other factors, NP95 and ZFP57, are responsible for 
maintenance of DNA methylation at multiple imprinted loci (Sharif et al., 2007; Mackay 
et al., 2008; Li et al., 2008). NP95 functions as a cofactor of DNMT1 during mitosis, 
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where NP95 was suggested to facilitate the localization of DNMT1 to the newly 
synthesized DNA strand (Sharif et al., 2007). ZFP57 is a KRAB zinc finger protein. 
Interestingly, ZFP57 and NuRD complex components, including CHD3, CHD4 and 
HDAC1, can interact with a co-repressor protein, Tripartite motif-containing 28 (TRIM28) 
(Schultz et al., 2001), suggesting a functional correlation between ZFP57 and the NuRD 
complex. Indeed, the Peg3 locus was affected in both the dsMta2-injected embryos (see 
2.3, 2.7 and Table 1) and the ZFP57 mutants (Mackay et al., 2008; Li et al., 2008). In 
contrast, the H19 ICR was not affected in ZFP57 mutants (Mackay et al., 2008; Li et al., 
2008). Therefore, it is unlikely that ZFP57 functions in concert with the NuRD complex 
at the H19/Igf2 locus. The functional correlation between ZFP57 and the NuRD complex 
at other imprinted loci remains to be determined. 
4.5 Additional functions of MBD3 and MTA2 in preimplantation embryos 
In addition to the phenotypes described in Chapter 2, MBD3-depleted embryos 
developed slower and were smaller than the control embryos (Reese et al., 2007). 
Reduced cell number was observed in our MBD3 RNAi embryos at the blastocyst stage 
(Reese et al., 2007), as well as in Mbd3-null E5.5 embryos (Kaji et al., 2007). The 
numbers of cells that undergo apoptosis in dsMbd3 embryos were not higher than in 
control embryos (Reese et al., 2007). Although MBD3 was suggested to repress the 
trophoblast lineage (Zhu et al., 2009), dsMbd3 RNAi blastocysts developed both the ICM 
and trophoectoderm layers and expressed marker genes for both lineages (Reese et al., 
2007). These data suggest that the reduced cell number in MBD3-depleted embryos is not 
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due to loss of lineages, but may be the consequence of mitotic defects or developmental 
arrest. Indeed, there was a significant increase in numbers of metaphase chromosome 
pairs in dsMbd3 RNAi embryos, suggesting a mitotic defect (Reese et al., 2007). 
However, although the dsMta2-injected embryos exhibited a similar phenotype of having 
increased metaphase chromosome pairs, they had normal numbers of cells and had 
similar sizes compared with the dsGfp-injected embryos (Ma et al., 2010). Genome-wide 
ChIP assays using antibodies against MBD3 and MTA2, as well as microarray analysis of 
gene expression changes in dsMbd3 and dsMta2 RNAi embryos may be able to uncover 
the underlying mechanism for these phenotypes through the indetification of new targets 
for MBD3 and MTA2. 
4.6 Genome-wide colocalization of CTCF and cohesins 
I demonstrated that cohesins colocalize with CTCF at five imprinted regions 
including the H19 ICR, IVR CBS, Igf2 IUCBS2, Gtl2 DMR, KvDMR1 (see Chapter 3 
and Fig. 4.1). At the H19 ICR, such colocalization depends on the CTCF binding sites on 
the maternal allele (Fig. 3.1 and 3.2). The results presented in this dissertation, together 
with recent discoveries that cohesins colocalize with CTCF genome-wide in human and 
mouse cell lines (Parelho et al., 2008; Wendt et al., 2008; Rubio et al., 2008), indicate that 
the cohesin complex is a general cofactor of CTCF at imprinted loci, as well as at other 
CTCF targets.  
Thousands of CTCF and cohesins binding sites were recovered by ChIP-on-chip 
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experiments using tiling arrays, and 56 to 77% of CTCF binding sites are also cohesins 
sites (Parelho et al., 2008; Wendt et al., 2008). Conversely, 65 to 89% of cohesins binding 
sites are CTCF sites (Parelho et al., 2008; Wendt et al., 2008). Cohesins may be recruited 
to these shared binding sites by CTCF, which has the zinc fingers that directly bind to 
DNA. However, it remains unclear if cohesins binding on these sites requires the CTCF 
protein, or vice versa. RNAi experiments targeting CTCF by siRNA or shRNA treatments 
showed reduced association of cohesins at a subset of CTCF binding sites: 12 sites from 
one study (Parelho et al., 2008) and 90 out of 167 sites from another study(Wendt et al., 
2008). Conversely, 12 other binding sites didn’t have changes in CTCF affinity when 
RAD21 was depleted (Parelho et al., 2008). However, due to the limited number of sites 
tested in this study (Parelho et al., 2008), it remains uncertain if CTCF requires cohesins 
at other binding sites.  
4.7. Cohesins’ dependence of the CTCF binding sites 
I showed that cohesins bind to the maternal H19 ICR, and such binding was lost 
when the CTCF binding sites were deleted from the maternal chromosome (Fig. 3.1 and 
3.2). There are two possible explanations for this observation. First, cohesins binding to 
the maternal H19 ICR may require the CTCF binding sites in the H19 ICR. In support of 
this idea, the consensus sequences of CTCF and cohesins binding sites are highly similar 
(Wendt et al., 2008). In addition, two other independent studies also revealed a 
requirement for CTCF binding sites for cohesins binding at the KSHV latency control 
region and human myotonic dystrophy gene DM1 (Stedman et al., 2008; Rubio et al., 
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2008).  
Second, cohesins may be sensitive to DNA methylation, because the H19∆R/+ mutant 
became methylated at the maternal H19 ICR in postimplantation tissues (Fig. 1.2) (Engel 
et al., 2006). Consistent with this idea, cohesins are enriched on the unmethylated 
maternal allele of the Gtl2 DMR (Fig. 3.5 B). Moreover, a subset of CTCF and cohesins 
binding sites exhibited cell-type specificity, and these sites are hypermethylated in cell 
types that are not bound by CTCF and cohesins (Parelho et al., 2008). Biochemical 
experiments examining in vitro binding of cohesins to unmethylated and methylated 
DNA may provide direct evidence showing cohesins’ sensitivity to DNA methylation. 
4.8. Other cohesin cofactors in transcriptional regulation 
Genome-wide localization of CTCF and cohesins strongly suggest functional 
correlation between these factors. Consistent with this idea, I observed similar changes in 
imprinted gene RNA levels between CTCF-depleted and cohesins-depleted MEFs (Fig. 
3.9, 3.10 and 3.12). However, we cannot rule out the possibility that CTCF and cohesins 
function independently at imprinted loci. In addition to CTCF, other partners of cohesins 
in gene regulation have been described, including the Polycomb protein complex PRC2 
(Schaaf et al., 2009), the Mediator complex (Kagey et al., 2010) and estrogen receptor α 
(ERα) (Schmidt et al., 2010). The Mediator- and ERα-associated cohesins binding sites 
are largely depleted of CTCF-associated cohesins binding sites (Schmidt et al., 2010; 
Kagey et al., 2010), suggesting that cohesins function through distinct cofactors.  
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4.9. Cohesins may not be involved in the insulator function at the H19 ICR 
CTCF’s role at the H19 ICR as an insulator protein regulating genomic imprinting is 
well-established (see 1.1.3.1 and 1.4.1). Surprisingly, I did not observe loss of insulation 
at the H19 ICR in MEFs upon depletion of CTCF by RNAi (Fig. 3.9 B). This finding 
could be attributed to the relatively short period (96 h to 144 h) of CTCF depletion, or to 
our siRNA experiments not reducing CTCF to levels below the threshold required for 
maintaining insulation at the H19 ICR in MEFs. Alternatively, MEFs with a stronger 
knock-down effect may not survive and therefore were not represented in the expression 
analysis. Another possibility is that CTCF may only be required for the establishment, 
rather than the maintenance of Igf2 imprinting. Our previous work, however, argues 
against this idea. Conditional deletion of the entire H19 ICR from mouse neonatal liver 
led to loss of imprinting, suggesting the ICR is required to maintain Igf2 repression on the 
maternal allele (Thorvaldsen et al., 2006). Nevertheless, the presence of CTCF prior to 
the RNAi treatment could be sufficient for establishing a chromatin state that is able to 
maintain imprinted gene expression in the context of MEFs. 
Similar experiments involving depletion of CTCF and cohesin complex subunits by 
siRNA or shRNA treatments have been reported by other groups. Wendt et al. showed 
reduction of H19 RNA levels and increased Igf2 RNA levels upon depletion of both 
CTCF and RAD21 in HeLa cells (Wendt et al., 2008). However, neither statistical 
analysis of the mRNA changes nor allele-specific expression analysis was performed in 
that study. Nativio et al. reported no changes in HB2 cells, a human breast epithelial cell 
line(Nativio et al., 2009). The disparity between these studies and our study could 
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originate from differences in cell types and species (mouse vs. human). A recent study 
using MEFs (the same cell type I used) by Yao et al. showed reduced H19 and increased 
Igf2 expression upon CTCF depletion by shRNA (Yao et al., 2010). However, the H19 
reduction was not statistically significant and the authors did not show the allelic 
expression profile of Igf2, even though they used a F1 hybrid MEF line from the 
Bartolomei lab. Therefore, it is possible that the phenotypes they described are consistent 
with our results and showing a non-allelic role of CTCF at H19. A better understanding 
of the role of CTCF and cohesins in insulator function at the H19 ICR relies on further 
analysis in other cell types such as TS cells (Fig. 4.1). 
4.10. Cooperation of CTCF and cohesins in transcriptional regulation of 
imprinted genes 
Although CTCF and cohesins may have independent functions at some genomic loci, 
I observed colocalization of CTCF and cohesins in all the imprinted regions tested (the 
H19 ICR, IVR CBS, Igf2 IUCBS2, Gtl2 DMR and KvDMR1) (see Chapter 3). Moreover, 
the similar effects seen upon siRNA treatments targeting CTCF and cohesins in MEFs 
suggest that CTCF and cohesins cooperate in regulating expression of imprinted genes. 
Despite the disparate observations by siRNA or shRNA treatments targeting CTCF 
and cohesins in our study and others (Wendt et al., 2008; Nativio et al., 2009; Yao et al., 
2010), one phenotype is strikingly similar, namely elevated Igf2 RNA levels after CTCF 
and cohesins depletion, which is independent of the CTCF binding sites at the H19 ICR 
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(Fig. 3.10). The colocalization of CTCF and cohesins at the Igf2 IUCBS2 (Fig. 3.10) may 
explain this phenotype. As briefly discussed in 3.2.1, besides the insulator mechanism, 
Igf2 expression may be repressed, non-allelically, by recruitment of CTCF and cohesins 
to the IUCBS2 (Fig. 4.1). I propose that the H19 ICR has higher occupancy of CTCF and 
cohesins through the four CTCF binding sites (within 2 kb), whereas the IUCBS2 and 
possibly IUCBS1 (Fig. 3.11) (3.5 kb apart) may have lower occupancy of CTCF and 
cohesins. By depleting CTCF and/or cohesin subunits, a significant reduction of CTCF 
and cohesins binding may be observed at IUCBS 1&2 but not at the H19 ICR. Further 
experiments assaying binding of CTCF and cohesins at the H19 ICR and IUCBS2 after 
siRNA treatments are currently ongoing.  
Although the role of CTCF at the H19 ICR is well established, its functions at the 
Gtl2 DMR and KvDMR1 remain to be elucidated. The colocalization of CTCF and 
cohesins at these DMRs suggests that the proteins function together. Although we did not 
observe loss of imprinting in any of the genes tested following CTCF and cohesins 
depletion in MEFs, mRNA levels of imprinted genes were increased or unaltered (Fig. 
3.12), suggesting a role in the repression at these loci. Elucidation of the function at these 
loci is complicated by the fact that CTCF and cohesins bind to thousands of genomic 
sites that depletion of these proteins may affect many different genes. The mechanism(s) 
by which CTCF and cohesins impact gene expression at imprinted loci other than the 
H19/Igf2 locus is (are) unclear. Interestingly, depletion of both CTCF and cohesins 
similarly affects the genes in the H19/Igf2 and Dlk1/Gtl2 imprinted clusters (Fig. 3.10 
and 3.12), suggesting CTCF and cohesins have similar roles within the same cluster, or 
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even across different imprinted clusters (see below). 
4.11. Possible mechanisms for the non-allelic functions of CTCF and cohesins at 
imprinted loci 
The aforementioned results suggest the following possible mechanisms: first, CTCF 
and cohesins function in concert to regulate a transcriptional activator or repressor. 
Removal of CTCF and cohesins would increase the activity of an activator (or diminish 
activity of a repressor), which would lead to overexpression of imprinted genes in the 
same cluster. Second, given that CTCF mediates inter- and intra-chromosomal 
interactions [for review, see (Williams and Flavell, 2008)], and is enriched at nuclear 
lamina-associated domains (Guelen et al., 2008), CTCF and cohesins could participate in 
the high-order chromosome organization that is required to localize gene loci to certain 
domains in the nucleus. Loss of CTCF and cohesins may therefore impair this chromatin 
organization, leading to elevated expression of imprinted genes. Third, CTCF and 
cohesins could function through the imprinted gene network (IGN). The IGN was first 
described in a microarray analysis that suggested co-regulation of imprinted genes 
(Varrault et al., 2006). Interestingly, H19, Igf2 and Dlk1 expression levels are 
co-upregulated or down-regulated in Zac1-overexpressed or depleted tissues, respectively 
(Varrault et al., 2006). Additional evidence for the IGN came from a study showing 
coordinated down-regulation of 11 imprinted genes (including H19, Igf2, Dlk1 and Gtl2) 
independent of DNA methylation during postnatal growth deceleration in various mouse 
tissues (Lui et al., 2008). Furthermore, Cdkn1c, an imprinted gene in the Kcnq1/Kcnq1ot 
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cluster, was not included in my analysis but identified as a member of the IGN (Varrault 
et al., 2006; Lui et al., 2008). It is of interest to examine whether depletion of CTCF and 
cohesins would affect Cdkn1c expression levels. CTCF and cohesins may play a role in 
the IGN because of their binding patterns in various related genes. However, the 
mechanism underlying IGN gene cross-talk and co-regulation remains to be elucidated. 
4.12. Tissue and cell type specificity of CTCF and cohesins functions 
The complexity of CTCF and cohesins is further highlighted due to their cell-type 
specific binding patterns. ChIP experiments targeting CTCF and cohesins in various cell 
types revealed different binding profiles (Essien et al., 2009; Schaaf et al., 2009; Schmidt 
et al., 2010; Kagey et al., 2010). As introduced in 1.4.3, analysis by Essien et al. 
suggested that CTCF binding sites at the imprinted loci described here had relatively low 
affinity (LowOc and MedOc binding sites) for CTCF. The LowOc and MedOc CTCF 
binding sites tend to be cell-type specific and developmentally regulated (Essien et al., 
2009). Similarly, cohesins also have different binding profiles between mouse embryonic 
stem cells and MEFs (Kagey et al., 2010), as well as among different human tissues 
(Schmidt et al., 2010) and Drosophila cell lines (Schaaf et al., 2009). These observations 
suggest that CTCF and cohesins have distinct functions in different cell types at a subset 
of targets. To illustrate further CTCF and cohesins’ roles in genomic imprinting, more 
cell types need to be investigated. By comparing the binding profiles of CTCF and 
cohesins at imprinted loci in different cell types (e.g., TS cells versus MEFs), and 
subsequently correlating these with the imprinted gene expression patterns, one would be 
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able to determine which binding sites are controlling imprinting, and which are 
controlling transcriptional levels. The F1 hybrid TS cell lines that we have derived can be 
a useful tool to study functions of CTCF, cohesins and other protein factors at imprinted 
loci, especially at extraembryonic-specific imprinted genes. 
In conclusion, the data described in this dissertation reveal new and important 
insights into the roles of protein factors in genomic imprinting (Fig. 4.1). Our data 
provide the first link between the NuRD corepressor complex and genomic imprinting. 
We also showed association of methylated DNA binding proteins MBD3, MBD1 and 
Kaiso with imprinted loci, in ES cells and MEFs. These findings suggest a mechanism by 
which germ-line DMRs can survive the genome-wide reprogramming during 
preimplantation development: methylated DNA binding proteins and NuRD complexes 
are involved in the protection of DMRs from DNA demethylation, as well as allelic 
repression of methylated imprinted genes. Further studies of the cross-talk between these 
proteins and their functions in postimplantation embryos will provide substantial 
knowledge of imprinted gene control. I also showed systematic colocalization of cohesins 
with CTCF at imprinted loci. Depletion of these proteins in MEFs led to similar changes 
in total expression levels of imprinted genes (typically increased expression), whereas 
monoallelic expression was maintained. These results uncovered non-allelic repressive 
roles of CTCF and cohesins in genomic imprinting.  
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Chapter 5. Materials and methods 
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Mouse strains 
ES cells, MEFs, embryos and neonatal liver used in this thesis are isolated from crosses 
between C57BL/6 (B6) (The Jackson Laboratory) females and males with Mus musculus 
castaneus Chr 7 in a B6 background [B6(CAST7)], or males with Mus musculus 
castaneus Chr7, distal 12 and X in a B6 background [B6(CAST7P12X)] as previously 
described (Mann et al., 2003; Reese et al., 2007). Throughout this dissertation, in 
allele-specific analysis, the B6 allele (B) is the maternal allele, and the CAST (C) allele is 
the paternal allele. TS cells are isolated from crosses between 129S1 (The Jackson 
Laboratory) females and males with Mus musculus castaneus Chr 7 in a B6 background 
[B6(CAST7)], or males with Mus musculus castaneus Chr 7, distal 12 and X in a B6 
background [B6(CAST7P12X)]. All experiments were conducted with the approval of the 
Institutional Animal Care and Use Committee at the University of Pennsylvania. 
Culture of ES cells 
ES cells are cultured in ES cell medium (Table 2) with supplement of 1000 U/ml LIF. 
Inactivated MEFs were used as feeder cells. MEFs were inactivated in Mitomycin 
C-containing medium (Table 2) for 2 h at 37 °C and trypsinized and frozen. For ES cell 
culture, plates/flasks were treated with 0.1% Gelatin (in PBS) for 15 min-2 h prior to cell 
plating. For a 6-cm plate, 106 MEFs were plated prior to ES cell plating.  
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Isolation and culture of F1 hybrid MEFs 
F1 hybrid MEFs were isolated from individual mouse E12.5-14.5 embryos generated 
from crosses between B6 (for both wildtype and the H19∆R/+ mutant) females and 
B6(CAST7P12X) males as previously described (Verona et al., 2008). The liver was 
removed from embryos for genotyping. The remaining of each embryo was placed in a 15 
ml conical tube and trimmed into pieces by a sanitize scissor. 2.5 ml 0.1% Trypsin-EDTA 
was added into each conical tube. After incubation at 37 °C for 30-45 min with 
occasionally agitation, the digested cells and tissues were transferred into a T75 flask 
with 12 ml MEF medium (Table 2). When the cells became confluent, MEFs were split 
1:8 or frozen as Passage 2 (P2). For siRNA and ChIP experiments, P4~P6 MEFs were 
used. 
Derivation and culture of F1 hybrid TS cells 
TS cells were derived from E3.5 blastocysts as described before (Himeno et al., 2008). 
Briefly, E3.5 blastocysts were flushed and washed a couple times with PBS. Each 
blastocyst was placed in a well on a 4-well plate that contained inactivated MEF feeder 
cells. 0.5 ml of medium (see below) was added to each well. The blastocysts were 
cultured for 2-5 days until they hatched and had outgrowth (~500 to 1000 µM in 
diameter). The outgrown embryos were then disaggregated by trypsin-EDTA treatment 
followed by vigorous pipeting. Disaggregated embryos were cultured for up to two weeks 
and expanded if colonies were seen. TS cells were cultured on inactivated MEFs (50% of 
what was used for ES cells, for a 6-cm plate or T25, 0.5 x 106 MEFs were used), in TS 
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cell medium (Table 2). For derivation, 70% conditional medium (CM) + 30% TS medium 
+ 1.5 x FGF4 and heparin (FGH) were used. To make the CM, inactivated MEFs were 
plated at a high density (For a 15-cm plate, 6 x 106 MEFs were plated) and cultured in TS 
medium without FGH for at least 72 h. The CM was harvested and centrifuged at 2,300 g 
for 20 min to remove cell debris, and the supernatant was collected and passed through a 
0.2 µm filter and frozen. For culturing TS cells, the medium were changed every 48 h, 
and fresh FGH was added each time. To passage TS cells, cells were treated with 0.1% 
Trypsin-EDTA at 37 °C for 3 min and 15 s and were split 1:5 to 1:20. To collect 
MEF-free TS cells, cells were trypsinized and re-plated in 70% CM + FGH for 45 min. 
The supernatant was transferred to a new plate for another 45 min. The new supernatant 
contained mostly TS cells and was used for protein and RNA analysis. 
PCR programming 
Except for the bisulfite mutagenesis assays, all PCRs were performed for 2 min at 95°C; 
32-38 cycles of 15 s at 95°C, 15 s at annealing temperature (listed in tables), 20-30 s at 
72°C; and a final 2 min extension at 72 °C. PCR conditions are listed in Table 3 (mouse 
genotyping), Table 4 (Bisulfite assays), Table 5 (Real-time PCRs), Table 6 
(Allele-specific PCRs), and Table 7 (All other PCR primers). 
Transgenic mice genotyping 
The Zp3-dsMbd3 transgenic mouse Line 37, was generated previously (Reese et al., 
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2007). Transgenic and non-transgenic littermates were genotyped by PCR assays for part 
of the transgenic containing the Egfp gene. The H19∆R transgenic mouse was generated 
previously (Engel et al., 2006). The mice carrying Mbd1-null, Mbd2-null and Mbd3-null 
alleles were generated by other labs (Hendrich et al., 2001; Zhao et al., 2003). For all 
transgenic mice lines, tail clippings, ear punches or other tissues from these mice were 
digested 4 h to overnight at 55 °C in 60 µg proteinase K/100 µl Quick Tail Buffer (50mM 
KCl, 1.5 mM MgCl2, 10mM Tris pH 8.5, 0.01% gelatin, 4.5% Tween-20, 4.5% Igepal). 
Then proteinase K was heat-inactivated for 10min at 95 °C. One µl of digested tissue was 
amplified using primers and PCR conditions listed in Table 3.  
Bisulfite mutagenesis 
The bisulfite mutagenesis for dsMbd3 RNAi embryos was performed as described (Reese 
et al., 2007). For dsMta2-injected and control embryos, the allele-specific DNA 
methylation patterns were examined for DMRs. Genomic DNA was isolated from two to 
twelve blastocysts using The QIAamp DNA Micro Kit (QIAGEN). The DNA was then 
denatured and treated with bisulfite using the Imprint DNA Modification Kit according to 
the manufacturer’s protocol (Sigma-Aldrich). Partial mutagenized DNA was amplified by 
the Epitech Whole Bisulfitome Kit (QIAGEN) according to manufacturer’s instructions.  
Half of a blastocyst equivalent of the mutagenized DNA or 2 µl of the amplified DNA 
were used for each PCR reaction (with 0.5 µM of each primer and 1.5 mM MgCl2, Table 
4) and the products were first analyzed by combined bisulfite and restriction analysis 
(COBRA) assays (Table 4). The products from a successful PCR that contains both 
135 
unmethylated and methylated strands were subsequently cloned and sequenced as 
described previously (Reese et al., 2007; Market-Velker et al., 2010b). Six or more clones 
were sequenced for each PCR reaction. The sequencing data was analyzed using an 
online tool BDPC [http://biochem.jacobs-university.de/BDPC/index.php; (Rohde et al., 
2008)]. Strands from a PCR that contained an identical pattern of unconverted cytosines 
and that could not be distinguished from other strands by polymorphisms were only 
counted once. For all three DMRs analyzed, two rounds of nested PCRs were performed. 
Primers, PCR conditions and polymorphisms between B6 and CAST are listed in Table 4. 
Chromatin Immunoprecipitation 
ChIP assays were carried out using the Chromatin Immunoprecipitation Assay Kit 
(Upstate 17-295 and 17-610) according to the manufacturer’s instructions and as 
previously described (Verona et al., 2008). Approximately 1 X 106 MEFs were used in 
each IP that resulted in 40-100 µg of ChIPed DNA. Cross-linking was achieved by 
adding 1% Formaldehyde to cell medium or PBS buffer and incubated 15 min at room 
temperature. All PCR primers and conditions are listed in Table 5 and 6. 
Antibodies 
The following antibodies were used in chromatin immunoprecipitation (ChIP) and 
western blot (WB): anti-Histone H3 (Abcam ab1791, ChIP 5µg); anti-Acetylated Histone 
H3 (Millipore 06-599, ChIP 5µg); anti-dimethyl-Histone H3 Lysine4 (Millipore 07-030, 
ChIP 5ul); anti-MBD3 (Santa Cruz Sc-9402,ChIP 20µl); anti-MBD1 (Santa Cruz 
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SC-25261, ChIP 10 µl); anti-Kaiso (Millipore 05-659, ChIP 10 µl); anti-CTCF (Millipore 
07-729, ChIP 5µl, WB 1:1000); anti-SMC1 (Bethyl A300-055A, ChIP 5µl; WB 1:1000); 
anti-RAD21 (Bethyl A300-080A, ChIP 5µl; WB 1:500); anti-αTUBULIN (Sigma T6199, 
WB 1:2000). All antibodies used and details are listed in Table 8. 
RNA extraction and reverse transcription (RT) 
Total RNA from ES cells, MEFs and TS cells was extracted using RNeasy Micro Kit 
(Qiagen) following manufacturer’s instructions. The reverse transcription reaction, 
primed with random primers, was performed using Superscript II or III reverse 
transcriptase (Invitrogen) following the manufacturer’s instructions. For each sample, 
-RT control was done without the Superscript II or III and confirmed negative by PCR of 
Gapdh. 
siRNA treatments 
MEFs were cultured in 24-well plates and treated every 48 h for two to three sequential 
siRNA treatments. Cells were trypsinized and plated at 30-40% confluency. 60-80 
picomolar (pM) siRNAs were mixed with 1 µl Lipofectamine 2000 (Invitrogen) and 
100µl OPTI low serum medium (Invitrogen) and added to the medium (high glucose 
DMEM+10% FBS) upon cell plating. The following siRNAs and amounts were used: 
control siRNA (Invitrogen 12935-300) (60 or 80 pM), CTCF (Invitrogen Stealth 
Ctcf-MSS203343) (60 pM); SMC1 (Invitrogen Smc1a-MSS216158) (60 pM); RAD21 
(Dharmacon RAD21 ON-TARGET plus siRNA J-058531-12) (40 pM). Additional 
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siRNAs were also tested: CTCF (Dharmacon CTCF ON-TARGET plus siRNA 
J-044693-9, 10, 11 and 12) and RAD21 [Dharmacon RAD21 ON-TARGET plus siRNA 
J-058531-9, 10 and 11; Santa Cruz Rad21 siRNA (m): sc-72050], among which, one 
siRNA targeting CTCF (Dharmacon 10, use 60 pM) and one siRNA targeting RAD21 
(Dharmacon 9, use 80 pM) were effective; and other siRNAs were not effective. 
Lentivirus-RNAi 
The pLKO.1 vector was used for cloning of short hairpin RNAs (shRNA), as instructed 
by the RNAi consortium and Addgene online protocol (Addgene). shRNA sequences (21 
to 25 bp) were either modified from the siRNAs (see above) or designed using online 
tools (GenScript; Invitrogen; siRNA Wizard; Yuan et al., 2004). A few nucleotides 
required for restriction enzyme digestion were added to the 5’ and 3’ ends of shRNA 
oligos. All forward strands had a 5’-CCGG- end and a –TTTTG-3’ end; all reverse 
strands had a 5’-AATTCAAAAA end. Each shRNA has a looping sequence (4 to 6 bp) 
based on the suggestion from online tools used (GenScript; Invitrogen; siRNA Wizard; 
Yuan et al., 2004). Moreover, it is suggested that a shRNA hairpin sequence should starts 
with a nucleotide G and ends with a corresponding C, to enable efficient transcription 
initiation by RNA Polymerase III U6 (GenScript; Invitrogen). Therefore, an additional G 
was added to the 5’ end of the forward strand of shRNAs that does not start with a G, 
following the added sequences for restriction sites; and an additional C was add to the 
reverse strand of shRNAs that does not end with a C. All target sequences were subjected 
to NCBI BLAST and tested for off-target effects, only sequences have no more than 15 
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nucleotides that are identical to mouse ESTs other than the target mRNA were used in the 
following experiments. In addition, a scrambled shRNA that was previously designed and 
cloned into the pLKO.1 vector by another lab (Sarbassov et al., 2005) and was deposited 
to Addgene (Addgene plasmid 1864, hairpin sequence: 
CCTAAGGTTAAGTCGCCCTCGCTCTAGCGAGGGCGACTTAACCTTAGG) was 
used as a control. A total number of 13 shRNAs were cloned and sequenced, including a 
shRNA scrambled control, a Ctcf-siRNA scrambled control, four shRNAs targeting 
CTCF, four shRNAs targeting SMC1 and three shRNAs targeting RAD21. The two 
strands of shRNA oligos were annealed and cloned into the pLKO.1 vector. The plasmids 
were sequenced and correct clones were expanded. They were subsequently transfected 
into MEFs and examined for target protein levels by western blot. Only shRNAs that can 
knock-down target proteins were included in following experiments. All shRNA 
sequences are listed in Table 9. To produce lentiviruses, 293FT cells (Invitrogen) were 
transfected with pLKO.1 shRNA plasmid, psPAX2 packaging plasmid and pMD2.G 
envelop plasmid (Addgene) at a ratio of 4:3:1, using Lipofectamine 2000. For a 15-cm 
plate, 15 µg of pLKO.1, 11.25 µg of psPAX2 and 3.75 µg of pMD2.G were transfected. 
DMEM (high-glucose) + 10% FBS was used as a plating medium for the transfection. 
Cells were fed with 293FT medium (Table 2) 6 h to overnight after transfection, and were 
cultured for another 96 h. The medium containing the lentiviruses were collected every 
48 h and combined, centrifuged at 800g for 5 min to remove cell debris, and subsequently 
passed through a 0.45 µm filter. The purified medium containing the lentiviruses particles 
were then subjected to ultracentrifugation for ~30,000 g for 2 h at 4 °C. For lentiviruses 
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produced by a 15-cm plate, ~500 µl RPMI 1640 medium were added to the pellets and let 
sit at 4 °C overnight. The lentiviruses were subsequently resuspended, aliquoted and 
frozen. To titrate the lentiviruses, 293FT cells were infected and treated with geneticin. 
Numbers of viable cells after 48 h of drug selection were counted and the virus titer were 
calculated. To infect TS cells, lentivirues were added to TS culture at a multiplicity of 
infection (MOI) = 5 to 20. To assist in effective infection, the TS cells were centrifuged at 
1,000 g for 1 h at room temperature or 37 °C (Golding et al., 2010), and incubated at 
37 °C for at least 24 h before drug selection. 
Real-time PCRs 
For both ChIP and RNA expression assays, real-time PCRs were performed using the 
LightCycler Real Time PCR System (Roche). Reactions were set up in duplicates or 
triplicates using the Ready-To-Go PCR beads (Amersham). Each PCR bead was 
dissolved ddH2O with 0.38-0.5 µl of TaqStart antibody (Clontech) in a total volume of 15 
µl, incubated for 5 min at room temperature. 10 µl was used for each PCR in a 20 µl 
system, which contains 0.2 to 0.6 µM primers (Table 5), 1x EvaGreen (Biotium) and 
1.25-5 mM MgCl2 (Table 5). For ChIP assays and relative RNA expression assays, data 
analysis was performed using the Light Cycler 4.0 software, using the Relative 
Quantification program (Monocolor) to determine the ratio of each ChIP sample relative 
to input or cDNA levels relative to house-keeping genes. For each pairs of PCR primers, 
a standard curve was generated prior to experiments and used to correct different 
efficiency between different PCRs (e.g., Igf2 versus Rplp0). For allele-specific PCRs 
140 
(H19, and Snrpn), data analysis was performed using Light Cycler 3.0 software. Relative 
signals from each allele were determined by melting-curve analysis and the relative peak 
areas for each allele were determined (Reese et al., 2007). 
Allele-specific PCRs 
For both ChIP and RNA expression assays, allele-specific PCRs were carried out with 
Ready-to-go PCR beads (Amersham) or GoTaq master mixture (Promega) as previously 
described (Verona et al., 2008). For most allele-specific PCRs, 0.3 µM of each primer 
(Table 6) and 0.1 µCi of [32P] dCTP were included in each PCR. The PCR products were 
digested with restriction enzymes listed in Table 6 and resolved in 7% or 12% 
polyacrylamide gels. These gels were dried, exposed to phosphor screens and scanned on 
a Typhoon Trio Phosphorimager (GE). The relative band intensities were quantified 
using Image J (NIH). Band intensities were normalized by numbers of radioactive dCTPs 
in each digested fragment. H19 and Snrpn RNA assays were conducted on cDNA using 
the LightCycler Real Time PCR System (Roche) (see above) as described previously 
(Reese et al., 2007). Peg3 and Dlk1 RNA assays were conducted with some modifications 
as previously described (Mann et al., 2004; Hagan et al., 2009). The gels were stained 
with ethidium bromide. The contribution of each parental allele to the total RNA was 
determined using the Quantity One software (Bio-Rad). All primers and PCR conditions 
are listed in Table 6. 
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Western blots 
Cell pellets were lysed with TNE (100 mM Tris, pH 7.4; 1% NP-40; 10 mM EDTA) 
buffer with 1:100 Proteinase inhibitor cocktail (Sigma) and 1 mM DTT. Lysates were 
mixed with 5X loading buffer, denatured by heating at 95°C for 10 min, and fractionated 
on an 8% SDS-PAGE gel. The protein was transferred to a nitrocellulose membrane 
(BioRad), blocked in 3% non-fat milk (BioRad) in TBST (0.05% Tween-20 in 1X TBS) 
and probed with primary and secondary antibodies (HRP-conjugated anti-mouse and 
anti-rabbit, GE). The blot was visualized using chemiluminescence (ECL Plus; GE). 
Quantification was performed using ImageJ (NIH). 
Statistics 
For real-time PCRs following ChIP experiments, one-tail paired T-test was used. For 
analysis of bisulfite treated DNA strands, Chi-square test was used. For RNA expression 
changes, two-tail paired T-test was used. For all tests, differences of p<0.05 were 
considered significant. 
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Table 2 Tissue culture medium 
Media Recipe 
ES cell 
15% Fetal bovine serum (FBS) 
1% Penicillin (500U/ml) & Streptomycin (5 mg/ml) (Pen/Strep) 
1% 200mM L-Glutamine (L-Gln) 
1% Non-essential amino acids 
0.1% Gentamicin 
55µm β-Mercaptoethanol (BME) 
Filled with DMEM (high-glucose) to 100% 
Add fresh: 1000 U/ml LIF/ESGRO (Millipore Chemicon) 
MEFs 
10% FBS 
1% Pen/Strep 
1% L-Gln 
0.1% Gentamicin 
Filled with DMEM (high-glucose) to 100% 
TS cell 
15%-20% FBS 
1% Pen/Strep 
1% L-Gln 
1% 100mM sodium pyruvate 
100 µM BME 
Filled with RPMI 1640 (pH 7.2) to 100% 
Add fresh:  0.1% 25 µg/ml FGF4 (Sigma F8424 or R&D 235-F4) 
   0.1% 1.5 mg/ml heparin 
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Media Recipe 
293FT cells 
10% FBS 
1% Pen/Strep 
1% L-Gln 
1% 100mM sodium pyruvate 
Filled with DMEM (high glucose) to 100% 
Mitomycin C medium 
5% FBS 
10 µg/ml Mitomycin C 
Filled with DMEM (high-glucose) to 100% 
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Table 3 Primers and PCR conditions used for mouse genotyping 
Transgenic 
mouse 
Primer (stock concentration in µM) sequence 
WT 
(bp) 
Mutant 
(bp) 
Temp 
(°C) 
Primer 
(µl) 
Reaction 
(µl) 
Reference 
Zp3-dsMbd3 
GFP-F2 (10): GCACAATCTTCTTCAAGGACGAC 
GFP-R1 (10): TCTTTGCTCAGGGCGGACTG 
 343 60 0.5 15 
(Reese et al., 
2007) 
H19∆R 
H19-2.3F (25): 
CAATGTTCATAAGGGTCATGGGGTG 
H19-2.0R (25): 
CGTAAAGTGTCACAAATGCCTGATCCC 
174 258 55 0.5 15 
(Engel et al., 
2006) 
Mbd1-null 
OXZ59 (common) (10): 
TCTTCTCAGACTGAGAAGGGTGA 
OXZ60 (WT) (10): 
CACTGAACATTGCCCAGAGCACA 
OXZ61 (mutant) (10): 
AAACGGCGGATTGACCGTAATGG 
300 500 55 1 20 
(Zhao et al., 
2003) 
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Transgenic 
mouse 
Primer (stock concentration in µM) sequence 
WT 
(bp) 
Mutant 
(bp) 
Temp 
(°C) 
Primer 
(µl) 
Reaction 
(µl) 
Reference 
Mbd2-null 
MBD2.P61(common) (15): 
ACGCTGGCCTAGTGCCGTGC 
MBD2.P62 (WT) (25): TTGTGGTTGTGCTCAGTTC 
ENP1(mutant) (10): TCCGCAAACTTCTATTTCTG 
~600 ~200 59 1 20 
(Hendrich et al., 
2001) 
Mbd3-null 
MBD3.P26(common) (15): 
TGTAGCCACCTAGCTCAAGG 
MBD3.P27 (WT) (10): CACGCTGGCGACTCTTATTC 
ENP1(mutant) (10): TCCGCAAACTTCTATTTCTG 
272 150 55 1 20 
(Hendrich et al., 
2001) 
146
 
 
 
Table 4 Primers and PCR conditions used for bisulfite mutagenesis 
DMR Primers for nested PCRs PCR conditions 
COBRA enzyme 
and products 
(bp) 
Reference and 
accession 
number 
SNPs: position - 
(B/C) 
H19 
ICR 
BMsp2t1: GAGTATTTAGGAGGTATAAGAATT 
BHha1t3: ATCAAAAACTAACATAAACCCCT 
94 °C 2min; 35 
cycles of 94 °C 
30s, 55 °C 30s 
(ramping speed 
0.5 °C/s), 72 °C 
1min 
HinfI:  
unmethylated 
uncut: 423; 
methylated: 
~210, ~200 
(Tremblay et 
al., 1997), and 
Abramowitz, 
unpublished;U
19619 
(1304-1726) 
1425 - T/C 
1485 - G/deleted 
1566 - G/A 
1654 - A/G 
Bmsp2t2c: GTAAGGAGATTATGTTTATTTTTGG 
BHha1t4ct: CTAACCTCATAAAACCCATAACTAT 
Snrpn 
DMR 
SnrpnA: TATGTAATATGATATAGTTTAGAAATTAG 
SnrpnD: 
AATAAACCCAAATCTAAAATATTTTAATC 
2 cycles of 94 °C 4 
min, 55 °C 2 min, 
HinfI: 
unmethylated 
uncut 451; 
(Lucifero et al., 
2002), and 
Abramowitz, 
2181 - G/A 
2241 - C/T 
2251 - T/G 
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DMR Primers for nested PCRs PCR conditions 
COBRA enzyme 
and products 
(bp) 
Reference and 
accession 
number 
SNPs: position - 
(B/C) 
SnrpnB: AATTTGTGTGATGTTTGTAATTATTTGG 
SnrpnC: ATAAAATACACTTTCACTACTAAAATCC 
72 °C 2 min; 35 
cycles of 95 °C 1 
min, 55 °C 2 min, 
72 °C 2 min 
methylated 262, 
351 
unpublished; 
AF081460 
(2151-2570) 
2259 - T/A 
2268 - G/A 
2281 - C/T 
2292 - C/T 
2348 - G/T 
Peg3 
DMR  
Peg3A-BL: TTTTGATAAGGAGGTGTTT 
Peg3D-BL: ACTCTAATATCCACTATAATAA 
94 °C 2min; 35 
cycles of 94 °C 
30s, 50 °C 30s, 
72 °C 1min 
unmethylated 
uncut 446; 
EcoRV: 
methylated 114, 
332; 
BsrBI: 
methylated 200, 
246 
(Market-Velker 
et al., 2010b); 
NT_039413.7 
(3,683,033-3,6
82,588) 
SNP :3,683,191-G/
A 
Peg3B-BL: AGTGTGGGTGTATTAGATT 
Peg3C-BL: TAACAAAACTTCTACATCATC 
Annealing 53 °C 
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Table 5 Primers and PCR conditions used for real-time PCR quantifications 
Region/Gene Primers 
Temp 
(°C) 
Primer 
(µM) 
MgCl2 
(mM) 
Reference 
H19 ICR 
(Rep1&2) 
H19 4017F: CAGGACTCAAAGGAACATGCTAC 
H19 3594R: GCAATCCGTTTTAGGACTGCG 
60 0.6 4 
Modified from (Verona et al., 
2008) 
Snrpn DMR 
SnUPCHIPs-F: 
AATCTGTGTGATGCTTGCAATCACTTGG 
SnUPCHIPs-R: 
ATAGGATGCACTTTCACTACTAGAATCC 
60 0.3 4 
Modified from (Verona et al., 
2008) 
IG-DMR 
IG-DMR207: TACGGAGATGTGCTGTGGAC 
IG-DMR442: CTCGCTAGTTCACGGAGGTC 
62 0.3 1.25 
Modified from (Verona et al., 
2008) 
Peg3 DMR 
Peg3F3714: GACGGTATCTAAGAGGGTGCAT 
Peg3R3838: GGTTCAGTGTGGGTGCACTA 
60 0.4 4 
Modified from (Verona et al., 
2008) 
DMD_UP 
5488F: CCCATAGTCCTTCCTGGGTA 
5357R: TGATGTGCCACCTGGATAGA 
64 0.3 3 
Modified from (Verona et al., 
2008) 
H19 promoter 
H19GB374: TGGGCAGTGAGTCTCCTTCT 
H19GB675R: GCCACTGTCTCCAAGGACTC 
64 0.6 4 
Modified from (Verona et al., 
2008) 
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Region/Gene Primers 
Temp 
(°C) 
Primer 
(µM) 
MgCl2 
(mM) 
Reference 
H19 Ex5 
 
RT1: GCACTAAGTCGATTGCACTGG 
HE5: AACACTTTATGATGGAACTGC 
60 0.5 2.5 
Modified from (Verona et al., 
2008) 
Myc region 
 
cMyc-f: GGATCCTGAGTCGCAGTATAAAAGA 
cMyc-r: CCTCTGTCTCTCGCTGGAATTAC 
60 0.4 4 (Stedman et al., 2008) 
IVR CBS 
H19IVR 2456F: GGCAATCCACACCTCCTCT 
H19IVR 2664R: GTGAGGTCAGCGGTTAGCAT 
58-64 0.3 3  
IVR Ctrl1 
H19IVR 77F: AGGCACTGCAGCTGGATTAT 
H19IVR 354R: CCCCTAAAGACCCACTCCAT 
56-64 0.6 2.5  
IVR Ctrl2 
H19IVR 6025F: TCAGTTGCAACAGGAACAGC 
H19IVR 6261R: TCTAGCAATGACCCTAACCACA 
61-64 0.5 3.5  
Gtl2 DMR 
Gtl2 1998F: TGGTTGGGCTATTGGAGTCT 
Gtl2 2158R: CAATGGGAGGGGTACAGATG 
61 0.5 3  
KvDMR1 
CTCFBS1 
KvDMR 2644F: ACCATGCAGAGAAAAGCACA 
KvDMR 2844R: CTAGCCGTTGTCGCTAGGAG 
56 0.4 5  
150
 
 
 
Region/Gene Primers 
Temp 
(°C) 
Primer 
(µM) 
MgCl2 
(mM) 
Reference 
KvDMR1 
CTCFBS2 
KvDMR 2258F: CTGAGAAGCCAAGTGGATCG 
KvDMR 2553R: CCACCAGCCTCAGCATATTT 
62 0.2 3  
KvDMR1 Ctrl 
KvDMR 1762F: CACTCACCTTGGGACTCGAC 
KvDMR 2007R: AGAAGCAGAGGTGATTCGTG 
58 0.6 4  
IUCBS1 
IUCBS1-961F: GCTCGAGCTTGACATCTGGT 
IUCBS1-1072R: TTCCATTCTCAAGGCTTGGT 
58 0.6 2  
IUCBS2 
IUCBS2-960F: ACTATGATAAGCCAGCCCTTC 
IUCBS2-1055R: GCCAGAAATGGTTAGTCATGG 
54 0.6 2.5  
H19 
HE2: TGATGGAGAGGACAGAAGGG 
HE4: TTGATTCAGAACGAGACGGAC 
55 0.4 4.5 
Modified from (Thorvaldsen et 
al., 2006) 
Igf2 
Igf2f: CGCTTCAGTTTGTCTGTTCG 
Igf2r: GCAGCACTCTTCCACGATG 
58 0.25 2.4 
Modified from Vigneau, 
unpublished 
Gtl2/Meg3 
Meg3f: TTGCTGTTGTGCTCAGGTTC 
Meg3r: ATCCTGGGGTCCTCAGTCTT 
60 0.4 2 
Modified from Vigneau, 
unpublished 
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Region/Gene Primers 
Temp 
(°C) 
Primer 
(µM) 
MgCl2 
(mM) 
Reference 
Dlk1 
Dlk1f: CGGGAAATTCTGCGAAATAG 
Dlk1r: TGTGCAGGAGCATTCGTACT 
60 0.4 1.25 
Modified from Vigneau, 
unpublished 
Ctcf 
CTCF5F1: GCCAGCAGGGACACATACAAG 
CTCF5R1: GCTTTCGCAAGTGGACACC 
56 0.5 3.5 Modified from (Wan et al., 2008) 
Smc1 
Smc1 3767: CAAGTACCCAGATGCCAACC 
Smc1 3983: CGATCCATGATAGGGGGTAA 
55 0.4 2  
Rad21 
Rad21 2815: CAAGGCTGCACACTCCTGTA 
Rad21 3045: CCCCATAAAAGTGCCAACAC 
55 0.3 2.5  
Actb 
B-actin-F: TGTTACCAACTGGGACGACA 
B-actin-R: GGGGTGTTGAGGTCTCAAA 
55 0.6 2 
Modified from (Mohammad et al., 
2008) 
Rplp0 
Arpp0#72L: TCCCACTTACTGAAAAGGTCAAG 
Arpp0#72R: TCCGACTCTTCCTTTGCTTC 
55 0.4 4.5  
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Table 6 Primers and enzymes used for allele-specific analysis by PCRs 
Region/Gene Primers Temp (°C) 
SNP 
(B/C) 
Enzyme 
Products 
(bp) 
Reference 
H19 ICR 
(Rep3) 
Rep3F2: CAGTTGTGTTTCTGGAGGG 
Rep3R2: TAGGAGTATGCTGCCACC 
62 A/T Tsp45I 
B 107, 29 
C uncut 
136 
(Verona et al., 2008) 
H19 Prom 
H19GB374F: TGGGCAGGTGAGTCTCCTTCT 
H19GB675R: GCCACTGTCTCCAAGGACTC 
64 G/A HphI 
B 216, 89 
C uncut 
305 
(Verona et al., 2008) 
H19 Ex5 
RT1: GCACTAAGTCGATTGCACTGG 
HE5: AACACTTTATGATGGAACTGC 
64 G/A HphI 
B 216, 89 
C uncut 
305 
(Verona et al., 2008) 
IG-DMR 
IG-DMR207: TACGGAGATGTGCTGTGGAC 
IG-DMR442: CTCGCTAGTTCACGGAGGTC 
62 A/G NcoI 
B 104, 95, 
37 
C 199, 37 
(Verona et al., 2008) 
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Region/Gene Primers Temp (°C) 
SNP 
(B/C) 
Enzyme 
Products 
(bp) 
Reference 
Snrpn DMR 
SnUPCHIPs-F: 
AATCTGTGTGATGCTTGCAATCACTTGG 
SnUPCHIPs-R: 
ATAGGATGCACTTTCACTACTAGAATCC 
60 C/T SmlI 
B 278, 145 
C uncut 
423 
(Verona et al., 2008) 
KvDMR1 
KvDMRfor: GCGGGTTTCTTCTCTGAGTC 
KvDMRrev: TGTCCTAGGCCACTCACCTT 
60 T/G BmgBI 
B 253, 99 
C uncut 
352 
(Verona et al., 2008) 
Peg3 DMR 
Peg3F3627: GCCTTGTCAGTTACCCTTGG 
Peg3R3838: GGTTCAGTGTGGGTGCACTA 
61 C/T AvaII 
B uncut 212 
C 155, 57 
 
IVR CBS 
H19IVR 2456F: GGCAATCCACACCTCCTCT 
H19IVR 2644R: GTGAGGTCAGCGGTTAGCAT 
63, add 
TaqStart 
A/G BseRI 
B 204, 4 
C 109. 96, 
4 
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Region/Gene Primers Temp (°C) 
SNP 
(B/C) 
Enzyme 
Products 
(bp) 
Reference 
Gtl2 DMR 
Gtl2 1915F: TGAAACCTGTTGGGCG 
Gtl2 2158R: CAATGGGAGGGGTACAGATG 
61 T/C HaeII 
B 109, 70, 
48, 17 
C 97, 70, 
48, 17, 12 
 
KvDMR1 
CTCF BS1 
KvDMR 2701F: CCCACCGAAGTAATCCAAAA 
KvDMR 3098R: TCAGCTAGGAAGGGATGAGG 
62 C/T Hpy188I 
B uncut 398 
C 292, 106 
 
KvDMR1 
CTCF BS2 
KvDMR 2258F: CTGAGAAGCCAAGTGGATCG 
KvDMR 2553R: CCACCAGCCTCAGCATATTT 
62 A/G MfeI/Tsp509I 
B 214, 82 
C uncut 
296 
 
H19 
HI3: CCTCAAGATGAAAGAAATGGT 
HE5: AACACTTTATGATGGAACTGC 
Probes: Mut CCACCTGTCGTCCATCTCC -FL 
Anc RED640- TCTGAGGGCAACTGGGTGTGG 
55 G/A N/A, real-time PCR 
(Thorvaldsen et al., 2002, 
2006) 
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Region/Gene Primers Temp (°C) 
SNP 
(B/C) 
Enzyme 
Products 
(bp) 
Reference 
HE2: TGATGGAGAGGACAGAAGGG 
HE4: TTGATTCAGAACGAGACGGAC 
55 G/A Cac8I 
B 173, 62 
C uncut 
235 
Igf2 
Igf18: ATCTGTGACCTCTTGAGCAGG 
Igf20: GGGTTGTTTAGAGCCAATCAA 
58 ? Tsp509I 
B 180, 20 
C 165, 20, 
15 
(Thorvaldsen et al., 2006) 
Snrpn 
Sn1: CTCCACCAGGAATTAGAGGC 
Sn3: TATAGTTAATGCAGTAAGAGG3 
Probes: Mut GAAGCATTGTAGGGGAAGAGAA 
-FL 
Anc RED640- 
GGCTGAGATTTATCAACTGTATCTTAGGGTC 
65 C/T N/A, real-time PCR (Mann et al., 2003) 
Gtl2 
Gtl3: CCAAAGCCATCATCTGGAATC 
Gtl4: CAGCCCTGTGAGGTAGGAAC 
55 T/? SfcI 
B 250, 87 
C uncut 
337 
(Mann et al., 2003) 
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Region/Gene Primers Temp (°C) 
SNP 
(B/C) 
Enzyme 
Products 
(bp) 
Reference 
Dlk1 
Dlk2up: CTGGCTTTCTTCCCGCTGGAC 
Dlk317dn: GACACAGCCAGGGGCAGTTA 
54 T/C DraIII 
B 212, 104 
C uncut 
316 
Modified from (Hagan et 
al., 2009) and Jimenez, 
unpublished 
Atp7a 
ATP7A FOR: GCCGCTTCATCTGTCTCTGTAG 
ATP7A REV: GCAGCACATTAGCAACTTCTAAC 
60 ? HpyCh4III 
B 315,232, 
47 
C 315, 279 
Mann et al. unpublished 
157
 
 
 
Table 7 Other PCR primers and conditions 
Gene and reference Primers Temp (°C) Reference 
Gapdh 
Gapdh F1: ATCACTGCCACCCAGAACAC 
Gapdh R1: ATCCACGACGGACACATTGG 
55 (Mann et al., 2003) 
Essrb 
Esrrb-c286f: ACTCTGCATCCCGGACCCCC 
Esrrb-c473r: GCGTGGGTGCTCAGGGCAAT 
55  
Eomes 
mEomes-F: GTGACAGAGGACGGTGTGGAGG 
mEomes-R: AGAGGAGGCCGTTGGTCTGTGG 
55 Modified from (Strumpf et al., 2005) 
Cdx2 
Cdx2f: CTGCGGTTCTGAAACCAAAT 
Cdx2r: CACCATCAGGAGGAAAAGTGA 
55 Vigneau, unpublished 
Fgfr2 
Fgfr2-F: GACAAGCCCACCAACTGCACC 
Fgfr2-R: CGTCCCCTGAAGAACAAGAGC 
55 (Strumpf et al., 2005) 
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Table 8 Antibodies 
Antibody (Ab) Protein size 
Western dilutions 
ChIP 
Primary Ab Secondary Ab 
Histone H3 (Millipore 06-755) 17 kD 1:1000 Rabbit 1:5000  
Histone H3 (Abcam ab1791) 17 kD 1:1000-1:5000 Rabbit 5 µg (5µl) 
AcH3 (Millipore 06-599) 17 kD 0.01-0.05 µg/ml (1:2000-1:10000) Rabbit 5 µg (5µl) 
H3K4me2 (Millipore 07-030) 17 kD 1:2000-1:10000 Rabbit 5 µl 
H3K4me2 (Abcam ab11946) 17 kD 1 µg/ml (1:1000) Goat 5 µl 
H3K4me3 (Abcam ab8580) 17 kD 1 µg/ml (1:200-1:600) Rabbit 5 µl 
H3K9me2 (Millipore 07-441) 17 kD 1:500 Rabbit 5 µl 
H3K9me3 (Millipore 07-442) 17 kD 1:500 Rabbit 5 µl 
H3K27me3 (Abcam ab6002) 17 kD 1:500 Mouse 5 µl 
AcH4 (Millipore 06-866) 10 kD 1:2000 Rabbit 5 µl 
H4K20me3 (Millipore 07-463) 10 kD 1:500-1:2000 Rabbit 5-10 µl 
α-TUBULIN, Clone DM1A (Sigma T 
6199) 
50 kD 0.5-1 µg/ml (1:1000-1:2000) Mouse 1:2000-1:10000  
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MBD1 (M-254) (Santa Cruz Sc-10751) 83 kD, 2-3 bands 1:200 (1:100-1:1000) Rabbit  
MBD1 (B-5) (Santa Cruz Sc-25261) 80 kD, 2 bands 1:100-1:500 Mouse 1:500-1:1000 10 µl 
MBD2 (Millipore 07-198) 48 kD 
1-4 µg/ml 
1:250-1:1000 
Sheep 1:500-1:1000 5-20µl, not working 
MBD3 (C-18) (Santa Cruz Sc-9402) 34 kD, 2 bands 
1 µg/ml 
1:200 (1:100-1:1000) 
Goat 1:5000 20 µl 
MBD3 (Abcam ab3755) 35 kD 1:1000 Rabbit 1:1000 5 µl, not working 
Kaiso, clone 6F (Millipore 05-659) 97 kD 0.5-2µg/ml (1:500-1:1000) Mouse 1:5000 Not working 
Kaiso (12H) (Santa Cruz, Sc-23930) 97 kD 1:200 (1:100-1:1000) Mouse 1:2000-1:3000 10 µl 
NP95 (Abcam ab22235) 90 kD 1:1000 Rabbit 1:5000  
ZFP57 (Abcam ab45341) 70 kD, 2 bands 1:1000 Rabbit 1:3000 5-10 µl 
CTCF (BD C39220) 140 kD 1:500 Mouse 1:1000  
CTCF (Millipore 07-729) 130 kD, 2 bands 1:1000 Rabbit 1:3000-1:5000 5-7.5 µl 
CTCF (Abcam ab70303) 130 kD, 2 bands 1:2500-1:10000 Rabbit 1 mg 
SMC1 (Bethyl A300-055A) 160 kD 1:1000 Rabbit 1:2500-1:5000 5 µl 
RAD21 (Bethyl A300-080A) 130 kD, 2 bands 1:500 Rabbit 1:5000 5-7.5 µl 
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Secondary antibodies: anti-Goat HRP (Jackson 705-035-003); anti-Mouse HRP (GE NA931); anti-Rabbit HRP (GE NA934); anti-Sheep 
HRP(Millipore 12-342) 
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Table 9 shRNA sequences 
Name Oligos (the hairpin sequences are underlined) Reference/Tool Stock/Note 
Ctcf 
Scrambled 
5’-CCGG GGCTTCGGAAATCAGTCCATACGTA CGAA 
TACGTATGGACTGATTTCCGAAGCC TTTTTG-3’ 
5’-AATTCAAAAA GGCTTCGGAAATCAGTCCATACGTA TTCG 
TACGTATGGACTGATTTCCGAAGCC-3’ 
(Invitrogen) Plasmid, bacteria 
Ctcf 343 
5’-CCGG G ACATGCAGATAACTGTGCTGGTCCA CGAA 
TGGACCAGCACAGTTATCTGCATG TTTTTG-3’ 
5’-AATTCAAAAA CATGCAGATAACTGTGCTGGTCCA TTCG 
TGGACCAGCACAGTTATCTGCATGTC-3’ 
Invitrogen Stealth siRNA 
Ctcf-MSS2033343 
Plasmid, bacteria, 
viruses 
Ctcf 178 
5'-CCGG GCGAAGAATGACCACAAATCT TCAAGAG 
AGATTTGTGGTCATTCTTCGC TTTTTG-3' 
5'-AATTCAAAAA GCGAAGAATGACCACAAATCT CTCTTGA 
AGATTTGTGGTCATTCTTCGC-3' 
(siRNA Wizard) 
Plasmid, bacteria / 
Not working 
Ctcf 1323 
5’-CCGG GCGGCATCGTCGTTATAAACA CTCGAG 
TGTTTATAACGACGATGCCGC TTTTTG-3’ 
5’-AATTCAAAAA GCGGCATCGTCGTTATAAACA CTCGAG 
TGTTTATAACGACGATGCCGC-3’ 
(Yuan et al., 2004) 
Plasmid, bacteria, 
viruses 
162
 
 
 
Ctcf 1717 
5’-CCGG G TGTCGCTACTGTGATGCTGTTCAAGAGA 
CAGCATCACAGTAGCGACA TTTTTG-3’ 
5’-AATTCAAAAA TGTCGCTACTGTGATGCTG TTCAAGAGA 
CAGCATCACAGTAGCGACA C-3’ 
(GenScript) 
Plasmid, bacteria, 
viruses 
Smc1 158 
5'-CCGG GGCCAAGCTAGTGATTGATGTAATT CGAA 
AATTACATCAATCACTAGCTTGGCC TTTTTG-3' 
5'-AATTCAAAAA GGCCAAGCTAGTGATTGATGTAATT TTCG 
AATTACATCAATCACTAGCTTGGCC-3' 
Invitrogen Stealth siRNA 
Smc1a-MSS216158 
Plasmid, bacteria, 
viruses 
Smc1 159 
5'-CCGG G TCAAAGCTCGTAACTTCCTCGTCTT CGAA 
AAGACGAGGAAGTTACGAGCTTTGA TTTTTG-3' 
5'-AATTCAAAAA TCAAAGCTCGTAACTTCCTCGTCTT TTCG 
AAGACGAGGAAGTTACGAGCTTTGA C-3' 
Invitrogen Stealth siRNA 
Smc1a-MSS216159 
Plasmid, bacteria, 
viruses 
Smc1 160 
5'-CCGG GATGCACGAATTGACCGACAGGAGA CGAA 
TCTCCTGTCGGTCAATTCGTGCATC TTTTTG-3' 
5'-AATTCAAAAA GATGCACGAATTGACCGACAGGAGA TTCG 
TCTCCTGTCGGTCAATTCGTGCATC-3' 
Invitrogen Stealth siRNA 
Smc1a-MSS216160 
Plasmid, bacteria, 
viruses 
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Smc1 2337 
5’-CCGG GGGCCTCGCATTAATGATATC CTCGAG 
GATATCATTAATGCGAGGCCC TTTTTG-3’ 
5’-AATTCAAAAA GGGCCTCGCATTAATGATATC CTCGAG 
GATATCATTAATGCGAGGCCC 
(Yuan et al., 2004) 
Plasmid, bacteria / 
Not working 
Rad21 9 
5'-CCGG G CGGAATGGATGACCGTGAA CTCGAG 
TTCACGGTCATCCATTCCG TTTTTG-3' 
5'-AATTCAAAAA CGGAATGGATGACCGTGAA CTCGAG 
TTCACGGTCATCCATTCCG C-3' 
Dharmacon RAD21 ON-TARGET 
plus siRNA-J-058531-09 
Plasmid, bacteria, 
viruses 
Rad21 12 
5'-CCGG GGAAGAAGCTTTTGCGTTG CTCGAG 
CAACGCAAAAGCTTCTTCC TTTTTG-3' 
5'-AATTCAAAAA GGAAGAAGCTTTTGCGTTG CTCGAG 
CAACGCAAAAGCTTCTTCC-3' 
Dharmacon RAD21 ON-TARGET 
plus siRNA-J-058531-12 
Plasmid, bacteria, 
viruses 
Rad21 1060 
5’-CCGG GCCCAGCTTAGCGATTATTCT CTCGAG 
AGAATAATCGCTAAGCTGGGC TTTTTG-3’ 
5’-AATTCAAAAA GCCCAGCTTAGCGATTATTCT CTCGAG 
AGAATAATCGCTAAGCTGGGC-3’ 
(Yuan et al., 2004) 
Plasmid, bacteria / 
Not working 
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